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Pollution, most particularly air pollution, is receiving 
a great deal of attention in the United Kingdom at 
the moment. However, tackling pollution (in all its 
forms) has not been foremost in the minds of health 
policy makers in recent years. It has been the role of 
public health professionals of all disciplines, and the 
wider public health workforce, to guard the public 
from the health impacts of pollution.
I chose to address pollution in this, my ninth, 
annual report because I believe it is time for policy 
makers to take seriously the threat to health 
posed by pollution, and therefore to understand 
that addressing pollution is disease prevention. 
Everyone understands that acute exposure to a 
toxic substance will cause ill-health. Lesser known, 
and understood, is the relationship between 
longer-term, lower level exposure to pollutants. 
We already know there is a link in some instances: 
think of the opportunities to improve health that 
may be at our ingertips if we can better integrate 
socio-demographic, health and environmental 
data – using this to better understand these threats.
And who will beneit from this? Clearly we will 
all beneit but those dedicated to reducing health 
and environmental inequalities may take particular 
interest in Chapter 6 of this report, ‘Pollution and 
inequality’.
I would like to see all forms of pollution at the 
forefront of professional and public attention. 
I hope this report helps to inform the conversation.
Prof Dame Sally C Davies
Foreword
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Chapter 1
Introduction
* Deinition adapted from https://www.chemicalsafetyfacts.org/ 
As Chief Medical Oficer for England I have a statutory 
duty to produce an annual report on the state of the 
public’s health. These reports – like me – are independent 
of Government, and call on stakeholders across the policy 
spectrum to make changes that will improve our health. They 
draw on the expertise of the Chapter Leads – preeminent 
academics and practitioners in their ields – who come 
together to give their views and inform my independent 
recommendations. I am grateful to them all for their help.
This year I have chosen to focus my report on the impact of 
pollution on human health.
Pollution affects everyone, every day. Our children are 
affected by noise pollution from roads near their schools; 
our houses are washed with light pollution every night; we 
are exposed to chemicals in the almost invisible dust in our 
houses. There are no aspects of our life that do not have the 
potential to be impacted by pollution. Most pollutants are 
by-products of actions and processes of society. The social 
and/or economic beneit of these processes may at times 
outweigh the generally low risk they pose to human health. 
There are some pollutants, however, which have either been 
shown to have a signiicant negative impact on human health 
or have limited evidence associated with them that implies 
this is possible.
Use of ‘Risk’ and ‘Hazard’ in this report
‘Hazard’ refers to the inherent properties of a substance 
that make it capable of causing harm to a person or the 
environment.
‘Risk’ is the possibility of a harm arising from a particular 
exposure to a substance, under speciic conditions.* 
On researching this report I expected to ind many concrete 
actions oficial bodies could take to reduce the impact of 
pollution on the public’s health. I have been surprised by how 
little we know about many of the common pollutants that 
surround us each day. There are some areas where we do 
know enough to act, and here we should do so with urgency. 
The chapters that follow contain numerous suggestions 
from experts for policy makers and oficials. I make my 
recommendations in this chapter.
Overall, I have been struck by the lack of evidence we have 
in this ield. This is not for want of trying on behalf of 
academics and practitioners. At the moment we do not have 
the systems in place to effectively monitor, understand, and 
act on data about the health impacts of pollution. The clarion 
call from this report is therefore to create these systems so 
that we can determine effective actions. As I will set out, 
this will require a conceptual shift: we must start to address 
pollution as disease prevention. And we must consider the 
impact on human health of all of the different singular 
pollutants alone AND in combination with others, over short 
AND over long-term periods.
First – some context. I became Chief Medical Oficer in 
2011, and pollution has featured in most of my reports. For 
example, in my irst surveillance report, published in 2012, 
I highlighted the World Health Organization’s inclusion 
of urban air pollution among the top ten risk factors 
for mortality in the UK. This should come as no surprise 
to the public health profession as we have our roots in 
environmental health. The early public health professionals in 
the nineteenth century set out to uncover the environmental 
causes of diseases and ind solutions to improve our 
ancestors’ health. 
This era saw great change to the way our society and built-
environment was structured, in order to improve health. 
The sweeping sanitary reforms and public works of the 
mid-nineteenth century are the basis of modern sanitation 
and drinking water systems, for example. This progress 
continued into the mid-twentieth century, with signiicant 
pieces of legislation such as the 1956 Clean Air Act which 
inally banished the infamous smog of UK cities. These 
achievements remain some of the biggest successes that we 
have had in improving the public’s health.
That is the past. Now the question for all of us working 
to improve the public’s health –must be: is our modern 
approach to pollution working?
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Purpose and remit of this report
Purpose
I intend my report to bring political, policy and health system 
attention to pollution as a threat to the public’s health, 
both at acute exposure but also at lower-level, longer-term 
exposure. I want to emphasise the role pollution plays in 
non-communicable diseases (NCDs) and recommend means 
to better understand and tackle this threat; we can structure 
our research and public sector organisations to look at the 
whole spectrum of pollution holistically. 
Remit
My reports cannot cover every aspect of a topic, to do so 
they would be unmanageably large. I have therefore placed 
a number of parameters around the report remit in order to 
make the scope of this report manageable and to ensure the 
recommendations I make are achievable. 
This report focuses on the direct impact of pollution on 
human health. This relects my role as Chief Medical Oficer. 
I do take a ‘one health approach’, which recognises that 
human illness, and the lora and fauna that surround us, can 
be closely linked. Whilst this report covers some pollutants of 
concern to environmental policy colleagues, other pollutants 
that concern them are not addressed.
Pollution is at once intensely personal, rooted in the 
experience we all have of our own lived environments, 
but also global in scale, with pollutants moving across 
international borders. This is why pollution is becoming 
established as a priority for the international community. The 
United Nations’ Sustainable Development Goals – the SDGs, 
(also known as the Global Goals), contain speciic targets for 
member states to substantially reduce the number of deaths 
and illnesses from hazardous chemicals as well as air, water, 
and soil pollution and contamination by 2030. My report is 
cognisant of this interconnected world, but focused on the 
people and pollutants in England.
Climate change is a very serious issue and whilst I recognise 
there are links between climate change and pollution, this 
report does not examine these issues. I stress, however, that 
I am of the view that greenhouse gasses are pollutants and 
likely pose long-term health threats. 
Chapter title
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Changing how we think about pollution
*  Adapted from ‘A Dictionary of Epidemiology’,edited by Miquel Porta, Oxford University Press, 2014.
** I also note the growing evidence that pollution, notably air pollution, increases risk of infectious disease – although currently the magnitude of this impact is smaller than that of NCDs
Pollution
Any undesirable modiications of our human environment 
including air, water, soil, and food by substances that are 
toxic or may have adverse effects on health – or that are 
offensive even if not necessarily harmful to health.*
Since the mid-twentieth century, pollution has slipped down 
the agenda as a public health issue. This was driven, in 
part, by the eradication of many of the contaminants with 
the most visible health impacts, with the remaining ones 
harder to elucidate. We also now face competing threats 
to our health, such as the obesity epidemic and declining 
physical activity levels. These threats are real and must be 
addressed. However, this has all resulted in a position where 
the impacts on human health of most pollutants are not fully 
understood, particularly where they act in concert. Instead of 
being seen as a health issue, pollution is often seen primarily 
as an environmental problem. This needs to change. As a 
society we need to regain a focus on pollution as a threat to 
human health.
By-and-large, pollution is currently thought of as an acute 
health threat: something which elicits a negative health 
response following a ‘dose’ of exposure. We think of 
pollutants as rapid poisons, rather than long-term risk 
factors for a variety of diseases. However this is not the case; 
evidence shows that many pollutants are risk factors for a 
range of NCDs such as cardiovascular disease, cancer, asthma, 
and chronic obstructive pulmonary disease.** We need to 
investigate the longer-term impacts of lower-level pollution 
exposure; this exposure is likely to have a signiicantly 
deleterious impact at a population level due to the extent of 
the exposure. Pollution should be recognised for what it is: a 
signiicant cause of NCDs. Addressing pollution is therefore 
disease prevention.
Recommendation 1
I recommend that Public Health England convene a 
Programme Board to co-ordinate government action to 
reduce the contribution of pollution to non-communicable 
diseases. This Board should include representation from 
Environment Agency and should be supported by the 
Government Expert Scientiic Advisory Committees.
We must consider the health impacts of all pollutants, 
addressing them proportionately to our best understanding 
of the risk. A step beyond focusing on the full suite of 
pollutants that we are exposed to, is considering how we 
are exposed to them. Pollution mixtures are the norm – be it 
chemical mixtures or cross-media mixtures. 
The UK Government’s publication, ‘A Green Future: Our 
25 Year Plan to Improve the Environment’ sets a vision – from 
‘the environment’s perspective’.
Recommendation 2
I recommend that the UK Government fulils its promise to 
publish a chemicals strategy, and that this strategy takes full 
account of the human health impacts of chemicals, including 
chemical mixtures.
As well as contributing to and causing NCDs, pollution 
contributes to inequalities. Health inequality remains one 
of the great social injustices in England today. There is both 
growing evidence and consensus that deprived groups in 
England are exposed more to pollution (notably air pollution), 
whilst certain groups – those with existing underlying medical 
conditions, the young and old, and others – likely face a 
greater health impact from pollution exposure. We must 
account for pollution within the health inequalities agenda 
and address and plan to prevent/ reduce pollution in the 
context of equality and fairness.
Vulnerable groups, such as young children, the elderly, 
those with underlying medical conditions and others, are at 
a disproportionately high risk from poor air quality. These 
groups can suffer large health burdens, and children, for 
example, can have lifelong poor health outcomes attributable 
in part to pollution exposure. I commend work to protect 
these groups, such as the work underway in London to 
improve air quality around schools currently exposed to the 
highest levels of air pollution in the city.
Recommendation 3
I recommend the Greater London Authority commission, and 
Public Health England support, the evaluation of the health 
and health economic impact of action taken in response to 
Mayor of London commissioned audits designed to improve 
air quality near schools in London.
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Acting where we can
There are pollutants where the evidence of their health 
impact is reasonably strong, often (but not always) where it 
has been easiest to measure. Where the evidence is strong 
that there are negative health consequences and evidence 
of effective interventions to address it, this action should be 
continued and accelerated. In other areas, where there is 
evidence of health impacts but not of the effectiveness of 
interventions to reduce this, then we must act to develop 
the latter.
Recommendation 4
Local government holds authority over local planning and 
infrastructure, and has expertise such as environmental health 
and public health colleagues. It can take powerful action to 
address and avoid negative health impacts from pollution. 
Local government and public health professionals in particular 
must seize this opportunity to improve the health of their 
local population by implementing concrete, evidence based 
actions to address pollution.
Recommendation 5
I recommend that in order to prevent ill health, local 
authorities need to broaden current environment strategies 
(e.g. those which may or may not cover NOx or noise); these 
strategies should be cognisant of all forms of pollution, 
and consider risk at both consistent low-level exposure and 
intermittent high level exposure.
Recommendation 6
I recommend that Public Health England supports local 
authorities’ response to the health impacts of all pollutants by 
making available:
a) up to date evidence on the health impacts of pollution 
and
b) toolkits to assist with Local Authority actions to avoid or 
ameliorate pollution.
Recommendation 7
I recommend that the potential impact of all relevant forms 
of pollution upon human health should be considered at all 
stages of local authority planning, considering risk at both 
consistent low-level exposure as well as intermittent high level 
exposure.
Outdoor air pollution has recently attracted a great deal of 
attention from media, scientists and policy professionals. 
Although there are great uncertainties over the exact extent, 
the evidence indicates a signiicant negative impact on 
human health (see Annex 1). This is, therefore, an example 
of where we must act, and where we know much of what 
will work. We need to roll out and embed into routine use 
actions that we know will improve health; evaluate and 
explore new ways to act (box 1) – not missing out on the 
opportunities for natural experiments as action is taken; and 
ill evidence gaps.
I welcome the government’s national standards for air 
pollution. Currently these standards are being breached. The 
Government’s NOx plan is a good overall document but as it 
is aimed at local authority level, it may
a) be implemented inconsistently,
b) contribute to inequality, and
c) contribute to complexity of local regulation for drivers.
Recommendation 8
I recommend that future UK government national standards 
for air pollutants, developed within the next ive years, should 
be increasingly stringent and driven by an ambition to protect 
human health.
Recommendation 9
I recommend that Department for Transport should agree 
with local authorities standardised mechanisms and protocols 
for surveillance and road charging (if introduced), such that 
a) health data and local authority data may be better 
integrated; and
b) vehicle drivers experience a simple system with 
consistency across England.
We must further expand this focus to indoor air. Work to 
gather evidence of health impacts, raise awareness of any 
harm and highlight actions to address this is needed, just 
as the Royal College of Paediatrics and Child Health/Royal 
College of Physician Working Group on indoor air quality and 
child health proposed.
Recommendation 10
I recommend that Department for Environment, Food and 
Rural Affairs investigate the availability and quality of (low 
cost) indoor air pollution monitors, publishing their results, 
in order to support the public’s use of home air quality 
monitoring equipment.
Chapter title
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Box 1  Solar-Assisted Large-Scale Cleaning System (SALSCS) for Urban PM
2.5
 Mitigation
 Professor David Y. H. Pui, University of Minnesota
A Solar-Assisted Large-Scale Cleaning System (SALSCS) is 
an emerging method used for air quality abatement – or 
to clean polluted air. In these towers, solar heating warms 
the polluted ambient air, drawn in at the base, which rises. 
A ilter bank, placed around the tower entrance, removes 
PM
2.5
 pollutants so that clean air exits from the top of the 
tower (Figure A). By placing the SALSCS near a large city, it 
pulls polluted air in and returns clean air to the city, reducing 
the PM
2.5
 concentration.
Figure A  Schematic diagram of the Solar-Assisted 
Large-Scale Cleaning System 
The irst pilot scale SALSCS in Xi’an, funded by the Shaanxi 
government, aimed to demonstrate the concept (Figure B). 
As well as PM
2.5
 ilters, catalyst-coated glass panels were 
added to reduce gaseous pollutants (for example, NOx). 
Short-term measurements showed PM
2.5
 concentrations in 
the district where the SALSCS was located approximately 
12% below the surrounding districts. This matched the 
projected impact of the SALSCS – based on the airlow 
through the system. Long-term measurements are now 
being conducted. This pilot tower is smaller than those 
proposed in modelling studies – for example its height 
of 60m, compared with proposed 500m towers. Models 
suggest 8 full scale SALSCS units could reduce PM
2.5
 in the 
Beijing urban area by 15% in 30 hours.
Figure B  A night-view of the 1st generation SALSCS 
built in Xi’an, Shaanxi Province (completed 
July 2016)
Further improvements to the SALSCS are being developed. 
A second generation SALSCS at Yancheng Science Park, 
Jiangsu Province uses water-spray droplets to coalesce and 
remove PM
2.5
 particles (Figure C). This gives dual capability, 
removing PM
2.5
 as well as atmospheric CO2 using NaOH 
solution. Its performance is now under evaluation. A 3rd 
generation SALSCS (called ACAN) has been designed and 
is under development. The air low through the ACAN is 
reversed (Figure D). A set of fans draws dirty air from the 
tower inlet and pushes it through the ilters (or water-
spray) located in the base. The clean air will bath the living 
quarters of the residents nearby, beneiting the immediate 
vicinity. The ACAN is intended for more targeted use: by 
placing it in the centre of a set of tall apartment buildings, 
it will promote air recirculation. Computational luid 
dynamics calculations show that more than 50% of the 
PM
2.5
 concentration can be removed within a few hours of 
operation.
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Figure C  The 2nd generation SALSCS built in 
Yancheng Science Park, Jiangsu Province 
(completed September 2017)
The SALSCS technology represents an effective and 
low-cost way to mitigate both PM
2.5
 and CO2, for the health 
and well-being of mankind.
Figure D  Schematic diagram of the 3rd generation 
cleaning system ACAN showing the reverse 
low coniguration
Chapter title
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Chapter 1
There is suficient evidence to say that a number of industries 
and sectors could be asked to take responsibility for the 
pollution they produce and its consequences for human 
health. In my report I have focused on the sector which I 
know best – the health service – and make recommendations 
relevant to both local hospitals and wider policy makers. 
Recommendation 11
I recommend that industry leaders should work to
a) be more transparent about the polluting effect of their 
activities,
b) strive to reduce this effect, using innovative interventions, 
and 
c) bring success and best practice to attention within their 
industry.
My reasons for focusing here are twofold. Firstly, if we are to 
get industries to act on the health impacts of the pollution 
they produce, much of which will be as a result of products 
and processes which we value, then it seems reasonable 
that health professionals and policy makers should lead 
the way and demonstrate all the great progress some have 
made. Secondly, it is the case that the health service in this 
country is a signiicant polluter simply due to its size. There 
is positive action being taken, some led by NHS Sustainable 
Development Unit and some led locally by trail-blazing 
trusts. Some of this is presented as case studies here (box 2), 
particularly in Chapter 2 of this report ‘Pollution from the 
Health and Care System’. The health service causes a lot of 
pollution – it makes sense to strive to reduce this.
To address the health impacts of pollutants the public sector, 
including the health and social care system, should implement 
actions that we already know work (see examples in this 
report). In leading the way, our NHS needs to demonstrate 
action and progress through transparency. 
Recommendation 12
I recommend that 
a) NHS Trusts report progress against their Sustainable 
Development Management Plans in their annual reports, 
supported by publication of all relevant underlying data;
b) Public Health England should aggregate and analyse 
progress annually for a national public report to NHS 
Improvement; and
c) NHS Improvement should review Trusts’ performance and 
recommend remedial action to Trusts, as appropriate.
* http://indepth.nice.org.uk/no-idle-zones-can-help-protect-vulnerable-people-from-air-pollution-says-nice/index.html
Recommendation 13
I recommend that 
a) Clinical Commissioning Groups should analyse local air 
quality monitoring data for breaches of air pollution 
standards, and publish these alongside the local hospital 
data for impacts on admissions for respiratory and 
cardiovascular disease and 
b) Public Health England should aggregate and analyse 
progress annually for a national public report to 
NHS England.
I commend the efforts of Ambulance Trusts to phase out 
diesel vehicles and reduce idling. South Central Ambulance 
Service NHS Foundation Trust is experimenting with 
photovoltaic cells to keep electrical equipment in ambulances 
powered, whilst avoiding idling. Innovation and exploration 
like this should be championed locally and nationally. 
Recommendation 14
I recommend that 
a) Ambulance Trusts should publish annually on their 
progress towards phasing out diesel ambulances, 
including explaining how their routine procurement 
decisions pay heed to National Institute for Health and 
Care Excellence guidance on low vehicle emissions* 
(nitrogen oxides and particles) and
b) Public Health England should aggregate and analyse 
progress annually for a national public report to 
NHS England.
Recommendation 15
I recommend Health Education England convene and lead a 
working group, to include the Royal Colleges and Faculties 
of Health, to ensure that the health impacts of pollution 
are included in curricula for all clinicians in training. The 
group should also ensure the health impacts of pollution 
are included in continuous professional development 
programmes for existing staff.
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Box 2  Nottinghamshire Healthcare NHS 
Foundation Trust
Lynn Richards, Energy and Environmental 
Manager and Sustainability Advisor, NHFT
Nottinghamshire Healthcare NHS Foundation Trust 
is committed to reducing the environmental impact 
associated with its service delivery and seeks to 
provide healthcare which is truly sustainable. Each 
year performance in key areas such as waste, energy, 
procurement and travel is monitored and progress is 
reported in the Trust’s Annual Report.
Our environmental objectives and targets are contained 
within the Trust’s Sustainable Development Management 
Plan (SDMP). In response to organisational change, making 
signiicant progress against the existing plan, and updated 
guidance from the NHS Sustainable Development Unit, 
incorporating the United Nations Sustainable Development 
Goals, the SDMP is currently being reviewed to make sure 
it accurately relects the ambitions of the Trust.
Within the Estates and Facilities Directorate, the Trust 
holds accreditation to ISO14001:2004 the internationally 
recognised environmental standard. This ensures that we 
set environmental objectives, meet compliance obligations, 
and make a commitment to the protection of the 
environment, and to the prevention of pollution. 
The Trust has a network of staff Green Champions, 
and with their support we actively undertake projects 
and engage with local and national campaigns, such as 
National Clean Air Day and Fairtrade Fortnight. These help 
to promote behaviour change both within and outside of 
the work environment, maximising the positive effects. 
The Trust has won awards for its environmental projects, 
for example for the Ray Crampton Energy Centre at 
Rampton Hospital. Not only has this helped to reduce the 
Trust’s carbon footprint and costs but it has also improved 
resilience and local air quality, as the site no longer needs 
to burn coal.
Box 3  City of York Council – a holistic 
approach to reducing pollution 
Mike Southcombe, Public Protection Manager, 
City of York Council
City of York Council takes a holistic approach to reducing 
pollution from all sources; examples of this are its’ One 
Planet York initiative and being the irst council to adopt a 
holistic Low Emission Strategy (LES) with policies to reduce 
both carbon and other pollution.
Planning applications are reviewed for contaminated land, 
air quality, noise and other pollution to mitigate the impact 
of new developments on people’s health and environment. 
Our contaminated land and low emission planning policies 
have been adopted by others to help developers to 
reduce pollution. York regulates pollution from industry 
and has written guidance to control noise from licensed 
premises and events, with an out of hours service to deal 
with complaints.
York is at the forefront of developing policies to achieve 
the health-based air quality objectives, hence being 
awarded Ultra Low Emission City status. An extensive 
Pay As You Go electric vehicle charging network, funded 
by grants and a green charity, meant York was an early 
adopter of electric vehicles. A taxi incentive scheme 
coupled with an emission based taxi licensing policy has 
resulted in 15% of York’s taxis being low emission (petrol 
hybrids). York’s citywide monitoring network (and several 
feasibility studies) enables an evidence based approach 
to air quality strategy and planning and led to the use of 
electric buses and the concept of a bus based Clean Air 
Zone (CAZ) in the city centre; the CAZ is currently out for 
consultation. Anti-idling policies were approved recently 
and follow on from public awareness-raising of the health 
impacts of air pollution, working with local universities, 
business and the public, including participation in National 
Clean Air Day.
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Chapter 1
Gathering data where we cannot act with certainty
*  Deined as chemicals contained in everyday consumer products
Unfortunately we do not currently understand enough about 
many pollutants to be certain whether they impact negatively 
on human health, especially at low to moderate levels with 
long-term exposure. We understand less still about what 
action we could take to ameliorate any harmful effects 
on health.
Some of these pollutants have been in our environment 
for centuries but have never had data collected about their 
health impacts. Additionally, new techniques can reveal 
previously unknown negative health impacts. I argue that 
we have not thought enough about the impact of multiple 
pollutants at low exposure across a long period or in relation 
to long-term health impacts (namely NCDs). Some pollutants 
are only just emerging; for example newly synthesised 
chemicals, new technologies such as nanoparticles and the 
potential harms from chemicals in products.* Chapter 4 of 
this report, ‘New horizons’, addresses some of the newer 
substances we need to consider as potential pollutants.
Recommendation 16
I recommend Public Health England investigate the creation 
and funding of a mechanism to synthesise evidence 
concerning the health impacts of all pollutants, and publish 
evidence-based statements on the health impacts of these 
pollutants in England.
Throughout this report, data, information and evidence are 
apparent as vital resources to address the health impacts 
of pollution, and priority areas for improvement. Data has 
emerged as a central theme in my previous annual reports 
– obviously in genomics but also in the metrics that we 
use to monitor issues such as mental health. The data and 
information revolution is happening across biomedicine 
and has the potential to improve the health of the public. 
Pollution and human health is no different: we have a 
real opportunity to capitalise on the use of data to better 
understand these health impacts.
Facilitated by new, especially mobile, technologies, there has 
been a recent growth in citizen science. This has a role in data 
collection and knowledge generation around the impacts of 
pollution on human health. Quality and standards of data 
collection must, however, be maintained to give reliable and 
useful data.
Recommendation 17
I recommend that UK Research and Innovation consider a 
health-related pollution topic for one of its irst, national 
Citizen Science endeavours.
There are two distinct, albeit inter-related, types of data 
of the health impacts of pollution (Figure 1.1) that can be 
improved through integration of different pieces of data;
a) Static research data – helps us to gain knowledge about 
health harms from pollution and; 
b) Surveillance data – allows the monitoring of known 
threats and for signals of new threats. 
Achieving this data integration will not be easy, but they 
would greatly help our understanding of, and ability to tackle, 
the health impacts of pollution.
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Figure 1.1 The relationship between research and surveillance dataset covering the health impact of pollution
Source Andrew R H Dalton
It is easy, of course, to agree that we should have high-
quality data used in a joined-up way – but what does this 
actually mean? Firstly, we need to integrate existing data 
and ensure wherever possible this is available open source. 
We need to use health data with a wider range of health 
outcome. In other words, not just focusing on mortality, 
but using data that capture the full health consequence of 
pollution on morbidity, mental health impacts, and impacts 
on quality of life. We need to collect new types of data, such 
as biomarkers and those relating to genetic susceptibilities. 
We need to develop bespoke statistical and research 
methods to mine these data. And we need to have access to 
surveillance data in real time, allowing us to act to improve 
health, identify vulnerable groups, and give insight into 
emerging issues. 
It is clear: the evidence base around the health harms 
caused by many individual pollutants is not strong. Many of 
the professionals I spoke to when researching this report, 
however, raised real concerns about pollutants; and we must 
remember that the absence of evidence is not evidence of 
absence. To me this highlights the need for better systems 
of monitoring and surveillance across a range of different 
pollutants. 
These data systems will build resilience to the new, currently 
unknown pollution threats, and impacts on human health. 
They will help to ill knowledge gaps highlighted in my 
report, such as the impacts of light pollution on human 
health. I note there is increasing public and policy concern 
about the impact of computer/smartphone screen use, and 
‘blue light’, upon human health. Research is on-going and 
this is an important area of investigation, particularly given 
children’s use of social media via smartphones, increasing 
their exposure to potential risk.
Recommendation 18
I recommend that Public Health England works to bring 
together all of the routinely produced data on the health 
impacts of pollution and the surveillance of pollution 
(including data held by local authorities, the Environment 
Agency and others), to ensure availability for the public, 
public sector and researchers.
Recommendation 19
I recommend Public Health England develop and embed a 
formal, structured programme of surveillance on the health 
impacts of pollution and regularly publish indings.
Recommendation 20
I recommend Public Health England explore the creation of 
an English health bio-monitoring data set, which includes 
human exposure to pollutant and health outcomes, and 
report publicly on their indings.
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Chapter 1
Changing the ways we work and do research
Trans-disciplinary working and research
Across the response to the health impacts of pollution 
and in all areas where action can be taken, I encourage 
consideration of the framework I suggest for pollution above. 
Action to reduce pollution is action to prevent ill health. 
Whilst it is always good for policy makers to think and then 
work in a joined-up way and multidisciplinary way, pollution 
is so complex that here it is an imperative (exempliied by 
the multi-faceted, successful response to lead pollution – see 
Box 4).
As well as changing how we think about pollution, and the 
data we gather, we also need to think about the way in 
which health professionals and researchers work. Aligned 
to the data issues explored above, we need more linked-
up, trans-disciplinary research. Until now researchers into 
the health impact of pollution found they do not it into 
funding structures. Too often these structures follow an 
old framework, with pollution being considered as an 
environmental hazard rather than as a broader health 
issue. As an example, if pollution is a driver of NCDs 
(as demonstrated for air pollution) then researchers in 
this ield should be able to easily apply for biomedical 
research funding.
Research is often funded and organised in terms of the 
methodology or research tradition. This will not be enough 
to understand the health impacts of pollutants: this is 
going to need evidence from different disciplines, including 
epidemiology and toxicology. Researchers need to be 
supported to work in trans-disciplinary ways, examining the 
health impacts of pollutants. Once the systems are in place, 
the researchers and research disciplines must work together 
in order to ill these evidence gaps. Different disciplines 
working on the same pollution problem, then synthesising 
these different type of information, will be the best way 
to answer the question of what the health impacts are. I 
believe that the new UK Research and Innovation (UKRI) will 
support a more trans-disciplinary research landscape: this 
must beneit work to understand the human health impacts 
of pollution. Shifts in funding, attitudes, and structures 
are required at the university level too if we are to fully 
understand the health impacts of pollution.
Recommendation 21
I recommend that UKRI convene a working group on the 
integration of health and pollution data. The Group should
a) include Health Data Research UK, other relevant bodies, 
and government Chief Scientiic Advisers;
b) review existing data coverage; review methodologies for 
linkage of data sets; and explore new opportunities for 
joined up data; and 
c) ensure data reviewed includes, as a minimum, data 
concerning the health impacts of pollution, socio-
demographic data and pollution data.
Recommendation 22
I recommend research funding and structures should be put 
in place which encourage research on the long-term impacts 
of low-levels of pollutant exposure on human health. These 
research structures should facilitate focused multi-disciplinary 
research into health and pollution.
Communication
Through all of this, there needs to be better communication 
with the public about the extent to which we understand 
health risks, what these risks are (including risk factors for 
NCDs), and what can be done. There are many skilled people 
working hard on this agenda already. Further, communication 
around pollution and health does not need to reinvent the 
wheel; we can draw on many other ields to understand what 
works. Relative risks can be challenging for some people to 
understand, and many of us remain under-equipped to make 
fully informed decisions about pollution with regards to their 
and their families’ health. Public health professionals play a 
key role in describing risk levels to local pollutions in layman’s 
terms, whether to allay fears or warn of unsuspected harms. 
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Box 4  Lead pollution – a pollution success 
story
Prof Roy Harrison, University of Birmingham
Lead was long recognised as a substantial hazard for 
workers in the lead industry – with limits enforced. In the 
1960s epidemiological studies revealed that exposure to 
lead at environmental concentrations, far below those 
experienced in industry, were leading to impaired IQ 
development in children. 
Lead is a multi-media pollutant with signiicant pathways 
for exposure through:
  The atmosphere. By far the greatest respiratory 
exposure for the majority of the population arose from 
emissions from road trafic.
  Drinking water. Although most sources of drinking 
water were low in lead, lead could be picked up in 
the distribution system, especially from household 
lead pipes.
  Soil and dust. Urban and roadside soils were heavily 
contaminated with lead, largely due to emissions 
from road trafic. Indoor dusts could also be heavily 
contaminated by outdoor dusts and from leaded 
paintwork. Old paints frequently contained a very high 
lead content, leading in some cases to clinical symptoms 
of poisoning in exposed children.
  Food. Foodstuffs contained lead from a range of 
sources, most notably atmospheric deposits to food 
crops and the use of leaded solders in cans. 
Faced with many exposures, the response had to be 
multifaceted. In 1985, the maximum lead content of 
petrol was reduced and the subsequent introduction 
of unleaded petrol led to a huge decline in airborne 
lead concentrations. Drinking water from sources most 
liable to dissolve lead was treated prior to distribution to 
suppress lead solubility, which together with widespread 
replacement of leaded pipework, led to a substantial 
reduction in drinking water lead concentrations. Limits 
were introduced on the lead content of paints. The use of 
lead in food cans was phased out, and this together with a 
reduced input of lead into unprocessed foodstuffs led to a 
dramatic fall in dietary exposures.
Lead levels in soils and dusts have responded slowly to 
these actions. 
As a result, population blood leads have fallen dramatically, 
as have cases of clinical poisoning. Blood lead levels in UK 
children fell from 140-360 µg L-1 in 1964 to around 37 µg 
L-1 in 1991-2 and have fallen further since.
The recognition of the wide range of sources of lead 
exposure coupled with the implementation of strong 
mitigation measures were the key to the resolution of this 
major public health issue.
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Chapter 1
Summation and chapter summaries
Below I summarise the contents of each chapter of my report.
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Summary of Section 1 ‘21st century threats’
* WHO 2017 Environmentally sustainable health systems: a strategic document
** WHO Europe 2017, Sixth Ministerial Conference on Environment and Health
Chapter 2  Pollution from the health and care system
Chapter 3  21st century chemicals
Chapter 4  New horizons
Instead of listing the traditional media where pollution 
is found, air, water, land etc. and their associated health 
impacts, this section presents a number of the threats from 
pollution that we currently face and potential solutions. We 
explore the polluting impact of healthcare as an example and 
how the NHS can be part of our answer to reduce pollution. 
We are faced with changing chemical threats and we explore 
some of the newer – and potential future – threats from 
pollution.
Chapter 2  Pollution from the health and care system
As presented throughout Chapter 2, our healthcare system, 
the NHS, is a source of pollution. Our duty of care to our 
patients has, to date, not extended to how we run our NHS 
in terms of the health impact of its pollution footprint. This 
concept of environmentally sustainable health systems has 
recently gained greater international focus.*,** WHO guidance 
echoes key themes presented in Chapter 2: minimising waste, 
using eficient procurement, prioritising prevention, and 
others. These are all required to switch the health system 
from having a negative to a neutral or positive environmental 
impact. 
Five percent of all road trafic at any one time is estimated to 
be on NHS business, be it patients going to and from care or 
the NHS’s leet of vehicles. This will be reduced if the right 
care is provided in the right place – using models of care with 
least amount of travel. Taking care to the patient will be part 
of this, so there is a role for us fulilling the potential that 
technology has.
There is limited direct evidence of the health impacts of other 
forms of waste in the NHS, although the continued use of 
landill and incineration must have some. There are ways to 
stop this – which will also improve NHS inances. It will not 
be suficient to recycle; we need to reduce waste produced: 
reduce unnecessary healthcare, and ensure more eficient 
procurement.
Healthcare should be responsible for the pollution footprint 
of it’s supply chain. Gaps in knowledge and environmental 
monitoring remain. Reducing pharmaceutical pollution – 
notably through waste and overprescribing reduction – has 
co-beneits (for inances, patients and others). Healthcare, 
and more signiicantly agriculture and aquaculture, 
contribute to the overall quantity of pharmaceuticals in the 
environment. Environmental antimicrobial pollution is a cause 
of antibacterial resistant bacteria, although the exact degree 
remains unknown
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Chapter 1
Chapter 3  21st century chemicals
Chemical mixtures are the norm in the environment, and 
these mixtures are growing increasingly complex. Constituent 
chemicals within these mixtures are mostly at a low 
concentration, with any one chemical unlikely to harm health 
on its own, but with less known about the health impact of 
the mixture. 
Large datasets, new epidemiological techniques, geospatial 
methods, ‘omics’, genetic approaches, and others will help us 
to better understand the threat posed. We cannot rely solely 
on observational sciences, be it to study mixtures or individual 
chemicals. Experimental studies will be critical, notably 
toxicological studies. These must focus on the substances of 
concern to human health, providing evidence to be collated 
with observational data to give the most accurate picture of 
health impacts. They also need a real world focus, focusing 
on levels of exposure faced by humans. 
In addition to new chemical threats, another change will be 
reassessing ‘legacy’ chemicals using 21st Century techniques. 
Metals are an example, one of the oldest legacy exposures, 
but whose risk can be revisited. This could include using 
genetic data to better understand and highlight individual 
susceptibility.
Some chemicals have been the subject of persistent 
discussion in terms of their health impact. These include 
dioxins, endocrine-disrupting chemicals, Bisphenol A, 
phthalates and others. Some of these have well deined 
hazard proiles, but exposures are believed insuficient to 
cause risk. Others have associations with diseases, but this 
has not been proven to be causal. These chemicals require 
vigilance. The chapter author suggests speciic research 
examining causal links between concentrations of chemical 
and health outcomes, rather than associations.
A particularly understudied area is the impact of chemicals 
on the genome and epigenome – the consequences of which 
could have intergenerational impacts. There is currently little 
evidence around this.
Chapter 4  New horizons
This chapter explores pollutants that are newer, or are less 
well established in terms of the evidence of health impact. It 
discusses some of the newer techniques to study and respond 
to the health impact of pollution.
Noise stands second to poor air quality in terms of the 
burden of ill health caused by a single pollutant, and 
is increasingly high on the international agenda. Over 
80 percent of people report being exposed to noise pollution 
in their homes. Links to ill health include, proximally, sleep 
disturbance and stress, with more distal associations with 
hypertension, cardiovascular disease and children’s learning 
development. Research may identify causal relations with the 
latter measureable health outcomes. Addressing noise level 
retrospectively can be costly – it is better to consider noise 
pollution in planning decisions.
Other proposed threats are either far less well established 
or appear to have more limited impact. Light has some 
known effects on the body – but whether this extends 
to light pollution having health impacts is not known. 
Nanomaterials are a new and exciting technology, with 
many applications. These will pollute and will penetrate the 
human body due to their size. These need to be examined 
as emerging chemicals. With very limited information on 
any adverse health impacts, we must maintain a targeted 
watching brief – one that is interdisciplinary, with particular 
focus on exposure assessment. This summary of nanoparticles 
could well be repeated for micro plastics – with no current 
evidence of adverse human health impacts, there is a need 
for coordinated multi-disciplinary assessment. 
New techniques and technologies, many of which are 
likely to be revolutionary across biomedicine, will play an 
important role in our understanding of the health impacts 
of pollutants. Advances in epigenetics, the understanding in 
the way genetic information is used, promises to increase our 
understanding of how pollution causes ill health. Meanwhile, 
genome sequencing tumours may allow us to pinpoint their 
environmental – pollution – cause. Not all advances are new 
technologies. Older traditions, such as epidemiology are 
also innovating to further our understanding of the health 
impacts of pollution.
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Summary of Section 02, ‘Socioeconomic world’
* Jerrett et al. 2001. Environment and Planning A, 33(955-973)
Chapter 5  Economics of pollution interventions 
Chapter 6  Pollution and inequality
The next section of my report addresses how pollution, a 
facet of the physical environment has interrelationships with 
social and economic thinking about health. This ranges from 
how pollution is a factor that adds to health inequalities, 
to how we examine the impact of interventions to reduce 
exposure to pollution through a health economic lens.
Chapter 5  Health economics of interventions to 
reduce pollution
Economics and economies play a pivotal role in all of 
health. Chapter 5 presents evidence of the health economic 
evaluations of interventions to address pollution in England 
(or that are of relevance to England). In addition to this, 
there are many other questions that arise from considering 
together human health, pollution and economics. These 
include assessing the cost of the health impacts of pollution; 
the relationship between economic growth, pollution 
production and associated ill health, as well as the insight 
economics gives around changing polluting behaviours, and 
others. 
Our best estimates of the overall cost of the health impact of 
pollution are likely to be underestimates. There are a number 
of reasons behind this, presented in the chapter. For one, 
we have far less evidence about the impact pollution has on 
morbidity and quality of life – compared with mortality – 
which are major drivers of cost. More work is required to get 
a fuller and more accurate measure of cost of ill health from 
pollution; this will help to stimulate an appropriate policy 
response. 
This chapter is informed by a systematic review of the health 
economic evaluations of interventions to reduce pollution. 
Although some actions have been shown to be beneicial 
from a health economic perspective, the review highlighted 
the gaps in evidence. This evidence base needs to be 
expanded, with results presented in a way that makes it easy 
for decision makers at a local and national level to implement 
the evidence based options. 
Evidence is presented that many decisions made in England, 
across all geographies, have an impact on health through 
pollution but do not take into account the health economic 
impact. A major reason for this is that the evidence of health 
economic impact or modelling of potential impact is not 
included in the decision making process. For example, an 
economic assessment of a transport decision might account 
for the cost of the infrastructure, the inancial gain to 
business and industry, but not the health economic impacts. 
Chapter 6  Pollution and inequality
This chapter collates the evidence around pollution and 
health inequalities, and considers the implications.
If we use the simple ‘source-pathway-receptor’ model that 
describes how a pollutant can get from ‘the environment’ 
to cause health harms, there are plausible inequalities across 
the whole pathway. In terms of evidence in England, much 
is focused on air quality and the differential exposure by 
socio-economic position. Here, there is growing consensus of 
a U-shaped exposure to raised mean concentrations (lowest 
exposure in rural areas which tend to be in the middle of the 
socioeconomic gradient); and of a linear relationship between 
exposure to short term exceedances of air quality targets and 
deprivation (more exceedances in the most deprived). There 
is much more limited evidence of other types of inequality, 
such as by ethnicity, gender or others, and of inequalities in 
exposure to other pollutants.
The chapter discusses ‘triple jeopardy’: a concept that states 
that:
“disadvantaged groups face: irst, increased risks from social 
and behavioural determinants of health; second, higher risks 
from high ambient pollution exposure; and, third, an effect 
modiication that makes exposure to ambient pollutants exert 
disproportionately large health effects on them compared 
with advantaged groups”.* 
This implies an interaction between the pollution 
and socioeconomic position – through an underlying 
susceptibility, therefore more severe health outcomes for 
a given ‘portion’ of pollution exposure. This is intuitive, 
but the evidence is not yet clear (although there are some 
suggestions), and is certainly not showing a consistent, large 
impact on clinically meaningful outcomes at present.
The evidence base of health inequalities associated with 
pollution in England is also restricted by a number of 
limitations. A major weakness is the use of area level data 
rather than individual-level (while area-level data remains 
helpful and hypothesis generating) Combining data, 
including pollution exposures, health outcomes and rich 
socio-demographic data will allow better understanding 
of this relationship. This matters because addressing health 
inequalities is a priority in England. There is one question of 
particular importance: do our wider efforts to address the 
health impacts of pollution have positive, neutral or negative 
impacts on health inequalities?
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Summary of Section 3, ‘Our human response’
Chapter 7  Environmental and health service pollution
Chapter 8  Environmental pollution – data, 
surveillance and health impacts
Chapter 9  Measurement and communication of 
health risks from pollution
The last section of my report covers three areas where we 
have addressed, and need to do more to address, the health 
impacts of pollution. The three areas might not appear 
to be direct responses to pollution but are important and 
share a number of facets: these areas are a) not speciic to 
any one pollutant, b) collaborative, and c) strive to ‘join up’ 
our response. These are not a series of interventions and 
solutions, examples of which are given through the whole 
report. Nor are these exhaustive, answering all threats to 
all pollution. Good work in these and other areas will make 
lasting and fundamental changes to our health in England. 
Chapter 7  Environmental and health service pollution
Chapter 7 explores how those working across environmental 
health are faced with the health consequences of pollution 
on a daily basis. Specialists in environmental health, and 
all allied practitioners working to curb pollution, are a vital 
resource to improve the public’s health and prevent chronic 
disease.
The environmental health workload can often be at the 
acute end of the response to the health impacts of major 
pollutants. As well as working to control the immediate 
acute health impact of pollution, the chapter describes how 
environmental health professionals engage in proactive and 
preventive work. They can use their considerable expertise in 
the planning processes, for housing, transport and more, to 
create an environment where it is easy for the public not to 
pollute nor be affected by pollution. Practically, the skills and 
responsibilities to do this locally now lie in one place – local 
authorities.
Polluters often do the minimum to reduce their health 
impact, often just meeting legal requirements. The chapter 
explores the need to forge an environment where individuals, 
institutions and public bodies ind it easy not to pollute – 
where making the no/low pollution choice is the norm, 
and where pollution levels are reduced as far as possible to 
improve health. It describes how this will require the provision 
of information to aid decisions, real leadership and structural 
changes to make the ‘right’ choice easier.
Many pollutants are continually produced as we live our daily 
lives. Other pollution events are sporadic and short lived. 
Fire reduction represents a great success, although there is 
more work to do. Fires produce acute, high concentrations of 
poor air quality. Reductions in ires associated with the waste 
disposal sector (where risk has increased with recycling) 
represent an excellent example of the multi-agency, multi-
sector working that is needed to prevent pollution and 
prevent ill health.
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Chapter 8  Environmental pollution – data, 
surveillance and health impacts
This chapter discusses the dificulty of studying and 
monitoring the health impact of pollution.
There is a proliferation of data, across pollution exposures 
and health outcomes, ‘Joined-up data’ increases size and 
richness of datasets, and can add a longitudinal component – 
all of which increases the ‘power’ of these data to answer 
question about the health impacts of pollution. Achieving 
this needs close collaboration and partnership between many 
institutions, the health sector, national and local government, 
academic and others. Data not only need integrating but 
also needs to be published, whilst ensuring that appropriate 
governance procedures remain. Access, particularly to 
routine monitoring data, must be fast enough to respond to 
emerging health threats from pollutants. 
The UK is well placed to remain a world leader in 
understanding pollution; methodological advances could 
allow us to capitalise on existing datasets to improve our 
knowledge.
Biomonitoring has great potential to transform how we 
gather knowledge on the health impacts of pollutants. Using 
biomarkers means we can overcome dificulties in relating 
environmental pollutant concentrations to the exposure faced 
by individuals: they can give us an exact, person speciic 
measure. When combined with health outcomes we can 
improve estimates of risk from pollutants and strengthen 
causal inferences to ill health. Internationally, biomonitoring 
data sets have provided valuable insights, and the chapter 
describes how an annual biomonitoring dataset would help 
us examine current and future pollutant threats, protecting 
the public’s health and monitor our actions.
In England we have an excellent and comprehensive set of 
surveillance systems for most infectious diseases. NCDs, 
however, do not yet receive the same attention in terms of 
surveillance. Environmental public health tracking, a set of 
techniques to carry out surveillance of the NCDs caused by 
pollutants, could ill this gap.
* Bandura described ‘self-eficacy’ as a personal judgement of “how well one can execute courses of action required to deal with prospective situations.” Bandura, A. (1982). American Psychologist, 
37(2), 122-147
Chapter 9 Measurement and communication of 
health risks from pollution
This chapter expands on the dificulties in measuring 
the health risks from pollution, and the challenge of 
communicating risk levels.
It is important to remember the context in which pollution 
sits when considering its health impact. Most pollution arises 
out of an activity that someone chooses to do: therefore 
there is always some inertia to maintain the status quo. 
Practically, this means we must be conident (not necessarily 
precise) about the health impact of a pollutant. We must 
then communicate this in an impactful way in order to elicit 
changes (a necessary – not suficient requirement). 
One question, across pollutants, is understudied; what is the 
balance in harm between short term exposure to high level 
and long term exposure to lower levels of pollutants? This 
has an obvious implication for measuring the total burden of 
pollutants, but also has implications for the policy response. 
The fastest way to address one type of exposure may not 
address the other. This chapter discusses the advantages 
collaboration across disciplines provides when trying to 
establish causation, and trying to synthesise results.
There is an existing body of evidence – often not from 
the world of pollution itself – to draw on upon when 
communicating risk. Valuable insights can be provided. 
For example, risk perception theory shows us the value 
of the emotive communication, and behaviour change 
theory highlights the importance of self-eficacy* in 
making changes.
The chapter describes other facets of successful risk 
presentation and communication. It explores openly stating 
both conidence in, and precision of, best risk estimates as 
a way to overcome the uncertainty we have around risks of 
pollutants, without compromising action. This openness and 
using emotive messages are two lessons for pollution risk 
communication. 
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Chapter 2
Introduction 
Healthcare can do much to improve health. The inancial cost 
of healthcare should be seen mostly as an investment; the 
environmental cost should mostly be seen as avoidable.
Not only can healthcare systems be disproportionately 
polluting, but they have special responsibilities and 
opportunities to be exemplary in not causing avoidable harm. 
There are many reasons why the health service pollutes:
  the size of the sector – small relative increases in eficiency 
or decreases in waste have high absolute consequences;
  the toxicity of many products used – many diagnostic 
reagents and the interventions (for example 
pharmaceuticals) are novel agents and therefore can 
have unexpected and polluting consequences on the 
environment unless rigorously and systematically tested.
Every healthcare practitioner has a duty to do no harm: 
“primum non nocere”. The same principle should be applied 
to healthcare systems such as the NHS. The inancial cost of 
waste and human cost of pollution caused by the NHS means 
we need to factor this into how we design and deliver models 
of prevention and care. It is counter-productive to provide 
healthcare in ways that pollute the conditions that create and 
protect health.
For instance, the NHS is now responsible for almost one 
in 20 of all vehicles on the road.1 Reducing the fossil fuel 
transport within the NHS creates multiple health beneits: 
reducing air pollution (PM/NOx); promoting physical activity; 
and the reduction of climate change inducing greenhouse 
gases – all of which have additional beneicial health effects, 
both immediate and long term. A 3% increase in uptake of 
active travel by NHS staff in England, for example, would 
mean healthier staff, saving over £265m in avoided health 
treatment costs and improving health by 114,000 QALYs.2
Healthcare’s role in pollution: 
part of the answer 
The NHS (both practically and symbolically) has a special 
role in not only curing disease but also in prevention. This 
translates into a responsibility to measure and address the 
preventable pollution for which the NHS is responsible: from 
toxic waste, to air pollution to greenhouse gas emissions. 
Examples of how the NHS contributes to pollution include; 
  business mileage and the movement of ambulances in 
2016 by NHS providers alone equates to around 680m 
miles per year, creating 517 tonnes of NOx and 27.3 tonnes 
of PM 2.5, this equals a health impact cost of over £15m 
per annum;3 
  annually NHS providers spend over £540m on energy 
which equates to the release of 3.7 million tonnes of CO2. 
There are still NHS providers burning coal and oil at health 
sites; both are very carbon and pollutant intensive fuels, 
with 176 gigawatt hours of energy from these in 2016.
The NHS in England spends approximately £16bn per year on 
prescribing drugs, much of which is disposed of in uncertain 
ways, either before or after being administered. Not only 
does this result in great inancial, but it is unclear exactly 
what the long term polluting effects of pharmaceutical might 
be on the environment.
Some level of pollution is inevitable in most health care 
activity. Much harm, waste and pollution can therefore 
be eliminated by reducing avoidable and unneeded health 
care by addressing over-diagnosis and over-prescription 
(supporting efforts to, for example, reduce over use of 
antibiotics). This is in addition to traditional waste reduction 
such as throwing away excess packaging, unused open 
packets etc. Waste extends to over diagnosis and over 
treatment.4 An estimated 20% of clinical practice has no 
beneit to the patient – whilst there is signiicant overuse of 
tests and interventions.5 Addressing waste produces higher 
value healthcare, providing more care for a given ecological 
footprint. Efforts to reduce waste – and pollution – also 
extend to having a much more strategic and ambitious 
approach to prevention: as the Prince of Wales said in 1891, 
“If preventable, then why not prevented”.6 Preventing ill 
health has the added co-beneit of reducing the need for 
future treatment – with its associated environmental impacts.
As responsible stewards, doctors can provide a more effective 
use of constrained economic and environmental resources.7
Crucially, this response should be done in a way that frames 
pollution as a direct health risk. It is much better to frame 
the pollution (for example diesel exhaust) as an immediate 
health risk, not simply as a distant environmental risk – a 
cause of non-communicable diseases just as smoking, obesity 
etc. are.
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There is increasing evidence to suggest that, with suficient 
will, the polluting ecological footprint of the health service 
in England could be substantially reduced – and in ways that 
would both strengthen the principles and goals of the NHS, 
and alongside deliver numerous other immediate and long 
term gains for health and wellbeing.8
Pollution and inances: 
“a convenient truth”
The link between inancial sustainability and environmental 
sustainability is a highly convenient truth, and an opportunity 
the system should seize. Much pollution caused by the health 
system is due to wasteful practices that generate harm to the 
environment (and in turn to the public and patients), waste 
money (and other inite resources), and jeopardise safety. 
Understanding the scale of the problem and the opportunity 
for improvement brings signiicant, multiple beneits for the 
health of both current and future generations, as well as 
preserving those resources now.
An example at the most critical part of the system – hospital 
admissions – shows that some enlightened hospitals systems 
assess every unplanned admission to quantify the degree of 
preventability, and thus the unnecessary activity, cost, harm, 
waste and pollution caused. This can be repeated across all 
other aspects of the health system. A population or public 
health approach to care9 (as practiced by systems such as 
Kaiser Permanente in the USA) can signiicantly reduce 
unnecessary and wasteful care, thus reducing harm and 
pollution.10
Given the multiple beneits of actions to reduce waste in 
the health system – reducing pollution, as well as reducing 
costs and harms, there have to be signiicant barriers to their 
implementation. The NHS is largely “funded for activity”, 
not for outcomes. There are unintended perverse incentives 
in the system: hospitals are rewarded for more activity 
and thus have very little incentive to invest in preventative 
programmes that improve health and avoid unnecessary care 
with the associated waste and pollution. Systems with a clear 
environmental and waste reduction policy include Kaiser 
Permanente in the United States. Here inancial outcomes and 
the health outcomes are aligned – encouraging prevention 
and promoting care, where appropriate, in the community, 
reserving hospitals for what only they can do.
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Pollution in the health and care system
Three speciic examples are considered here as they fulil 
the important criteria of being widely understood and 
measurable, and areas where action is possible and effective.
Travel and air quality
The health system in this country, like in nearly all countries, 
is large (employing over 1.2 million people in England – the 
ifth largest employer in the world), reaches every town and 
community in the land, and involves the movement of many 
goods, services and people. The movement of staff, patients, 
visitors, and the coordination of logistical support for the 
health service means that approximately 3.5-5% of all road 
trafic in England at any one time is estimated to be on some 
sort of NHS business.11
Much of this is avoidable if we are to bring the right care to 
the right people at the right time. We need to understand 
that there is a price to pay for this scale of transport and 
travel, not just in terms of time or money but in terms of 
air pollution (NOx, PM10 and PM2.5) and greenhouse gas 
generation. Because no-one pays today for the true, full 
social cost of fossil fuel use and pollution (much of the cost is 
deferred to the future) and because large hospitals are ixed 
and immovable assets, we focus much of our specialised 
care there. These contain a critical mass of expertise and 
equipment but mean that our models of prevention and care 
are largely centralised.
Table 2.1 Air quality and the NHS leet, 2016
Sources of air pollution in England 
from travel
Miles 
(million)
CO2e 
emissions (t)
PM2.5 (Kg)
Nitrous 
Oxide (NO
x
) 
(Kg)
Total health 
and non-
health 
impacts (£)
NHS providers and Ambulance Trusts 
(Business mileage, ambulance leet, patient 
and visitor travel and staff commuting)
7,231 1,067,713 237 5,232 £646,427,991
Primary care and commissioners 
(Business mileage, patient and visitor travel 
and staff commuting)
1,976 426,008 61 1,319 £142,461,818
Total 9,208 1,493,721 299 6,551 £788,889,810
Source created using information from Health Outcomes of Travel Tool; a modelling tool for the harm; air pollution, noise, 
GHGs and accidents from all travel in the NHS including all business mileage and ambulance leet, available at 
https://www.sduhealth.org.uk/
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Despite the extraordinary growth of person-held ICT, the 
miniaturisation of near patient testing, and the potential 
savings from such developments, there is little evidence 
that care is being taken to the patient. Consequently, our 
ability to invest in modern ICT systems, prevention, care 
in the community, powering public, patients, and primary 
care is all hindered by the centralisation of healthcare 
facilities. This results in such a high proportion of road trafic 
being on NHS business which contributes to air pollution, 
wasted time, higher risks of road injury and community 
severance*, all of which adversely affect health. Figure 2.1 
describes how investment in sustainable transport can affect 
improved health.
* ‘Community severance’ (also known as ‘the barrier effect’) is a term to describe transport system interference with people’s mobility and ability to access goods and services e.g. heavy road trafic 
impeding local people’s ability to navigate their neighbourhood by foot.
The health service has an important opportunity to be a 
part of the solution to the pollution challenges we face, not 
part of the problem. Moreover, health services and health 
professionals have an important responsibility to visibly 
show that they take their contribution to air quality (and 
other issues such as climate change seriously). Some hospital 
Trusts, Bart’s NHS Trust in East London, and Great Ormond 
Street Hospital, for example, have speciic programmes to 
reduce the damaging effect their activities have on air quality 
through reducing their energy use, stopping ambulance 
idling, other fuel eficient driver training and increasing zero 
carbon forms of transport in patients.
Box 1  Personalised Care for Lung Fibrosis Patients: Reducing unnecessary travel
Idiopathic Pulmonary Fibrosis (IPF) is a condition that causes 
progressive scarring of the lungs resulting in shortness of 
breath, leading to the need for extra oxygen. Treatment is 
given to relieve symptoms and to try to slow progression. 
University Hospitals North Midlands (UHNM) University 
Hospital is a specialised centre for the management of 
patients with IPF
The issue? 
It is only in the past few years that drugs have become 
available to treat IPF. These can only be prescribed by 
specialised centres. These drugs have side effects for which 
patients require close monitoring and regular clinic visits 
and assessments. As a specialist centre for IPF, UHNM sees 
patients referred from a large area across the Midlands and 
Wales. For some patients this means a lot of traveling.
Patients with IPF can also require prompt support, especially 
as the disease progresses. This is usually provided in close 
collaboration with the patients’ carers, local community and 
hospital-based respiratory services. Thus communication 
between all parties has to be effective.
Action taken
To address the issues of frequent clinic attendances in 
person and prompt intervention to support patients, the 
team in Stoke have developed a bespoke ‘app’ – accessible 
by phone, tablet or computer – on a secure hospital 
website. This allows patients to track and report their 
symptoms from home instead of attending the hospital in 
person. 
The patient-generated reports are reviewed by the clinical 
team daily, who can then guide the patient/carer. The 
app includes the patient’s history and co-morbidities. 
Functionality is especially useful to enable patients to 
recognise symptoms and drug side effects. It also supports 
patient/carer participation in the management of their 
disease with real–time communication between them and 
the clinical team avoiding the need to make unnecessary 
visits to the hospital clinic. 
The impact? 
There are currently over 250 IPF patients at the trust. 
Although the app was only recently launched over 
50 patients are using it. This can mean a reduction in 
appointments of up to 50% meaning a saving in carbon 
costs as well as better outcomes for patients. The trust is 
hoping the project will enable a reduction to two visits a 
year for the mild to moderate disease and four visits for 
severe. 
Lessons learned 
  Internal testing was required to ensure patient safety and 
the suitability of the application 
  A simple user guide was produced;
  Security of the system, data entry and conidentiality 
were addressed by entry protection on the Trust website; 
  The application can be used on a variety of devices for 
example smart phone, tablet, laptop or desk computer 
according to patient preference;
Scaling up
Replication of this application is possible across other 
specialist centres in the NHS and for other conditions. 
The trust has received funding to develop a similar self-
management system for Chronic Obstructive Pulmonary 
Disease patients. The clinical team are also currently in talks 
with commercial parties to roll-out the applications across 
the wider NHS economy.
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Figure 2.1 Virtuous cycle of investing in sustainable health and sustainable transport
Source 2009 NHS Carbon Reduction Strategy12
Authors’ suggestions for improvements
  All hospitals could have travel plans as part of their 
Sustainable Development Management Plans (SDMPs) 
including:
• plentiful active and low carbon travel opportunities 
to and from health facilities (walking, cycling, public 
transport etc.);
  Energy strategies in the NHS could consider non-
combustible renewable heat and co-generation (for 
example fuel cell combined heat and power), the use of 
renewable source electricity (either by generation on site or 
through energy contracts) and District/Community Heating 
Schemes:
• this should include restricting use of energy resilience 
equipment. It should be used for energy resilience, 
where necessary, but not for short term inancial gain 
through incentivised combustion of heavy polluting 
fuels to support the national grid.
  The NHS could adopt innovative models of prevention and 
care that allow patients and staff to travel much less whilst 
receiving high quality care (telecare, long term condition 
monitoring, virtual clinics, specialists in primary care 
settings);
  All action to reduce pollution in the NHS could be elevated 
from “expectations” to “must dos”. This requires complete 
buy-in and adoption from the regulatory agencies 
such as Care Quality Commission, NHS England, NHS 
Improvement, Department of Health and Social Care and 
National Institute for Health and Care Excellence.
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Box 2  Reducing our emissions for sustainable healthcare is Care Without Carbon
Hayley Carmichael and Will Clark, Sussex Community NHS Foundation Trust
Sussex Community NHS Foundation Trust spans 1,000 
square miles, employing almost 5,000 people. Delivering 
care in homes and across over 70 sites will always involve 
travel. However, we believe that minimising that travel is 
essential for the delivery of sustainable healthcare. For us, 
sustainable healthcare is about more than saving money, it 
is about reducing our impact on the environment, improving 
wellbeing for our staff, and ultimately our patients. To 
achieve this we created our Care Without Carbon (CWC) 
strategy.
Tackling local air pollution, through the reduction of 
our vehicle emissions is one way that CWC is making a 
difference. The aim is to reduce travel to its lowest possible 
level, while also encouraging take up of low/ zero emission, 
low carbon and active travel alternatives. 
Firstly, we set up a travel bureau to support our staff in 
making fewer, cleaner, journeys. The travel bureau offers 
local public transport guidance, season ticket loans, a cycle 
to work scheme and route planning for drivers. Secondly, 
in tandem with the travel bureau we introduced a low 
emission pool car and lease scheme for staff, and even 
electric bikes.
A practical and effective solution
When Gina Cooper took on a new role at the Trust as a 
Patient Advice and Liaison Service (PALS) support worker, 
it required her to travel many more miles for work than 
before. Without a vehicle, the long public transport journeys 
would have been an excessive time burden and impractical.
“I don’t own my own car, but the new role demanded one. 
With pool cars, I didn’t have to buy a car. Instead I’m now 
travelling up to 120 miles a week, often to several locations 
a day from the base. The pool cars are hybrid, so very 
eficient to run, and at least twice a week I car-share with 
colleagues to different locations – a requirement of using 
the scheme is that we share travel wherever possible, I’ve 
saved over 700 car miles through car sharing so far.”
An approach that works
We have increased our low emission pool leet (vehicles 
available for staff use from key sites) from 13 to 21 vehicles 
– available at six sites. This has: cut our grey leet mileage 
(staff using their own cars for Trust work) by 826,000 miles, 
helped us to reduce local air pollution, our carbon footprint, 
and given a healthy return on investment on each vehicle. 
Since 2010 we have reduced our overall travel carbon 
footprint by 24% – on track to meet our 2020 target of 
34%. Although the quantity has not been modelled, this 
will also reduce other air pollutants. As part of this, we have 
cut the engine emissions from our owned and leased leet 
by 26.4% down to 111.1 gCO2/km.
Pharmaceuticals and medical supplies: waste 
and post use toxicity
Pharmaceutical products cost the NHS in England more 
than £15 billion a year. This accounts for almost one-ifth of 
the total NHS carbon footprint.13 With the current ways in 
which drugs are prescribed, huge quantities are never used 
or never have any positive therapeutic beneit.14 Further, 
these can then enter the environment and pollute. Critically, 
there is currently no evidence of harm to humans from non-
therapeutic exposure to pharmaceuticals in humans (of which 
pollution is one constituent part). Indeed for one method 
of exposure, ingestion of drinking water, in 2012 the WHO 
concluded that:
“Trace quantities of pharmaceuticals in drinking-water are 
very unlikely to pose risks to human health because of the 
substantial margin of safety between the concentrations 
detected and the concentrations likely to evoke a 
pharmacological effect.”15
There is room for vigilance, and some unanswered questions 
– and this is only an assessment of harm from a human 
health perspective. There is evidence of some harm from 
pharmaceutical pollution not associated with direct human 
exposure – notably from antimicrobials in the environment 
(more below).
Active pharmaceuticals and their metabolites do enter into 
living systems and the environment,16 through a number of 
routes (Figure 2.2). Two of these – from human excretion 
of therapeutic drugs, estimated to be the major source 
of pharmaceuticals in the environment;17 and from drugs 
not taken and inappropriately disposed of – lie ‘within’ 
health care. The former is inevitable, but can be reduced 
by appropriate use of medication (stopping overtreatment), 
whilst the latter can be stopped through correct disposal 
and providing correct quantities of medications. In terms 
of disposal, England by law (European Directive 2004/27/
EC) must have appropriate schemes to manage unused 
pharmaceuticals. In England, household pharmaceutical 
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waste disposal is provided by pharmacies. Medicines are still 
disposed of in uncontrolled ways,18 although the implications 
for active pharmaceuticals in the environment depends on the 
route of disposal (for example if incinerated – they will not 
enter the environment). Other routes into the environment, 
such as the manufacture of pharmaceuticals, are in the supply 
chain for healthcare: others still, such as farming livestock, 
crop production, aquaculture, and others lie outside of 
healthcare – and outside of the scope of this report.
The nature of pharmaceutical pollution will not be static 
through time, nor does it occur in the absence of other 
threats. Demographic changes are likely to increase the 
prevalence of long term conditions such as Type 2 diabetes: 
with more people relying on maintenance drugs, the 
pollution burden will steadily increase.19 Pharmaceuticals are 
also parts of chemical mixtures; therefore any health effects 
need to be examined in the presence of other chemicals and 
stressors. 
Figure 2.2 Occurrence, sources, and fate of pharmaceuticals in the environment
Source adapted from Li,W. ‘Occurrence, sources, and fate of pharmaceuticals in aquatic environment and soil’
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Box 3  Health effects of pharmaceutical 
pollution in England
Paul Kay and Lee Brown, University of Leeds
It is now well established that pharmaceuticals used 
in both human and veterinary scenarios enter the 
environment and are routinely present in English rivers. 
Average concentrations across rivers are in the order of 
100 ng L-1, although can reach several µg L-1.i Globally, 
higher concentrations in the mg L-1 range have been 
found.ii Historically, compared to many environmental 
pollutants, pharmaceuticals have been monitored to a 
limited extent – although this is changing. More work is 
needed to robustly determine their occurrence in sewage 
and the water cycle, and critically, their fate and effects in 
the environment. 
Even the most advanced treatment processes fail to 
remove all drug residues from waste and drinking water, 
whilst many compounds are rarely detected in potable 
waters. Others, such as carbamazepine, are frequently 
detected. All, however, at concentrations well below 
(orders of magnitudes) levels of therapeutic effectiveness. iii 
As for rivers and groundwaters, our understanding of 
pharmaceutical concentrations in drinking waters is limited 
to a relatively small number of research studies. It should 
be remembered that these substances, in contrast to 
many environmental pollutants, are designed to be given 
to humans and may not represent the same level of risk 
to health. Indeed, current understanding indicates that 
impacts in humans due to exposure to drug residues 
in drinking water are very unlikely, with concentrations 
typically being three orders of magnitude lower than the 
minimum therapeutic dose (MTD).iv
Although the potential for health harm is low there are a 
number of outstanding questions before this can be fully 
quantiied.v It is unclear if daily exposure to sub-therapeutic 
doses of pharmaceuticals in drinking water, over a period 
of decades, will have health impacts. Much remains to be 
learnt about how different chemicals interact and whether 
mixtures of chemicals, including pharmaceuticals, can exert 
effects not associated with single compounds. The effects 
of metabolites compared to their parent compounds are 
also less certain and risk assessment approaches need to 
continue to be developed to consider all of these factors. 
Pharmaceuticals are designed not to bio accumulate – 
therefore bioaccumulation is one route where health 
impacts are unlikely.
References
i Kay, P., et al. 2017. Environmental Pollution, 220, pp.1447-1455 
ii Hughes, S. Ret al., 2012. Environmental Science & Technology, 47(2), pp.661-677 
iii Furlong, E.T., et al., 2017. Science of the Total Environment, 579, pp.1629-1642
iv WHO, 2011. Pharmaceuticals in Drinking Water. World Health Organization, Geneva, 
Switzerland.
v Caban, M., et al 2016. Current Analytical Chemistry, 12(3), pp.249-257
Box 4  SIRUM: Saving Medicine – Saving 
Lives
Kiah J Williams, SIRUM
Industry experts estimate that 2-3% of the $270 billion of 
prescription drug sold each year in the United States go 
unused.20 The most recent, 2010, estimates place the cost 
of unused medicine in England at £300 million.21 What 
happens to the billions of dollars of medicine that do not 
reach patients who need it? Currently, incineration, landills 
and waterways remain the most common destination for 
unused medicine, with the majority incinerated. Each fate 
is uniquely detrimental to our environment and potentially 
to health – medical waste incinerators are estimated to 
be the third largest producer of dioxins in United States22, 
whilst waterways have traces of pharmaceuticals.
SIRUM is a nonproit company that uses an online platform 
to facilitate the redistribution of unused medicine – 
much like recycling – converting medicine destruction 
into donation. It collects unopened, unexpired medicine 
from health facilities, manufacturers, wholesalers, and 
pharmacies and uses an online platform to connect surplus 
medicine with safety-net clinics and pharmacies. The 
program reduces the amount of time and cost associated 
with disposal of unused medication, and increases access 
to prescription drugs for low-income patients who utilize 
safety-net clinics and pharmacies for their health care. The 
network of hundreds of medicine donors has redistributed 
over $11 million worth of medicine at National Average 
Drug Acquisition Cost (NADAC) value, enough to ill 
300,000 prescriptions. 
SIRUM combats important social issues, but by preventing 
medicines from entering the waste stream and reducing 
the amount needed to be produced, it reduces pollution. 
According to the Natural Resource Defense Council 
(NRDC), the production of one pound of pharmaceutical 
active ingredient can generate between 200 to 30,000 
pounds of waste.23
By ensuring all medications are safely redistributed and 
used for their intended purpose – to make people well 
and keep them healthy – SIRUM believes that millions of 
people will get the medicine they need while dramatically 
reducing the environmental impact of production and 
needless destruction of these valuable resources.
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Hospitals are a signiicant concentrated site for 
pharmaceutical products, although still likely to only a make a 
small contribution to the overall amount of pharmaceuticals in 
the environment.24 The primary approach has to be to reduce 
overtreatment, reduce unused medication and ensure correct 
disposal. There are far too few incentives to reduce wasted, 
out of date supplies that need to be disposed of. Although 
recycling unused drugs is hard, there are now some schemes 
internationally that recycle unused medicines: particularly 
in the United States (see Box 5). Such schemes can address 
the cost of waste, improve access to drugs for those most in 
need – and, in what is likely a small part, reduce pollution. 
They must also work within the legal requirements of supply 
– such as including a secure chain of custody. 
Beyond waste reduction, although there are mechanisms to 
promote the removal and degradation of pharmaceuticals 
products from for example hospitals or wastewater treatment 
plants, it is not clear what the cost beneit is in relation to the 
possible health hazards.25 Further, internationally there are 
different approaches to address hospital efluence. One is to 
treat hospital waste separately – including onsite treatment; 
whilst the other is ensuring waste is channelled only into 
central waste water treatment – then ensuring the treatment 
process is highly effective. For onsite treatment, in order to 
prevent the spread of antibacterial resistance genes (below), 
it will be particularly important to focus on the bacterial 
component of the waste, as resistance genes can mobilise 
and spread within and between bacterial species. Wastewater 
treatment systems represent a signiicant and chronic source 
of antibiotic resistant bacteria and genes released into the 
environment. They also relect the drug-use habits of the 
population in the antibiotics that persist in the efluent as 
it is discharged into receiving rivers. As such, signiicant 
innovation is required in wastewater treatment systems to 
mitigate these threats to the environment and human health. 
The challenge to the research community will be in providing 
the evidence base needed to justify appropriate wastewater 
engineering targets, while also considering the effects of 
chemical mixtures and the importance of co-selection (i.e., 
metals and biocides).26
Healthcare is responsible for its supply chain – the production 
of the pharmaceuticals that treat patients. There are still 
gaps in our knowledge of environmental pharmaceutical 
contamination from manufacturing sites. There is evidence 
of high concentrations of pharmaceutical pollution linked 
to manufacturing sites in Europe, as well as examples in 
China, India and elsewhere in Asia.27 Where the data exist, 
internationally there is evidence of sites with environmental 
concentrations thousands of times higher than seen from UK 
efluence, indeed similar to therapeutic concentrations.28
Currently, the strongest evidence of human health impacts 
in England from pollution at these manufacturing sites, 
given the potential global spread antibiotic resistance genes, 
relates to antibacterial drug resistance (see Box 6). High 
concentrations in the environment impact on antibacterial 
resistance.29 These would notably be industrial sources and 
sites, but also farming, aquaculture and others. In terms of 
antimicrobial resistance, focus on these high concentration 
sites should not exclude other sources. Sources such as 
excretion, which have a large total load but spread through 
the environment, contribute – with a much greater total 
number of bacteria exposed.30
The Davos declaration of 2016, an industry agreement 
to combat antimicrobial resistance, explicitly states a 
commitment to “reduce environmental pollution from 
antibiotics”, in order to reduce antimicrobial resistance.31 
Both industry, in working to meet this declaration, and 
the NHS, through its procurement, have a role in reducing 
manufacturing pharmaceutical, including antimicrobial, 
pollution. Further information for users and transparency in 
the supply chain will be critical to allow consumers to make 
choices that reduce pharmaceutical pollution. 
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Box 5 Industry efforts to control PIE
Jason Snape, AstraZeneca Global Environment Steve Brooks, Pizer Inc
One of the consequences of delivering essential medicines 
to patients is that active pharmaceutical ingredients 
(APIs) can ind their way into the environment. By far the 
greatest environmental load of pharmaceuticals is a result 
of patient use (excretion after therapeutic use or improper 
disposal). On a global scale, pharmaceutical manufacturing 
operations contribute a small part of the total environmental 
burden of pharmaceuticals. However, it is recognised that 
manufacturing discharges have the potential to result in ’hot 
spots’ unless these are adequately assessed and controlled 
by manufacturers.i
Detection of trace levels (typically ng/l) of APIs in 
drinking waters has raised some concerns; however, the 
UK Drinking Water Inspectorate (DWI) and the World 
Health Organization (WHO) have both concluded that 
concentrations of pharmaceuticals found in drinking water 
are signiicantly lower than therapeutic doses and are 
unlikely to elicit a pharmacological effect (in the case of 
the WHOii) or pose an appreciable risk to human health (in 
the case of DWIiii). Additional published studies have also 
concluded that pharmaceutical exposure via drinking water 
is unlikely to pose a risk to humans.iv,v,vi Research concerning 
relationships between environmental concentrations 
of antimicrobials (for example from agriculture, animal 
husbandry, manufacturing efluent, human use and 
excretion) and the development of antimicrobial resistance 
(AMR) continues to evolve and more work in this area 
is required. 
The pharmaceutical industry recognises there are concerns 
about pharmaceuticals in the environment and is proactively 
engaged in efforts to better understand, and where 
appropriate, take steps to further reduce risk for example 
through its EcoPharmacoStewardship (EPS) initiative. 
Many pharmaceutical companies are members of the 
Industry AMR Alliancevii and in September 2016, 13 leading 
pharmaceutical companies signed the AMR Roadmap 
to further commit to curb the development of antibiotic 
resistance.viii
The AMR Roadmap includes commitments to reduce the 
environmental impact from the production of antibiotics and 
to develop and apply a common framework for managing 
antibiotic discharge across the supply chain by 2020. The 
AMR Roadmap companies are also committed to working 
with independent technical experts to establish science-
driven, risk-based targets for discharge concentrations for 
antibiotics, by 2020. The AMR Industry Alliance issued 
its irst progress report in January 2018 (https://www.
amrindustryalliance.org/progress-report/).ix 
Additionally, the Pharmaceutical Supply Chain Initiative 
(PSCI; https://pscinitiative.org/home) actively educates 
industry suppliers on environmental management and the 
need to manage the speciic environmental risks associated 
with APIs in manufacturing efluents.
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Box 6  Environmental pollution is a driver of antibacterial drug resistance
William H Gaze, European Centre for Environment and Human Health, University of Exeter 
Andrew C Singer, NERC Centre for Ecology and Hydrology
Environmental pollution containing antibacterial resistant 
(ABR) bacteria, drug residues and other bioactive 
compounds is associated with the evolution and spread 
of ABR. Resistance evolves through mutation or by 
genetic exchange, mobilising clusters of ‘linked’ ABR 
genes between bacteria. Linkage of genes conferring 
resistance to antibacterials and co-selecting compounds 
such as biocides and metals means that ABR may 
evolve in the presence of a range of environmental 
pollutants, increasing ABR in the environment and the 
risk of transmission to humans. Conversely, environmental 
bacteria harbour diverse ABR genes that evolved to give 
protection to natural antibacterials produced by micro-
organisms, and environmental pollution is likely to play a 
role in ampliication and transfer of these genes to clinical 
pathogens.
Antibacterial drugs are excreted by humans and animals 
in an active form which enter the environment through 
waste water or application of sewage sludge and manure 
to farmland. Globally, more than half of antibacterial 
drugs are used in farm animal production. Therefore, most 
antibacterial drugs enter the environment as pollutants 
where they are usually present at considerably lower 
concentrations than are used to treat infections. However, 
the concentration of antibiotics in UK sewage efluent may 
be suficient to select for some ABR genes.i The production 
of many antibacterial drugs occurs in India and China. 
Despite regulation to control pollution, concentrations of 
drugs downstream of manufacturing facilities can exceed 
UK river concentrations by 1,000-fold. This has been shown 
to exert a strong selection pressure for emergence of novel 
resistance mechanisms.ii 
Concurrent with the risk of waste water and agricultural 
pollution driving selection for ABR is the risk posed by ABR 
bacteria. A considerable proportion of bacteria released 
into the environment are native to the gut of humans 
or animals treated with antibiotics. A study in the River 
Thames demonstrated that levels of ABR are predictable and 
associated with waste water and agricultural pollution. iii The 
cocktail of resistant bacteria, antibacterial drugs, biocides 
and metals presents a signiicant risk of ABR spread and 
transmission to humans. It is known that novel ABR genes 
in Gram-negative pathogens such as those conferring 
resistance to 3rd generation cephalosporins (for example 
blaCTX-M), carbapenems (for example blaNDM-1) and 
colistin (eg. mcr-1) originated in environmental bacteria. 
A critical point to note is that evidence suggests the 
environment is the single largest source and reservoir of 
ABR.iv Recent estimates suggest over six million exposure 
events occur in UK bathing waters each year resulting in 
ingestion of ABR E. coli and an association between bathing 
water exposure and gut colonisation by blaCTX-M bearing 
E. coli has also been reported, although the number of 
resulting infections is unknown.v,vi 
Evidence of environmental transmission of ABR to humans 
is increasing, but it is currently not possible to determine 
the relative contribution environmental pollution plays in 
increasing ABR infections in the clinic. Mitigation strategies 
are available to reduce both ABR bacteria and drug 
residues in environmental waste streamsvii, however more 
evidence of the contribution of environmental pollution to 
clinical infection by ABR pathogens is necessary to inform 
decision making. 
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Authors’ suggestions for improvements
  Medical doctors and others in healthcare need training 
in order to increase awareness of environmental issues 
related to treatment strategies. 
• This could include environmentally better prescription 
choices, producing the same health beneit for the 
patient with the smallest pollution footprint (not simply 
substitute the type of pollution)
• Information on the environmental characteristics of 
treatments must be made readily available to support 
this.
  The adequacy of packaging sizes to consumers’ needs and 
doctor’s prescriptions might be reconsidered and there 
could be a need for systematic reporting of internet and 
OTC sales.
  Major improvements in waste management could be 
focused on the improvement of collection schemes for 
unused human and veterinary medicines, as well as 
tracking their eficiency.
  More efforts are needed to improve and harmonise 
monitoring for pharmaceuticals in the environment.
  Engage industry and consider environmental standards 
in production and purchases globally. This should focus 
on industry transparency, as well as monitoring active 
pharmaceuticals in the supply chain, reductions in 
discharges, including economic incentives for less polluting 
manufacture.
  The research community should provide the evidence base 
in order to select appropriate wastewater engineering 
targets with respect to pharmaceuticals and underpin 
innovations wastewater treatment systems, including 
considering the effects of chemical mixtures and the 
importance of co-selection (i.e. metals and biocides).
A low harm and low waste, health and care 
system
Healthcare organisations create huge amounts of waste; 
in 2016/17 over 590,000 tonnes from NHS providers in 
England alone was created, which is more than the entire 
municipal waste from some European countries like Cyprus 
and Luxembourg.32,33 This waste is generated from ofice 
materials, clinical waste, food, drugs, and medical devices: 
all of which must be disposed of in careful (and costly) ways. 
The WHO estimates that 75-90% of waste from healthcare 
facilities is non-hazardous – akin to waste from other sites 
such as ofice or household waste.34 The remaining 10-25% 
may be infectious or biohazardous, therefore needing speciic 
disposal in order not to create harm. 
All medical care involves some pollution. All unnecessary 
care, therefore, costs: in harm to the patient and the purse, 
and is unnecessarily polluting. Important categories of 
waste in healthcare include overtreatment, failures of care 
coordination, and failures in execution of care processes: 
these all impact on quality of care and cost.35 Ensuring the 
incentives lie with the originator of any waste and pollution 
(akin to “polluter pays”) can be hugely beneicial for health. 
All reduction of waste starts with procurement. Leaner 
procurement mechanisms such as “Just in time supply 
chains” and collaborative arrangements whereby the NHS 
buys the “service”, not the “product” can greatly reduce 
waste and thus associated pollution: this incentivises the 
provider (on whom the cost falls) to reduce waste and 
pollution. Environmentally preferable purchasing (EPP), the 
purchase of the least damaging products and services, and 
green procurement, purchasing with consideration of the 
amount and toxicity of waste also play an important role in 
waste – and pollution – reductions.36 Healthcare plastics, 
particularly PVC (prevalent in single use medical items such 
as anaesthetic masks) gives off harmful chlorine gas when 
incinerated. A push to phase this out by manufactures, for 
healthcare providers to procure less harmful alternatives 
(green procurement) and polluter-pays incentives (plastic 
industry funded recycling schemes for PVC), will all contribute 
to reducing this harmful pollutant.
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Too much waste is caused by poor stock control, and ends 
up in landill or being incinerated (which in turn generates 
carbon dioxide, nitrogen oxides, and particulate matter). It 
is a legal requirement for NHS trusts to consider the waste 
hierarchy and strive to move away from disposal and progress 
to energy recovery, recycling, reuse and ultimately reduction/
elimination. Some trusts have been zero waste to landill for 
a number of years, meaning all waste not required by law to 
be treated/incinerated (that is, hazardous clinical) is reused, 
recycled or sent for energy recovery. Dealing with waste 
in a less polluting way is important (for example replacing 
landill with mixed dry recycling, energy to waste recovery), 
but absolute reduction in waste (starting with procurement) 
and circular approaches to resource management should be 
the priority.
Global economics now make it cheaper to manufacture single 
use items within healthcare rather than carefully assess where 
multi-use items re-sterilised would be equally safe, cheaper, 
and cause less pollution through landill and/or incineration. 
Further, there can be a clinical inertia – or comfort – in using 
single use due the perceived beneits, but this can go beyond 
necessity. There is sometimes good evidence to invoke the 
precautionary principle and promote, if not require, the use 
of single use items (Prion disease outbreaks where the long 
term risk is initially unknown). When good research, however, 
establishes the true risk, then we should not perpetuate a 
culture of single use inappropriately and universally. From 
a health and pollution perspective, the adoption of every 
single use item should be considered, not the default. The 
overuse of disposable equipment has a downside, being 
disproportionately polluting. This may impact on human 
health, for example via plastic (or metal) incineration and 
landill. That said, it must also be acknowledged that 
there can be an economic argument for switching to and 
maintaining single-use. This argument can be increasingly 
persuasive in areas as in times of resource constraint. 
Box 7  RecoMed: helping hospitals to recycle PVC and save costs
Jane Gardner; Head of Consulting Services, Axion
NHS Provider spend more than £80 million on waste each 
year. Hospitals can play a key role in contributing to valuable 
savings by recycling waste materials, such as plastics. 
PVC is a widely-used plastic used in healthcare that can 
be readily recycled into new products. It is used to make 
40% of medical devices, especially those used frequently 
in anaesthesia and critical care. A large proportion of PVC 
is used in anaesthetic facemasks, post-operative oxygen 
masks, luid administration sets and associated tubing. 
The average UK hospital uses more than 12,000 oxygen 
masks per year and around eight million anaesthetics are 
administered each year. It is estimated that up to 2,250 
tonnes of PVC could be recycled by collecting these items 
alone from 150 hospitals in the UK. 
Set up in 2014, RecoMed is a unique UK-wide scheme 
that collects single-use waste PVC items used by healthy 
patients who have undergone elective surgery and sends 
these for recycling. Funded by VinylPlus, the European PVC 
industry sustainability programme, the scheme provides an 
alternative, sustainable disposal route for waste medical 
items made from high-quality medical grade PVC. Run 
by project partners Axion, a resource recovery specialist, 
and the British Plastics Federation (BPF), RecoMed supplies 
recycling containers, communication materials and 
collections to participating NHS and private hospitals.
RecoMed recycling bins are sited on wards next to non-
infectious clinical waste bins. Clear instruction is given to 
staff on what items can be accepted. Daily collections are 
taken to a central waste hold from where the RecoMed 
team deliver them to specialist recyclers.
Pioneered by anaesthetists, the award-winning scheme is 
now active in ten hospitals where it is helping clinical teams 
to increase recycling and reduce waste costs in theatres. The 
scheme is already showing tangible results with a total of 
3,573 kgs of waste high-grade PVC collected – equivalent to 
119,100 masks. This has been recycled back into new goods, 
such as horticultural products.
RecoMed collects accurate data on the tonnage recycled to 
calculate carbon savings. Each tonne of recycled PVC will 
replace about one tonne of virgin PVC compound used in 
new products, thereby reducing their carbon impact. This 
data can be used by individual hospitals to demonstrate 
efforts to reduce their overall environmental impact, as well 
as their inancial savings. Recycling is much cheaper for 
hospitals, given the cost of clinical waste disposal, which 
ranges from £350 to £600 per tonne.
There’s huge potential for further development. RecoMed 
offers the healthcare sector a major opportunity to increase 
their recycling efforts, whilst achieving helpful savings on 
high specialist waste disposal costs. It could be expanded 
to include single-use medical devices made from other 
polymers.
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Box 8  Greenhouse gases (GHG) in 
healthcare and global climate 
change – lessons for other pollutants
Burning of fossil fuels causes much of the climate change 
happening today, and the health sector in this country 
is an important source of pollution in the form of 
greenhouse gases. In 2015, the total carbon footprint of 
England’s health and care sector was 26.6 million tonnes 
of carbon dioxide equivalent (MtCO2e). This accounts for 
well over a third of public sector emissions in England.
The pollution caused by greenhouse gas emissions is 
important to assess for three reasons:
  The health effects of carbon pollution pose the biggest 
strategic threat to health we face37
  The emissions caused by any activity or any sector is 
quantiiable with the use of nationally and globally 
agreed standards
The emissions allowable to keep within safe boundaries for 
human health are well understood through high quality 
science from the global scientiic community under the 
auspices of the UNFCC IPPC38 and through a clear legal 
requirement in this country.39
The footprint of the NHS in the country was irst calculated 
in 2009 in the context of the 2008 Climate Change 
Act. It aspired to cover all three GHG emission scopes 
(1: All direct GHG emissions; 2: Indirect GHG emissions 
from consumption of energy used on site but generated 
elsewhere, and 3: Other indirect emissions that are a 
consequence of the operations of an NHS, but are not 
directly owned or controlled by the NHS). It revealed the 
very large proportion (60%) that could be attributed to 
what the NHS procured. Pharmaceuticals and medical 
devices formed 29% of the total footprint.40 Consequently, 
the NHS set itself a level of ambition to reduce the 
entire footprint of the health care sector in line with the 
Climate Change Act Another example of a co-beneit has 
subsequently emerged: the reduction in energy use has 
helped not only reduce air and carbon pollution, but it has 
also saved the NHS £80 million in 2016/17.
Laws such as the Climate Change Act (2008) establish 
scrutiny processes that can be applied to any sector 
including the health sector. The Climate Change Act, for 
instance, established the Climate Change Committee that 
ensures the government sets targets. This applies to GHG 
pollution, although other mechanisms at a national level 
address other forms of pollution: for example COMEAP 
(the Committee on the Medical Effects of Air Pollutants) 
provides independent advice to government on how air 
pollution impacts on health. Subsequent research and 
proposed actions to limit the effect of such pollution on 
health complements COMEAP’s work.41
Authors’ suggestions for improvements
  Waste reduction, notably through eficient procurement, 
must be at the centre of all efforts to reduce pollution and 
harm caused by healthcare.
  NHS bodies should use incentives to comply with the waste 
hierarchy, such as built into waste-management/ recycling 
contracts.
  Healthcare waste-management operations at local, 
regional and national levels should be well organised and 
well planned.
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Summary and conclusions
The data and case studies presented give a compelling case 
for the health system to reduce the harm associated with 
health care. Laws such as the Public Services (Social Value) 
Act (2012) mean the NHS is now under a legal obligation to 
consider the environmental harm (as well as the social and 
economic beneit) for which it is responsible. This ranges from 
its huge purchasing power on energy, food, pharmaceuticals, 
etc., to speciic innovations that need to be spread rapidly 
(such as solar power assisted ambulances that need not idle 
their diesel engines42).
The most effective intervention in reducing pollution and 
harm is to provide healthcare only when and where it is 
needed, meaning that preventing the preventable should 
be a fundamental principle of improving health: less 
(healthcare) really can lead to more (health). Thirdly, many of 
the interventions that improve health (reducing air pollution 
through more active travel, improving home insulation, 
reducing overuse of antibiotics) have multiple beneits, 
both for patients now but also for the public in years and 
generations to come.43 The time is right to quantify, assess 
and incentivise cleaner, and greener, health and care for 
current and future generations.
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Key points
  There are tens of thousands of chemicals in use across 
many sectors with major use in consumer products, 
petrochemicals (fuels and lubricants) and polymer plastics. 
Speciality chemicals are a broad class including crop 
protection products. All have the potential to pollute either 
through deliberate release or from inadequate waste 
disposal. Some chemicals are in fact highly complex and 
variable mixtures. 
  Humans can therefore be exposed to a complex mixture of 
chemicals via various routes and from a variety of sources.
  New technologies, particularly DNA sequencing and 
analytical technologies for nucleic acids, proteins and 
metabolites are providing new genetic and physiological 
understanding that may necessitate re-visiting old chemical 
pollutants and their risk assessments.
  There will be a much greater need to take into account 
genetic and physical susceptibilities to speciic chemicals in 
their risk assessment.
  Mixtures and complex chemical combinations are providing 
new challenges for risk assessment.
  There is a need to consider the health effects of biological 
materials from natural and manmade sources.
* https://echa.europa.eu/information-on-chemicals/pre-registered-substances
** Chemicals in the context of this chapter will be taken to include all molecules regardless of use, products thereof, and include natural chemicals. 
Overview
The use of synthetic chemicals in society can be traced back 
to the start of the industrial revolution in the 1700’s. Prior 
to this time natural chemicals and elements, for example 
metals were used but the industrial revolution saw the 
irst manufacture and use of synthetic chemicals in bulk 
quantities. The manufacture of sodium carbonate by the 
LeBlanc process (dating to 1791) provides our irst report of 
chemically mediated environmental damage and litigation 
due to the discharge of hydrochloric acid from the process. 
Compared to then, the obvious, but notable change is the 
vast number of chemicals now on the market. Currently 
145,297 chemicals (including duplicates) are pre-registered 
under REACH*, whilst globally, production of chemicals 
has increased from one million tonnes in 1930 to several 
hundreds of million tonnes today.
Chemical manufacture has provided many beneits to 
society, for example increased food production, hygiene 
improvements, drugs, new materials and electronics 
manufacturing. However there have also been adverse 
consequences from these chemicals contaminating the 
environment causing harm to both wildlife and humans. 
Consequentially there is generally a risk/beneit ratio that 
needs to be calculated for chemical use. This is not a 
static ratio, calculated once and never revisited. As new 
understanding, often resulting from new technologies (often 
resulting from new technologies themselves dependent on 
new chemicals) increase our understanding of risk then this 
risk/beneit ratio will need to be revisited. Furthermore, new 
alternatives may provide the beneit with reduced risk, or 
conversely may even provide an equal or greater risk to the 
chemicals they have replaced.
This chapter explores some of the chemicals for which we still 
have concerns in the 21st century.** Many of these are not 
new. The prodigious advances in our scientiic understanding, 
particularly since the elucidation of the structure of DNA in 
1952 and establishment of molecular biology, together with 
the parallel revolution in instrumentation and computing, 
have, led to an ability to recognise a much wider range of 
hazard types associated with chemicals and susceptibilities 
resulting from a variety of physical and genetic factors. 
Similarly advances in analytical chemistry, and associated 
technologies, have reduced the limits of detection and means 
that we can detect chemicals in environmental samples and 
humans at lower and lower concentrations leading to a 
revolution in understanding of human exposure to chemicals. 
Many of these methods generate so-called ‘Big Data’ that 
is the focus of Chapter 8, ‘Pollution – data, surveillance 
and health impacts’. In totality these methods and data 
have led to an appreciation of the potential risks associated 
with chemical use but also challenges in terms of correctly 
interpreting the available data. 
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Box 1 The precautionary principle
The precautionary principle states that “When an 
activity raises threats of harm to human health or the 
environment, precautionary measures should be taken 
even if some cause and effect relationships are not fully 
established scientiically.”*
While laudable this can raise issues as scientiic 
understanding of the interaction of chemicals with 
biological systems is further and more rapidly understood. 
In particular 
a)  if new understanding causes existing chemicals to be 
withdrawn on a precautionary basis are the alternatives 
used any better?, and 
b)  as new biochemical cause and effect relationships are 
understood there is a need particularly to understand if 
these relationships are causal in respect of disease and 
of suficient concern to justify precautionary action.
* Tickner, J.A. and C. Raffensperger, The precautionary principle: A framework for 
sustainable business decision-making. Corporate Environmental Strategy, 1998. 
5(4): p. 75-82.
* A condition in which the limbs are underdeveloped or absent.
Epidemiology and health 
outcomes
Epidemiology has played a crucial role in the identiication 
of human harm. For example, epidemiology was essential in 
identifying the phocomelia* (a condition in which the limbs 
are underdeveloped or absent) caused by thalidomide and 
mesothelioma caused by asbestos ibres. The association of 
the exposures in this case with the adverse outcome was 
strong enough to allow intervention long before causality 
was proven.1,2 For both of these examples, and others such 
as lung cancer and smoking, there are some critical factors 
that allowed epidemiology to be effective. The exposure was 
easily determined and the adverse outcome was unusual so 
epidemiology could come to a proven association between 
the exposure and outcome that was suficient to justify 
intervention. For thalidomide there was the additional 
advantage that only a year was required to assess if the 
intervention of removing the exposure was successful as 
phocomelia occurs during, and is observed, at birth, whereas 
other adverse outcomes, such as some cancers have long 
latency periods making it dificult to assess the effectiveness 
of interventions. 
Epidemiology in the 21st century is more complex. For many 
environmental exposures, including ‘21st century chemicals’, 
associations can be much more dificult to derive for two 
major reasons. The exposure can be dificult to measure, 
particularly if at low level concentrations or a chemical 
combination. Secondly, the adverse outcomes often have 
a high background level in the general population making 
the determination of an increase in events dificult to 
distinguish. An example would be reported headaches and 
dizziness from low level or intermittent fume exposure. An 
increase in dizziness and headache is dificult to quantify 
against the high background, and dificult to associate with 
an exposure, making epidemiological association of cause 
and outcome challenging. These factors provide a critical 
challenge to epidemiology that can often only be resolved 
by larger studies to gain statistical power that then become 
increasingly expensive. Epidemiology, though, is beneitting 
from the data now available from electronic systems such as 
internet, satellite imaging and mapping and personal devices. 
Ultimately this will beneit the development of epidemiology 
to inform on human risk. 
This is an important factor in looking at how we go ahead 
in the 21st century and dictates that epidemiology alone will 
not be suficient. We are going to need more experimental 
studies where confounding variables can be separated. These 
experimental studies are going to need to focus more on real 
world exposures rather than doses high enough to get an 
effect, and be carefully designed to ensure as far as possible 
the data are translatable back to humans. This is also going to 
need to be achieved against a background of reduced animal 
use and needs to take into account human diversity. 
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Burden of disease from 
pollutants
A Lancet Commission has recently examined the burden 
of disease from pollutants in detail. Worldwide premature 
deaths due to pollution were estimated to be nine million 
worldwide in 2015 (16% of the total) with the majority 
of this burden falling on low to upper middle income 
countries. A common factor across all countries, however, 
is that the majority of the burden is due to air pollution.3 
This seems unlikely to change during the 21st century as air 
is arguably the most dificult to control of all the exposure 
routes. However while tackling air pollution, it is important 
not to forget the burden of disease due to land, food and 
water chemical exposures. Such exposures, although more 
prevalent in lower to middle income countries, still contribute 
to the overall burden in high income countries. Furthermore 
the nature of exposure is changing. Experimental methods 
to recognise acute hazards are well developed and so is risk 
management/prevention of acute exposure. For the 21st 
century the emphasis is going to be on the long term low 
level exposure that are both more dificult to assess (often 
requiring long extrapolations from acute exposure effects) 
and more challenging to manage.
Chemical regulation in the 
21st century
Chemical legislation ensures a uniform approach to 
controlling the risks associated with the use of chemicals 
across a given product sector and geographical area. In 
the European Union the primary legislation for regulating 
chemicals is ‘Registration, Evaluation, Authorisation & 
restriction of Chemicals Regulation’ (REACH) (EU No 
1907/2006) and ‘Classiication Labelling and Packaging 
Regulation’ (CLP) ((EC) No 1272/2008), which outline 
a common set of rules across the EU that govern how 
chemicals are classiied, labelled and packaged. Equivalents 
exist globally such as the Toxic Substances Control Act 
in the US, whilst equivalents exist globally. The EU has 
some additional regulations; the Plant Protection Product 
Regulation (EU No 1107/2009), the Biocidal Product 
Regulation (EU No 528/2012), the Water Framework Directive 
(2000/60/EC) and the Cosmetics Regulation (2009/1223/EC).
These pieces of regulatory legislation require agencies to 
oversee them, for example the REACH, CLP and Biocidal 
Products Regulations are overseen by the European 
Chemicals Agency (ECHA) and in the US the Environmental 
Protection Agency (EPA). Testing uses speciic protocols, 
often agreed globally by the Organisation for Economic 
Cooperation and Development (OECD), but the protocols 
generally only apply to data generation, not to interpretation. 
Although guidance for interpretation is available, it can differ 
between agencies and countries. Data can be reviewed and 
interpreted by different, independent agencies that can lead 
to differing opinions, as has been seen recently with the 
evaluation of glyphosate by IARC and EFSA. Though the 
opinions of all agencies are valid, they are often different 
because they are based on different criteria; for example 
active substance versus formulation. These differences can be 
somewhat opaque and can lead to public confusion. 
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Box 2 REACH regulation 
The REACH Regulation entered into force on 1st June 
2007 and is designed to ensure a high level of protection 
for human health and the environment from chemicals, as 
well as the free circulation of chemicals in the EU market 
enhancing competitiveness and innovation. Crucially 
REACH shifted the responsibility to manage chemical risks 
from public authorities to industry.
REACH implementation requires data, which are usually 
derived from companies testing their chemicals (with 
additional data from academic sources). Testing uses 
speciic protocols, often agreed globally by the OECD, but 
the protocols generally only apply to data generation, not 
to interpretation. Although guidance for interpretation is 
available, it can differ between agencies and countries. 
OECD tests can be used to determine a chemical’s hazard 
by comparing the available data on a chemical to the 
standardised criteria for classiication and labelling outlined 
in the United Nations Globally Harmonised System of 
classiication and labelling of chemicals (GHS), which is 
implemented in the EU via the Classiication Labelling 
and Packaging Regulation (CLP). Currently the REACH 
regulation requires that substances manufactured or 
imported within the EU at a quantity of one tonne per 
annum or more are registered.
For chemicals where it is deemed that their use poses an 
unacceptable risk to human health or the environment, risk 
management measures may be implemented and placed 
on a list of substances of very high concern. This may be 
followed by restriction or authorised use classiications. 
Before a chemical is subject to restriction or authorisation 
under the REACH regulation, the risks of the chemical, 
its alternatives and the socioeconomic impacts of that 
regulatory action are considered.
‘21st century chemicals’ and 
new science
Understanding the impact of chemicals on health in the 21st 
century requires an appreciation of the advances in science 
over the last century, especially the last 50 years. Genomic 
methods and genetic biology in particular have had a 
substantial impact. It is now possible for the whole genomes 
of individuals to be sequenced quickly and at relatively low 
cost, giving rise to the very real possibility that each of us will 
have our personal genome as part of our medical records 
within the foreseeable future. The same technology means 
that many thousands of endpoints can be assessed for a 
chemical. Consequentially we can now measure chemical 
effects on biological systems before the development of 
recognisable physical outcomes. This raises the question how 
such effects relate to, and predict, adverse health outcomes. 
Other molecular biology advances include high throughput 
screening, quantitative structure–activity relationship models. 
These approaches to testing and assessment are all advancing 
our ability to conduct hazard assessment more rapidly but 
translating this knowledge to and actual assessment of risk 
is becoming more challenging. The challenge, though, of 
managing hundreds of thousands of chemicals on the market 
will not be achieved without high throughput methods and 
grouping approaches.
Chapter title
Annual Report of the Chief Medical Oficer 2017, Health Impacts of All Pollution – what do we know? Chapter 3 page 6
Chapter 3
New interactions or susceptibilities can be identiied and 
thus ‘old’ chemicals have to be reconsidered in terms of 
their potential toxicology. Chemicals can only be regarded 
as no longer relevant to health when there is no longer any 
exposure – that is when they are removed entirely from the 
environment. There are therefore some chemicals that are 
both legacy chemicals but are still a 21st century concern 
due to the impact of new technologies recognising new 
interactions and potential toxicities. One such example 
is diesel particles, which act through newly identiied 
mechanisms in immune cells, contributing to asthma 
development and exacerbation.
Allied with the development of new technologies has been 
the development of new biomarkers. These give greater 
insight into alterations in biochemistry and physiology, 
and therefore to changes that may occur due to chemical 
exposures that may not have been previously detected. 
Biomarkers are further discussed in Chapter 8, ‘Pollution – 
data, surveillance and health impacts’.
Figure 3.1  Association of biological changes and apical outcomes
Source Professor Timothy W. Gant
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Mixtures and chemical 
combinations
Historically chemical hazard evaluation tended to be 
considered in terms of individual chemicals but exposure 
to individual chemicals is not strictly representative of the 
real world scenario. We are exposed throughout our lives 
to complex mixtures of chemicals from a variety of sources 
on a daily basis and these mixture exposures can change 
both temporally and spatially. Furthermore chemicals are 
often used in mixtures, and many chemical products are 
mixtures in their own right. The challenge: to assess health 
risk from chronic, lifelong exposure to complex chemical 
combinations is dificult. It requires the nature of the 
composition to be taken into account but also the interaction 
of those chemicals. Further interactions with the wider 
environment and lifestyle need to be taken into account. 
These complexities are often poorly understood, resulting 
in a default of adding up the hazard potential of individual 
chemicals – which may be an underestimate if effects are in 
fact synergistic. 
This issue becomes particularly acute when considering 
chemicals that fall into the class of unknown or variable 
composition, complex reaction products or biological 
materials (UVCB). The composition of these substances 
cannot be easily identiied for various reasons, including 
having too many chemicals within them or showing variance 
in composition (between batches). Though it might be 
considered that these are rare, in fact the opposite is the 
case. Most reined oil products fall into this class, as do 
substances such as natural oils and perfumes. As of January 
2017, 21% of substances registered under REACH were 
Chemical Substances of Unknown or Variable Composition 
(UVCBs).4 There is a need for better methods to assess the 
hazard of these UVCB mixtures and put them into groups. 
One such UVCB grouping project using oil products as an 
exemplar is Cat-App.*
*  https://www.concawe.eu/mediaroom/cat-app-project/ 
21st century pollutants 
The next sections address some of the classes of chemicals 
often found in the environment that could continue to be 
a source of concern into the 21st century, even as in some 
cases their environmental concentration, or use, declines. 
In some cases compounds are subject to restrictions and 
authorisations but this can then drive replacement by 
alternatives that may be less adequately tested – this can lead 
to ‘regrettable substitution’ where a chemical with a greater 
hazard is substituted for one with a lesser hazard.
Dioxins and polychlorinated biphenyls
Dioxins and polychlorinated biphenyls (PCB’s) are a large 
category of chemicals. Exposure was irst noted in the 1940s 
with experimental demonstrations of toxicity in the 1970s. 
One example, 2,3,7,8-tetrachlordibenzodioxin (TCDD) is 
classiied as a Group 1 carcinogen by IARC. Studies following 
up past exposure, such as from the Seveso industrial accident 
or after exposure to herbicide agent orange have identiied 
possible birth defects in the exposed populations at high 
doses,5,6 with studies continuing to assess long term impacts. 
The major observable toxicity in acutely exposed humans 
is chloracne.7
Dioxins and PCBs fall within a class of chemicals listed as 
persistent because they do not degrade in the environment. 
They also have little solubility in water, therefore tend to 
accumulate in fat sources and concentrate up the food 
chain. Though historically more than 90% of exposure has 
been through the food chain8 this has been falling in recent 
years. Their metabolism and excretion from the body is 
also slowly adding to their ability to accumulate in humans, 
animals and ish. Estimates from food samples collected in 
the US in 1995 showed that freshwater ish had the highest 
concentration, with fruits and legumes containing the lowest 
concentrations.9 The UK Committee on Toxicity of Chemicals 
in Food, Consumer Products and the Environment (COT) has 
more recently reviewed exposures from food and found that 
the levels are greatest from oily ish and some meats such as 
deer. Importantly, exposure has been declining since 1980 
and continues to do so.10 The current estimate for exposure 
is for 70% of the tolerable daily intake (TDI) and therefore 
though a current concern decreased use does not indicate a 
need for continued vigilance.11
Since the 1980’s dioxins have been known to elicit many of 
their toxicological effects via binding to a speciic intracellular 
protein, the aryl hydrocarbon receptor (AHR).12-15 What had 
not been known until recently is that this mechanism is 
important in the activation of immune system cells and is a 
link to autoimmune diseases (see Figure 3.2).16 There may 
therefore be a link between exposure to these chemicals 
in the environment and the substantial rise that has been 
observed in autoimmune diseases over the last decade.17 
Evidence has recently been published in respect of a 
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mechanistic link between diesel particles from transport 
and immune cell activation that could partially explain the 
increases in asthma incidence that affect 1:12 adults and 1:11 
children in the UK.18 
Figure 3.2  Role of the AHR receptor and activation by environmental pollutants in autoimmune and allergic 
immune diseases 
Source Professor Timothy W. Gant
Polycyclicaromatic hydrocarbons (PAHs)
Polycyclicaromatic hydrocarbons (PAHs) are a large group of 
carcinogenic chemicals formed as byproducts of combustion 
and widely distributed in the environment. PAHs are found 
in both air resulting from vehicle exhaust particulate matter19 
and in soil, typically in old industrial sites or heavily populated 
areas.20,21 Additionally, PAHs result from wood and biomass 
burning.22-24 Emissions overall have been declining in the 
UK since 1990 particularly from commercial and agricultural 
sources, the latter probably relecting the much decreased 
use of biomass burning.19 However, despite an overall 
decrease in PAH levels since 1990, they have been increasing 
again between 1995 and 2010. This is probably due to 
the increasing use of wood burning stoves.25 Nevertheless 
monitoring stations across the UK still indicate the PAHs in 
the atmosphere are much less than the 1ng/m3; the European 
commission target value. 
Many, but not all, PAHs are carcinogens and classiied by the 
IARC as class 1 (carcinogenic to humans). Carcinogenicity 
of certain PAHs has been well studied in laboratory animals, 
with observed increased incidence of skin, lung, bladder, liver 
and stomach cancer. Therefore increases in the environment 
would be of concern and there are some indications of 
health effects associated with wood burning that could be 
due to PAHs such as inlammatory responses,26 vascular 
dysfunction27 and breast cancer.28 In addition to cancer 
effects recent discoveries in basic science have thrown new 
light on the relationships between asthma and air pollution 
mediated though the AHR receptor (Figure 3.2).29 
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Box 3 Indoor air pollution
Professor Alastair Lewis, National Centre for Atmospheric Science, University of York
Air pollution found inside homes and the workplace 
makes an important contribution to an individual’s overall 
exposure to any given pollutant. Indoor air pollution can 
be affected by outdoor concentrations, with air pollutants 
exchanged readily where buildings have poor insulation 
and high ventilation rates. In the UK, outdoor air quality 
has improved over the past 40 years and buildings have 
become more energy eficient, with low rates of air 
exchange. A consequence has been that indoor air pollution 
is increasingly decoupled from air quality outdoors; it is now 
affected predominately by emissions and activities occurring 
within buildings themselves. 
The chemical and biological classes of air pollutants found 
indoors are broadly similar to those found outside, with 
similar underlying biological mechanisms for impacting 
on human health. There are however differences in the 
relative distribution of pollutants and chemicals. Most of 
the key outdoor air pollutants are found indoors, including 
particulate matter (PM
2.5
 and PM
10
), NO
2
, CO, and a range of 
volatile organic compounds (VOCs). Ozone is not found in 
substantial concentrations indoors since as a reactive species 
it is readily destroyed on indoor surfaces. Few UK homes 
burn high sulphur-content coal and a consequence is that 
SO2 is also not found in large amounts indoors.
The key sources of indoor air pollution are related to 
combustion-related processes and emissions associated 
with the consumption of manufactured chemical products. 
Combustion sources in the home release a broad range of 
pollutants (as they do outside) including PM, NOx, CO and 
VOCs. The largest indoor combustion sources are from 
central heating (as a primary heat source), cooking (including 
direct combustion and oils/fats released as aerosols) and 
discretionary activities including decorative use of open ires, 
solid fuel stoves and candles.
Indoor air pollutants deviate most substantially from 
outdoors in the relative amounts of VOCs. Outside, VOCs 
are now found at typically very low concentrations, rarely 
above limit values set in air quality legislation. Indoors, 
VOCs can be found at substantially higher concentrations 
relecting the wide range of products that emit this class of 
pollutant. Well-established sources of VOCs include building 
materials (wood treatment, carpets, paints, looring and 
so on) and furniture; both sectors are subject to product 
regulation that aims to minimise indoor emissions. In 
addition a wide range of other consumer products also 
release VOCs indoors, including adhesives and inks (where 
the VOC is a solvent), pesticides and volatile fragrance 
contained in cleaning and personal care products. 
Most VOCs are considered to be of low toxicity, however 
long-term impacts on health are uncertain. Further, 
there is evidence that the trend for increased building 
energy eficiency and increased public consumption can 
result in elevated concentrations indoors. A chemical of 
speciic health interest indoors is formaldehyde. Outdoors 
formaldehyde, typically at low concentrations, is rarely 
considered in the context of direct harm to health. 
Indoors formaldehyde can be ten to 100 times higher 
in concentration, a result of direct emissions and from 
secondary production where formaldehyde is formed as 
other VOCs oxidized in air. Formaldehyde has a wide range 
of reported health impacts including as an eye and lung 
irritant, and it carries longer-term cancer risk. 
There are some notable differences in how individuals 
can manage exposure to indoor air pollution that differ to 
outdoors. Outdoor air pollution is not the consequence 
of the actions of any single individual. Concentrations in 
the home are largely a consequence of a series of speciic 
occupant actions coupled to the building air exchange rate, 
both factors over which individuals have a substantial degree 
of autonomy and control. In most locations (away from busy 
roads), outdoors air is likely cleaner than indoors for the 
majority of classes of air pollution. In such circumstances 
reducing the indoor emissions of pollutants, for example by 
changing patterns of discretionary combustion and chemical 
consumption, may lead to direct reductions in exposure, as 
can actions that increase ventilation through simple actions 
such as opening windows more frequently. 
A barrier to supporting more direct individual action is a 
lack of a reliable low-cost measure of indoor pollution to 
support decision-making and a limited awareness of how 
personal actions impact on indoor air quality. More broadly 
variability in indoor air quality is a major confounding factor 
in the interpretation of epidemiological data on outdoor 
air pollution effects, since indoor exposure cannot be easily 
predicted based on simple factors such as age, postcode, 
and income.
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Microplastics
The world economy generated about 299 million tonnes of 
plastic in 2013.30 Approximately 2-5% of this is estimated to 
have ended up in the ocean, much in the form of discarded 
plastic packaging.31 Thus, between ive and twelve million 
tonnes of plastic waste was discarded directly into the 
environment, much of it non-biodegradable. Over time this 
will break down to form microplastics that are found in 
deep sea creatures, indicating just how pervasive these 21st 
century pollutants have become.32,33
Microplastics are small plastic particles, less than 5mm in 
diameter, that arise in the environment from the degradation 
of discarded plastics (secondary microplastics) or are 
manufactured (primary microplastics) – including cosmetics* 
and products, such as those used in oil drilling and as 
abrasives. Other sources of these particles (and ibres) are 
vehicle tyres, road paint and clothing.33 As these particles are 
now extensively found in the environment there are concerns 
about their transfer into food chains and into the air. For 
this reason the major exposure routes of concern in respect 
of human exposure are ingestion from food and inhalation. 
Consequentially there are three main concerns: 
a) physical toxicity such as blockage of the gut, 
b) chemical toxicity arising from chemicals released from the 
particles that could be plastic monomers, colourings and 
plasticisers and; 
c) lung damage such as inlammation and secondary ibrosis. 
The human exposure, hazard and therefore consequences 
of exposure to these microplastics are largely unquantiied. 
The plastics themselves will be of different types and 
so the identity and quantity of the chemicals involved 
could be challenging to assess: as is the degree to which 
component chemicals of the plastics will be released into the 
environment. 
The consequence, even the extent, of exposure in humans is 
unknown. Exposure to microplastics through food is possible, 
based on studies of seafood; however, it is unknown if this 
translates into meaningful exposure in the population.34 
There is an absence of toxicological data that has meant that 
effective risk assessment is not possible. It is possible that 
lipid soluble phthalates and other chemicals from the plastics 
could be absorbed from microplastic ingestion, as they are 
lipid soluble. Humans, however, are already almost universally 
exposed to these chemicals as a result of their use in plastic 
products. Phthalates used in plastic are currently considered 
to have a low hazard despite some concerns in respect of 
their potential ability to interact with hormonal systems.35
Nevertheless, the burden in the environment should not 
be further increased.35 Microplastics can potentially act as 
vectors for, and enhance the transport of, other organic 
* There are now extensive voluntary bans in place on the use of these particles in consumer products because of the concerns about the subsequent transfer of the particles to the environment. 
** WHO International Programme on Chemical Safety (2011)
materials.36 They can also break down to very small sizes 
which can be translocated from the gut37 and in some cases 
across the placenta.38 In marine organisms blockage of the 
intestinal tract can occur, although this is unlikely to occur in 
humans due to the larger size of the intestine. There is also a 
theoretical possibility for physical toxicity from accumulation 
in organs such as the kidneys. Thus more work on the 
potential for human health effects is required.
Recently cosmetics manufacturers have voluntarily reduced 
or eliminated plastic micro-particles as exfoliants because of 
concerns over their release into the environment. However 
microbeads are only a small part of the overall problem. 
A substantial amount of plastic waste still enters the 
environment from land and at sea and will contribute to the 
problem of microplastics in the environment for a long period 
even if further environmental contamination does not occur.
Endocrine-disrupting chemicals (EDCs)
Endocrine-disrupting chemicals (EDCs) are substances that 
alter the functions of the hormonal system and consequently 
can cause adverse effects for human health.39 As public 
concern has increased and NGOs have taken an active 
interest, intergovernmental initiatives have been introduced to 
better screen and regulate such chemicals, and thus improve 
environmental and public health protection. 
Public concern started to grow in the 1960s40 following 
observations of reproductive failure in wildlife species, 
especially birds.41 The term ‘endocrine disruptor (ED)’ was 
adopted to describe these chemicals.42 A widely used 
deinition is ‘an exogenous substance or mixture that 
possesses properties that might be expected to lead to 
endocrine disruption in an intact organism, or its progeny, or 
(sub)populations’** and scientiic criteria for the identiication 
of EDCs have been published.43
A body of literature now documents an increasing incidence 
of breast cancer in women44, decreased sperm counts and 
increasing incidence of testicular cancer in men45 and other 
endocrine disorders increasing in the human population. As 
all of these cancers have a hormonal component association 
has been made with EDCs as a means of explaining the 
increase in incidence. In humans there are examples of such 
toxicity with potent pharmaceutical agents, for example 
diethylstilbestrol but association of most environmental 
pollutant EDCs with human disease is not proven and 
therefore contentious. There could be other physiological and 
lifestyle factors that could account for, or contribute to, the 
increases in hormonal cancers observed. 
EDCs will remain chemicals of concern for the 21st century 
and while the hazard characteristics of some EDCs have been 
established, the risk to human health has not. The focus 
therefore needs to be on establishing actual risk. Given the 
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complexity of the endocrine systems and health end points 
this is a substantial task.
To address the issues some international endocrine relevant 
chemical screening programmes have been created, and 
in 1998 the intergovernmental OECD work programme on 
Endocrine Disruptor Testing and Assessment was initiated. 
The irst ED tests to be developed have focused on the 
oestrogen, androgen, thyroid, and steroidogenesis pathways. 
However, the array of modes and mechanisms of action 
that require test method development are expanding to a) 
include other related endocrine pathways,46 and b) speciically 
to address mechanisms/modes of action, with respect to 
temporal considerations through life and for subsequent 
generations.47,48 The need for the development of further test 
methods therefore remains. 
Bisphenol A and phthalates
Bisphenols and phthalates are important in the production 
of plastics of various types and exposure is almost universal. 
Some of these chemicals, in particular Bisphenol A, have 
given rise to other products with different uses. For example 
tetra-bromo-Bisphenol A, which is used as a lame retardant 
particularly in electronics. Some chemicals in these classes 
have given rise to concern for two reasons; a) they have a 
well-deined hazard, interacting with endocrine targets, and 
b) because of the almost universal exposure primarily often 
from food. 
Deined hazards have, however, given rise to a great deal of 
misunderstanding amongst both the public and professions. 
Furthermore increases in endocrine associated tumour types 
have led many to make an assumption that there is a causal 
relationship between these endocrine acting chemicals and 
the rises in speciic tumours such as breast and testicular. 
Making these associations can lead to misunderstanding. 
For example although Bisphenol A, a chemical with a known 
and deined ability to activate the oestrogen receptor it is 
metabolised rapidly in humans to a non-active metabolite 
and rapidly excreted, resulting in a low internal exposure. This 
means that, though there is a well-deined hazard, potential 
exposure at the relevant internal organs is low to negligible 
thereby substantially mitigating risk. Phthalates, identiied 
as category 2 reproductive toxicants, have been banned 
from use in general consumer products, including toys and 
cosmetics.
This indicates a challenge that we need to face in the 21st 
century – to regulate chemical use on the basis of risk 
rather than hazard. There is no doubt that Bisphenol A and 
many other chemicals pose a particular hazard at certain 
concentrations. For Bisphenol A though the risk – a product 
of hazard, exposure and vulnerability – is largely discharged 
on the basis of relevant internal exposure. Though the battery 
of tests for assessing hazard are incomplete hazard testing is 
arguably more advanced than the understanding of risk, and 
for this reason regulation is often based on hazard. Where 
more understanding is required is at the level of exposure and 
mode of action pathways. With more understanding of these 
facets of the toxicological pathway then regulation could 
move towards the level of risk and also address vulnerabilities. 
Overall this would be a more satisfactory approach, driving 
innovation and leading to the use of more sustainable 
chemicals with decreasing hazard proiles. Such testing would 
lead to a) a more appropriate regulatory framework and b) 
reduced use of alternative chemicals as replacements for 
which there is often less available safety, and a lower level 
of risk understanding than for the chemical they replace. 
For example, Bisphenol A has often been replaced by the 
structurally similar Bisphenol S, about which less is known in 
respect of its hazard or risk. 
Perfluorinated chemicals
Perluorinated chemicals (PFCs) have been manufactured 
for approximately the last 50 years and are used in a wide 
variety of products on account of their hydrophobic, non-
combustible properties and resistance to degradation. 
The latter means that in the environment some such as 
the long chain (eight carbons or more) are persistent and 
bioaccumulative, and can be transported to environments 
distant from their source.49 Some, such as the perluorinated 
acids are water soluble and can undergo aqueous transport 
over long periods of time.50 One PFC (perluorooctane 
sulfonic acid – PFOS) is listed in the Stockholm Convention 
on Persistent Organic Pollutants (2009), meaning its use 
is restricted whilst others are being considered. They are 
used in a wide range of industrial and household products. 
PFCs are found in varying concentrations in many aquatic 
environments51 and, the serum and breast milk of many who 
live in industrialised countries though levels may have peaked 
in the last decade of the 20th century.52
Positive associations with health outcomes in human 
epidemiological studies are increases in serum levels of 
cholesterol and uric acid, possibly due to competition in the 
kidney for transporter proteins.53 The outcome of increased 
cholesterol might be anticipated to be cardiovascular disease 
but this has not been observed in epidemiological studies. 
In high dose animal models a variety of health outcomes are 
reported including immune responses,54 thyroid hormone 
effects55 and liver toxicity.56 Thyroid hormone effects have 
been a particular concern for the developing foetus. Here, 
the hormone is vital for neurological development and 
because some PFCs can compete for thyroxin on the thyroid 
hormone transport protein this could potentially limit delivery 
to the fetus.55 Some neurotoxicant behaviour has have been 
modelled in the mouse57 though the relevance for this at 
human exposure levels is not clear.
Other effects are seen in the liver including peroxisome 
proliferation, a biological effect known not to be relevant for 
human liver disease.58 All of these effects occur at exposure 
levels several orders of magnitude above those generally 
observed for human exposure. In exposed worker studies 
some associations of perluorinatedoctanoic acid (PFOA) 
with diabetes mortality have been observed.59 Currently 
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PFCs appear not to be anywhere near exposure levels for 
the majority of the population that could lead to health 
outcomes, and there is still debate regarding the toxicity of 
PFCs on human health in the general population. However, 
as they continue to be manufactured and released into the 
environment, and persist for a long time in the environment 
and the human body, there is a need to maintain vigilance for 
health outcomes. Monitoring is particularly important around 
sites where these are used intensely, such as the international 
examples near airields and military sites where large volumes 
of ireighting foam are used. Further, there clearly is a 
need for more mechanistic evidence that would direct the 
epidemiology in terms of health outcomes as well as adding 
causative weight to the indings of such studies. 
Metals
Metals of all types constitute an interesting challenge for 21st 
century. For some of the recognised more toxic metals, such 
as lead, controls brought in to reduce emissions including 
the removal of lead additives from vehicle fuel have led to 
dramatic reductions since the turn of the century. The same 
is true for mercury. Resulting from restrictions put in place 
following the recognition of the role of mercury in causing 
Minimata disease have reduced emissions from the industrial 
sector. In contrast the transport sector has been contributing 
to an increase in various types of metal exposure. Trafic 
associated metals from transport take the form of particles. 
These particles come, not from the combustion of fuel, but 
from brake wear which means it is applicable to all types of 
vehicles no matter what the fuel type or if they are running 
on roads or rails. Common amongst the increasing particulate 
metal exposures are arsenic, iron, tin, copper, nickel and 
vanadium. All of these metals can elicit toxic effects in 
suficient dose. Further, in the particle sizes in which they are 
released from brakes they have the capability to penetrate 
deep into the lung where they can be absorbed into the 
systemic circulation.
Although environmental lead concentrations have been 
decreasing, a legacy lead contamination remains particularly 
in brownield land development sites. This risk is managed 
by measurement and risk assessment when these sites are 
developed. Such measures should suficiently mange any 
residual risk. However there are still debates about whether 
the current limit levels are suficiently protective. These 
debates will continue as science develops and in particular 
as the use of genomics and allied technologies lead to an 
improved understanding of hazard and vulnerability. There 
will remain a continuous need to revisit such legacy metals. 
There are many more metals that have an associated hazard 
potential. As these metals are used in new applications, 
such as batteries, there is a need to ensure that eficient 
collection and recycling processes are in place to prevent their 
release into the environment. Many toxicological hazards 
can be effectively managed through correct use and disposal 
methods that substantially reduce or eliminate contamination 
and exposure. It is when these risk management standards 
are not properly implemented or enforced that environmental 
contamination can occur leading to human exposure and 
risk. This just a role for governments and its departments; all 
chemical users have a role to play. 
Flame retardants
Flame retardants (FR) are a family of chemicals incorporated 
into a diverse selection of consumer products including 
clothes and other fabrics, electronic goods, furniture, looring 
and in building materials to prevent them igniting. There are 
various types of lame retardants but amongst those that 
have caused the most concern to date are those that fall 
within the class called brominated lame retardants. These 
chemicals are persistent in the environment and can stay in 
the body for several years. Many types of lame retardants 
within this class now have restricted uses or are banned from 
use altogether. While widespread in the environment,60 with 
bans in place levels should start to slowly fall. 
Exposure to brominated lame retardants is mostly through 
food but also from household dust (ingestion, inhalation 
and through skin). The highest dietary exposure in the 
European population tends to be from ish, whereas exposure 
in the US is mostly from meat and dairy products another 
important source. These compounds have a low acute 
toxicity; however, the concern in respect of human health 
is long-term interference with the thyroid hormone system 
because there is some structural similarity between the 
chemicals and thyroid hormones. They are thus classiied as 
EDCs. In addition, because of the propensity of brominated 
lame retardants to accumulate in lipid, they can be found 
at levels of up to 400 times higher (than blood levels) in 
human breast milk, which could be a concern both because 
of the levels and the exposure of infants at a susceptible 
life stage. Though these chemicals are widespread in the 
environment there is, to date, no known causative linkage 
between exposure from the environment and adverse health 
outcomes.
Despite there being no direct linkage to health outcomes, 
the persistence of these chemicals in the environment means 
they are being phased out. Where this is possible, without 
endangering life though rendering products inlammable, 
it is to be encouraged. The persistent, bio-accumulative 
nature of these chemicals means that when they get into 
the environment through inappropriate disposal of waste or 
other means they are dificult to remove. For these reasons 
some of the restricted or banned brominated versions 
are being replaced by other chemicals such as those that 
use chlorines. Some of these are equally persistent and 
bio-accumulative which means that it is certain we will 
be detecting these chemicals and versions thereof in the 
environment throughout the 21st century. Much of this 
chemical contamination could likely be avoided by rigorous 
enforcement of waste disposal. 
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To determine the necessity of the use of these chemicals 
much better data are required to determine beneits in terms 
of lives saved. These data should be assessed alongside 
hazard and risk data to determine acceptable use in terms 
of the balance of beneit and risk. Another, more laudable 
alternative would be to use materials and manufacturing 
techniques that provide natural lame resistance. 
Continuing monitoring will be essential as will further work 
to understand if there are any health consequences from 
long term low level exposure to these chemicals. Those that 
are bio-accumulative should be restricted, or removed from 
use. This would drive innovation into the development of 
alternatives that, if released into the environment, would 
not accumulate there. Examples of innovation could include 
better materials and manufacturing to provide an intrinsic 
lame resistance. 
New challenges
Risk communication
All of the sections above highlight an area in which 
attention is still required – risk communication. Many public 
concerns associated with the use of chemicals stem from 
misunderstandings about beneits versus risk. All too often 
hazard is confused with risk, and regulation on a hazard 
basis does nothing to help this. As science uncovers new 
mechanistic understanding and, in particular, vulnerabilities, 
there needs to be a vigorous effort to translate this 
information into a clear understanding of risk. This can only 
be accomplished by an understanding of both exposure 
and mode of action pathways. This information, with 
associated uncertainties, then needs to be converted into 
communications that state the case accurately and can be 
easily understood. 
Risk also needs to be assessed alongside beneit. There 
is a role here for both academics and independent 
bodies. Ultimately, however, it is going to be government 
departments and agencies that need to make decisions 
and provide advice. It is therefore important that real risk 
is effectively assessed and not confused with perceived 
risk. Risk assessment should take account of data lacks and 
uncertainties and communicate effectively hazard and risk 
assessments and associated uncertainty. 
Cross and trans-generational effects
Cross-generational effects are those that occur in the 
developing fetus and/or the subsequent generation that 
develops from the germ cells within the fetus as a result of 
direct exposure in the womb. Trans-generational effects 
are those that occur in generations not exposed to the 
original exposure and result from heritable changes in the 
gametes. Both can lead to adverse health outcomes and have 
recently developed a higher proile due to new biological 
understanding. The oestrogenic drug diethylstilbesterol is 
an exemplar of cross-generational effects. Used in mothers 
to prevent miscarriage and premature labour, it led to 
vaginal carcinomas in the female offspring and congenital 
abnormalities in males.61 Furthermore, experiments in 
animals, with a variety of chemicals, have shown high dose 
exposure in pregnancy during the development of primordial 
germ cells (that give rise to the gametes) can affect the 
reproductive organs of both the fetus and/or the subsequent 
generation that develops from the fetus. An example of such 
a chemical is the fungicide vinclozolin, which affects the 
testes, and is passed down the male but not the female line.62 
Transgenerational effects are less common, where the health 
outcome is observed in a generation not directly exposed or 
derived from the exposed gametes. 
Studies with vinclozolin and other similar chemicals are largely 
at high dose (and thus are hazard studies), up to a million fold 
greater than environmental exposure. Nevertheless, they set a 
precedent for the existence of chemically induced epigenetic 
toxicity, and highlight that more research is needed to 
enhance understanding of risks to human health that could 
cascade across the generations. There is to date only limited 
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evidence of effects in humans.61 For example, epigenetic 
changes in human sperm have been shown to be affected 
by environmental inluences such as smoking behaviour62 
and paternal smoking has been epidemiologically associated 
with obesity in sons.63 Together with the evidence from 
model systems (including potential mechanisms of epigenetic 
toxicity), the increasing human studies warrants further work 
in the area. 
Susceptibility
Since the human genome was irst sequenced in 2003, 
the cost of sequencing has dropped exponentially and the 
capacity increased even more. Benchtop sequencers that 
can sequence the whole genome are available and multiple 
genomes can be sequenced in a few days. This technology 
has been applied to many genomes from humans of different 
backgrounds and animal species. In addition many cancer 
types have been sequenced. Furthermore the sequencing 
of epigenetic changes has also been developed. In parallel, 
computing power and associated software has improved such 
that these sequences and their analyses are available with a 
few clicks from a computer mouse. 
There have been many net beneits from this work, but one 
is particularly important for risk assessment – the knowledge 
of human genome diversity. This diversity can indicate 
differential susceptibility. To use this knowledge effectively 
there is a need to understand the mechanism by which a 
chemical causes toxicity and in particular, the key molecular 
interactions. Therefore we will have new knowledge that 
potentially allows assessment of susceptibilities within a 
human population and can be built into risk management as 
appropriate. For optimal impact, however, such susceptibility 
assessments require data that are generated about the 
mechanism of action, which is currently not typically done for 
chemicals. 
Conclusions
‘21st century chemicals’ risk assessment will be driven by 
two factors, new materials, but perhaps more strongly 
new technology leading to new biological understanding. 
As more is understood about the interaction of chemicals 
with biological systems, the risk from legacy chemicals, new 
chemicals, and chemical mixtures (a particular challenge) 
will need to be re-assessed on an ongoing basis. Two 
technologies in particular will drive this development, 
analytical techniques leading to better and more sensitive 
measures of exposure and the ‘omics methods for the 
genome, proteins and metabolites that will provide a greater 
understanding of hazard, mechanisms and susceptibilities. 
All these methods will produce large amounts of data that 
will themselves raise more questions. Therefore the major 
challenge ahead will not be generating data, but generating 
the right data and making the right interpretation from all 
the data available. Care will need to be taken to ensure that 
the new hazards recognised are real and relevant to human 
risk. Otherwise, there will be a danger that chemicals will be 
replaced with substitutes with less desirable hazard proiles. 
The future is good for the development and use of less 
hazardous chemicals, and a safer, healthier environment.
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New horizons, an introduction
Previous chapters have largely focused on well-understood 
and well-evidenced impacts of pollutants on health. 
However, the population will be exposed to many other 
pollution pressures whose effects on our health are less well 
understood. For example, one group of chemical pollutants 
of concern are the so-called contaminants of emerging 
concern (CECs). These are pollutants that so far have not 
been studied extensively and which are not routinely 
monitored, where there is a concern from stakeholders 
(scientists, regulators, NGOs etc.) that the pollutant may 
be harming human or environmental health. CECs include 
pollutants such as nanomaterials, human pharmaceuticals 
(see Chapter 3 of this report, ‘21st century chemicals’), 
natural toxins, veterinary medicines and micro-plastics (see 
Chapter 7 of this report, ‘Environmental health – response to 
pollution’). 
Physical pollutants such as light pollution may also be 
adversely affecting our health, whilst sound is not a new 
issue – although there is a more recent understanding on the 
extent of the harm from this pollutant on human health. The 
world is also rapidly changing due to climate, demographic, 
technological and land-use changes and these changes will 
also have implications for the exposure of people in England 
to both the known pollutants and CECs. In this chapter, we 
describe some of the concerns around the impact of these 
more novel pollutants on human health and future drivers of 
pollution exposure and risks. We highlight the need for future 
work and potential management interventions to reduce 
exposure to these substances. We also highlight some of 
the emerging techniques and methods to combat pollution. 
This includes advances in methods to ascertain knowledge 
about the health impacts of pollutants, such as the use of 
epigenetics, mutational signatures in tumours, and the use of 
emerging epidemiological techniques. 
Noise pollution
This section is authored by  
Stephen Stansield, Professor of Psychiatry, Wolfson Institute 
of Preventive Medicine, Queen Mary University of London
Background
The most frequent human responses to environmental noise 
are annoyance and sleep disturbance. Annoyance, which 
includes mild anger and feelings of intrusion of privacy, is 
also a response to disturbance of activities by noise. The level 
of annoyance to noise is inluenced by many other factors 
including sensitivity to noise, fear of the noise source, and 
feelings that the noise producers are taking insuficient 
care. Annoyance to environmental noise increased in the UK 
between 2000 and 2012 despite little increase in exposure, 
suggesting that tolerance of environmental noise has 
decreased.1 Noise exposure during sleep induces arousals, 
delays sleep onset, reduces slow-wave and REM sleep and 
increases the length of time spent awake.2 Short-term effects 
of noise on sleep include impaired mood, increased daytime 
sleepiness, and impaired cognitive performance. Generally 
noise exposure in health studies is measured as the average 
sound pressure over a speciic period using decibels as the 
unit (dBA is the unit of A-weighted sound pressure level in 
decibels) weighted according to differences in human hearing 
sensitivity at different frequencies.
The extent of noise pollution
In 2012, 83% of a survey sample in the UK reported they 
heard road trafic noise, 72% aircraft noise and 48% noise 
from building, construction and road works at home in the 
last 12 months.2 Forty eight per cent reported that their 
home life was ‘spoiled to some extent’ by environmental 
noise. Road trafic noise is the most prevalent form of 
environmental noise exposure. 125 million people across 
Europe are exposed to noise levels above 55dBLden, a level at 
which human health effects are thought to become evident.3 
Although cars and planes have become quieter than in the 
past there are now many more of them.
The health effects of noise pollution
In general, acute responses to noise, deined as unwanted 
sound, include startle responses and physiological arousal. In 
the longer term, repeated exposure and arousal may lead to 
more serious health effects which may be part of the body’s 
response to chronic stress. In recent years studies have shown 
that environmental noise exposure has been associated 
with a range of health outcomes (Basner et al, 2014). The 
mechanism of noise effects on health is thought to be via the 
stress hypothesis where prolonged noise exposure increases 
physiological arousal and the secretion of stress hormones 
such as adrenaline, noradrenaline and cortisol. This causes 
raised blood pressure and heart rate, raised blood sugar and 
blood lipids and may lead to arterial endothelial dysfunction.4 
There is convincing evidence that road trafic noise is linked 
to increased risk of hypertension (meta-analysis of 24 studies 
between 1970 and 2010, OR=1.034 95%CI 1.01,1.06 per 5 
dB increase in 16hr average road trafic noise level).5 There 
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is also a small but consistent risk of coronary heart disease 
related to road trafic noise (OR=1.08 95%CI 1.04,1.13 
per 10dB Ldn increase in road trafic noise).6 In ecological 
studies aircraft noise has been associated with increased 
cardiovascular disease risk and hospital admissions.7 
Aircraft and road trafic noise exposure have also been 
associated with increased risk of stroke8.9, diabetes mellitus10 
and even mortality.11,12 Some variation in the magnitude 
of these associations may be related to noise exposure 
misclassiication and noise levels at residences are only 
an approximation of noise exposure across the day. One 
suggestion has been that effects of noise might be explained 
by concurrent air pollution exposure but Tétrault (2013)13 
found that the point estimates of the association between 
road trafic noise and cardiovascular disease changed less 
than 10% after adjustment for air pollution.
Environmental noise exposure is also related to a range of 
other effects. In children aircraft noise exposure has been 
linked to delays in children’s reading on standard scales in 
cross-national studies.14,15,16 Prenatal exposure to modelled 
road trafic noise has been related to low birth weight 
in a large Canadian study, adjusting for the effects of air 
pollution.17 However, two contemporary reviews have found 
no consistent association between environmental noise and 
prematurity and low birth weight but the studies examined 
were very heterogeneous.18,19 
Noise pollution and the burden of ill health
In order to assess the magnitude of the effects of 
environmental noise exposure on health the WHO published 
the burden of disease from environmental noise in Europe, 
based on noise exposure, the distribution of exposure and 
existing exposure-response relationships. 61,000 DALYs were 
attributed to ischaemic heart disease based on hypertension 
and IHD outcomes, 45,000 DALYs to cognitive impairment in 
children and young people, aged 7-19 years, 903,000 DALYs 
to sleep disturbance, 22,000 DALYs to tinnitus, and 654,000 
DALYs for annoyance.20
In terms of the health effects of environmental pollution 
in Europe, environmental noise comes second in burden of 
disease to air pollution and arguably is responsible for more 
disturbance of quality of life. Environmental noise is also 
responsible for more life years lost than other signiicant 
environmental pollutants such as lead, ozone and dioxins.21
What can be done to reduce noise exposure 
and consequent health effects?
Interventions to reduce population noise exposure can be 
considered at several steps along the pathway from the noise 
source to the receiver.22 Reduction of noise at source is an 
ideal but often expensive solution such as designing quieter 
cars and aircraft and the provision of sound absorbing tarmac 
to reduce tyre noise or grinding rail tracks to reduce noise. 
More easily achievable source reductions include airport 
* https://www.gov.uk/government/publications/noise-policy-statement-for-england
night curfews, changes in numbers of lights from airports 
and changes in trafic lows on motorways. Interventions 
between the source and the receiver, such as sound insulation 
of windows or noise barriers along roads and railways 
have been shown to be effective in reducing levels of noise 
exposure.23 New/closed infrastructure interventions include 
closure of light paths, introduction of bypasses and urban 
planning control such as the avoidance of new buildings, 
especially sensitive buildings such as schools, close to noise 
sources. Other physical interventions include the availability of 
a quiet side to dwellings exposed to road trafic noise which 
has been shown to reduce annoyance and the availability 
of green space for psychological restoration.24 Education/
communication interventions help to educate people to 
change behaviour to reduce noise exposure or to explain 
the reasons for noise changes which may help to reduce 
community annoyance levels. 
At the level of public policy the European Noise 
Directive requires EU states to map noise levels in urban 
agglomerations and develop action plans to reduce noise 
levels in the highest exposed areas.3 This has focused 
attention on noise as an issue, with increasing effort to 
standardise data collection across countries, but there is still 
incomplete data from many areas. In England, the Noise 
Policy Statement for England* sets out the long-term vision of 
government noise policy to promote good health and a good 
quality of life through management of noise. Its aims are to 
avoid signiicant adverse impacts on health and quality of life, 
mitigate and minimise adverse effects and where possible 
contribute to the improvement of health and quality of life. 
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Light pollution and health
This section is authored by  
John O’Hagan, Public Health England
Humans evolved with the sun as the main source of light. 
Therefore, daily activities took place when it was light: 
when the sun went down, we sought shelter and slept. Fire 
provided a form of artiicial light, which was developed into 
lamps by burning oils and then candles. Despite this, one 
hundred years ago when houses had artiicial light in the 
form of gas lamps, most people’s day was still driven by the 
availability of daylight. The incandescent light bulb and the 
installation of electrical supplies into factories and homes 
changed this, extending the day with suficient levels of light 
to carry on complex tasks. 
Since then lighting has changed. The focus on energy 
eficiency meant that the incandescent light bulb was 
phased out, moving to luorescent lighting and then to 
LEDs. Fluorescent lamps provided one health concern. Linear 
luorescent lamps were known to leak small amounts of 
ultraviolet radiation, managed using plastic diffusers to ilter 
it or by the distance the lamps were from people. Following 
concerns from dermatologists, scientists at what is now 
Public Health England carried out an extensive study of the 
emissions from compact luorescent lamps. This showed that 
some emitted levels of ultraviolet radiation could exceed the 
exposure limits for workers, especially when used close to 
the skin. A small proportion of the population appeared to 
be particularly sensitive to these emissions. However, there 
were signiicant beneits to some people who needed a light 
source, for example, those needing a source close to the page 
of a book so that they could read.
Ideally, light should be controlled so that it only illuminates 
the areas where it is required – and only for the times when it 
is required. Light pollution is not new – the orange glow from 
sodium lighting above towns and cities has been a problem 
for decades. LEDs, coupled with well-designed optical 
systems, provide an opportunity to control light distribution, 
speciically to ensure that light goes onto the surface to be 
illuminated and not, for example, into the sky. There are also 
concerns that 24-hour light may have an adverse effect on 
lora and fauna.
Moving to a 24-hour society presents some challenges for 
our bodies. We evolved to experience a reddening sky as we 
move into the evening. Our melatonin levels should start to 
increase to prepare ourselves for sleep and to facilitate the 
body’s repair mechanisms. When we get up in the morning, 
the sunlight should suppress our melatonin levels, whilst 
serotonin production is increased to prepare us for activities 
of the day.
In the early 2000s a type of sensor was discovered in the eye, 
in addition to the long known about rods and cones, which 
was also sensitive to light. Intrinsically photosensitive retinal 
ganglion cells (iPRGCs) were identiied as the main sensors 
for entraining our circadian rhythms. Humans have a natural 
body clock that has an approximate 24-hour cycle. However, 
light is the main trigger to ensure that we stay entrained. 
The initial research on iPRGCs, suggested that melatonin 
suppressed was most effective at a wavelength of about 480 
nm (blue light). However, this wavelength is close to the peak 
wavelength known to cause adverse photochemical changes 
in the retina, which at high levels can result in eye injury. 
More recent studies have suggested that the rods and cones 
also contribute to the body’s response to light and circadian 
processes. Therefore, it is likely that bright light, of almost any 
wavelength, could have an impact. Disruption of the circadian 
system can have a major impact on sleep quality and daytime 
alertness, which in turn impacts wellbeing and safety. It is a 
bit like having permanent jet lag.
As artiicial lighting technology developed, installers 
recognised the importance of ensuring the observer was 
shielded from high luminance (bright) sources of light 
because of glare, which in extreme cases can be very 
stressful. An obvious example of a shield is the lampshade 
used in the home. Some LED installations, however, have LED 
chips visible, which can form a source of glare. An extreme 
example is daylight-running lights on cars. These are clearly 
visible to other road users and pedestrians. At night, if they 
do not dim, they can be very dazzling and more so for young 
children (who have higher transmission of light through to 
the retina) and older people (who will suffer from scattering 
of the light, particularly in the lens of the eye). This means 
that older drivers, in particular, will be dazzled by oncoming 
vehicles with the risk that they may not see hazards until too 
late. The problem is exacerbated by fog.
Local authorities have been replacing mercury and sodium 
street lights with LEDs. If this is done purely on the basis 
of energy eficiency and cost, it is possible to end up with 
installations that may not be it for purpose. Some streetlight 
luminaires have LED sources that can be seen physically 
projecting below the luminaire, becoming a glare source or 
light pollution. The light spectrum may be enriched in the 
blue, which may be beneicial for keeping drivers alert, but 
many people will ind the light uncomfortable. High levels 
of blue light are known to cause damage to the retina in 
the eye. This only tends to be a problem for blue LEDs and 
not for white-light LED sources containing a blue LED and a 
yellow phosphor. It is possible to have LED street lighting that 
directs the light only to the areas that need to be illuminated, 
minimising the light that goes in the sky. They can also be 
provided in a range of colour temperatures, where warmer 
colours are likely to be more appropriate for populated areas.
Aside from the wavelength and brightness, there may be 
another impact of LED lighting. Some of the LED sources 
assessed by Public Health England and others vary in 
illuminance at a frequency of 100 hertz. At the extreme, 
the LEDs switch on and off 100 times per second. This is of 
concern for a number of reasons. Some people seem to be 
very sensitive to this light modulation, resulting in headaches, 
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migraine and less speciic feelings of malaise. However, most 
people will experience phantom arrays (as happens when 
you move your eyes quickly when behind a car with its brake 
lights on, particularly in the dark) and there is the risk of a 
stroboscopic effect. This effect may manifest itself as moving 
objects appearing to jump, rather than move smoothly. More 
seriously, rotating machinery, which could include the blades 
on a food mixer, may appear to be stationary if the rotation 
rate matches the modulation rate or is a multiple of it.
Nanomaterials
This section is authored by Alistair Boxall, University of York
Nanomaterials (NMs) are generally regarded as materials that 
have one or more dimensions of less than 100 nanometres 
in size. At this size range, the materials have very different 
properties from their equivalent ‘bulk’ material and 
consequently NMs are now being used in a wide range of 
products including cosmetics, paints and coatings, medicines 
and medical devices, water treatment technologies and 
agrochemicals.25 Release of NMs into the natural environment 
is inevitable. Emission pathways include: entry to air from 
vehicle exhausts; entry to surface waters from down-the-
drain chemicals that are released to the sewerage system 
or from runoff from highways and buildings; entry to 
soils through direct application of agrochemicals and the 
applications of sewage sludge to land as a fertiliser.26 NMs 
may also occur naturally in the environment or be formed 
from the breakdown of larger man-made particles such as 
plastics and polymers.27 
The analysis of NMs in environmental matrices is challenging 
– due to their size – so much of the work done to quantify 
concentrations of these materials in the environment has 
involved the use of models. Predictions from these modelling 
exercises suggest that highest concentrations of NMs in 
surface waters will be in the tens of microgrammes per litre 
range in surface waters, tens of mg kg-1 range in soils and 
100s of ng m-3 in the air compartment.28
Consumers will be exposed to residues of NMs in the 
environment through breathing contaminated air, the 
consumption of contaminated soil or drinking water, or 
through skin contact with contaminated soil or water. NMs 
can also be accumulated by plants, ish and shellish29,30 so 
exposure from consumption of contaminated food items 
may also occur. While it is inevitable that human exposure 
to residues of NMs in the environment is occurring, there is 
less direct evidence of this. The only experimental evidence 
of such exposures comes from studies that used magnetic 
analyses and electron microscopy to demonstrate the 
presence of magnetite nanoparticles in the human brain.31 
They proposed that the most likely source of these particles 
was from airborne particulate matter pollution. 
Modelling studies have attempted to quantify the importance 
of environmental exposure to a particular NM compared 
to exposure in occupational and product-use settings. For 
example, Tiede et al. (2015)32 explored the potential exposure 
of consumers from drinking water. They concluded that for 
the majority of types of nanoparticles that were studied, 
human exposure via drinking water was less important than 
exposure via other routes. The exceptions were some NPs 
from clothing materials, paints and coatings and cleaning 
products containing Ag, Al, TiO
2
, Fe
2
O
3
 engineered NPs and 
carbon-based materials. A similar study by Nowack et al., 
(2013)33 concluded that environmental exposure to materials 
used in agricultural production, drinking water treatment, 
groundwater remediation and in medical textiles is more 
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signiicant than occupational exposure or exposure during use 
of a product by consumers.
Evidence for potential effects of NMs on human health 
generally comes from in vitro studies and in vivo studies using 
model test organisms. For example, silver nanoparticles have 
been shown to reduce lung function, produce inlammatory 
lesions in the lungs of rats and also to accumulate in the 
brain.34 At the cellular level, the particles reduce mitochondrial 
function and increase membrane leakage and alter levels of 
glutathione.34 Whether or not environmental exposures can 
result in these types of effects is however, uncertain.
It is inevitable that the English population will be exposed to 
NMs via the natural environment. The degree of exposure 
will vary depending on the particle and product type and, 
in a few instances, environmental exposure will be more 
important for health than other exposure scenarios (i.e. in 
occupational settings or during product use). NMs do have 
the potential to cause toxicological effects but whether 
exposure concentrations are high enough to reach toxic 
levels is still unclear. As the nanotechnology sector is rapidly 
growing, and exposure levels will continue to increase in time, 
there is a real need to begin to better align environmental 
exposure studies with toxicological studies in order to better 
characterise the risk of these materials.
Box 1 Health concerns over Carbon Nanotubes
Dr Craig A. Poland and Dr Rodger Dufin, MRC Centre for Inlammation Research, University of Edinburgh
Carbon nanotubes (CNTs) are classiied as a ‘nano-object’ 
as they have two dimensions within the nano-range 
(1-100nm) but can have a length many millimetres long. Due 
to exceptional structural and electrical properties, interest 
has increased in the commercial use of CNTs within various 
industries – mostly relating to use within electronics and 
composites. However, concerns have been raised as to the 
possible health effects arising from exposure to CNTs owing 
to their similarity to certain pathogenic ibres, most notably 
asbestos. 
These concerns have led to a signiicant body of work 
addressing the respiratory toxicity of CNTs utilising different 
models. Typical lung responses noted in numerous studies 
include inlammation, formation of granulomas (typical 
of a foreign body reaction), ibrosis and lung cancer.i A 
signiicant concern has been whether or not CNTs could 
reach the pleural cavity and cause mesothelioma, a hallmark 
cancer of asbestos exposure with a long latency period 
(>30yrs). Several studies have shown that lung exposure 
can lead to deposition of CNTs in the sub-pleural region, 
transition from the lung into the pleural cavity and length-
dependent accumulation. The retention of CNTs in the 
pleural cavity has been shown to cause inlammation, 
ibrosis and mesothelioma.ii 
It is important to note that not all CNTs display the same 
level of pathogenicity and results are conlicting. This, 
in part, is because CNTs are produced in a vast array 
of different shapes and sizes which impacts on toxicity 
meaning there is a spectrum of toxicity associated with 
CNT exposure. Broadly, those very short and/or highly 
curled CNTs, forming a compact structure (<4mm), show a 
much lower toxicity than those which are longer (>10mm) 
with a straighter, iber-like morphology. The association 
between shape/ length has also been shown for other 
nanoibres with materials such as titanium dioxide showing 
greater toxicity with increased length.iii In addition, concern 
has been raised over platelet-shaped nanoparticles such 
as graphene-based nanomaterials leading HSE in recent 
guidanceiv to consider nanoplatelets alongside CNTs.
Irrespective of hazard status, the risk of human health 
effects is very much dependent on exposure. Exposure 
is most likely to occur in the occupational environment 
during the production of CNTs as well as the incorporation 
of CNTs into products further down the manufacture 
chain (for example addition to a composite resin). Another 
area of possible exposure is during recycling of CNT 
containing products. A limited number of studies have 
shown CNTs (and other nano-carbons) can be produced 
from anthropogenic sources such as diesel exhaustv, 
leading to possible exposure of the public from the 
general environment. However, CNTs produced from 
anthropogenic sources are not the same as those shown 
to cause respiratory toxicity in animal models (for example 
they are shorter, more compact – generally types thought 
to be less harmful). The possible impact of anthropogenic 
CNTs on health is yet to be fully elucidated. Another source 
of exposure is through interaction with CNT containing 
products yet exposure to free CNTs is unlikely due to being 
sealed within products (such as electronic circuitry or 
embedded within a composite resin).
Numerous exposure limits have been proposed for CNTs 
based on either mass or ibre number metrics yet there are 
currently no statutory limits for CNTs or other engineered 
nano-ibres. Evaluation of CNTs by the International Agency 
for Research on Cancer led to the classiication of a speciic 
multi-walled CNT (MWCNT-7) as a Class 2b carcinogen with 
all other forms of CNT as Class 3 (Unclassiiable).vi
References
i Poulsen et al. (2016) Nanotoxicology;10(9):1263-75, Porter et al. (2010) 
Toxicology;269(2-3):136-47, Kasai et al. (2016) Part Fibre Toxicol; 13(1):53.
ii Rittinghausen et al. (2014) Part Fibre Toxicol; 11:59
iii Porter et al. (2013) Toxicol Sci.;131(1):179-93
iv Health & Safety Executive. (2013) Publication HSG272
v Jung et al. J Air Waste Manag Assoc. 2013 Oct;63(10):1199-204.
vi IARC (2017) Monograph Vol. 111
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Biological pollutants
This section is authored by  
Bjarne W. Strobel, University of Copenhagen 
Natural toxins, agents of biological origin, are chemicals – 
therefore much of their characteristics as pollutants are the 
same as synthetic chemicals. Natural toxins are perhaps more 
familiar as contaminants of food. Examples range from the 
most acutely toxic, notably toxins that cause Paralytic Shellish 
Poisoning to pyrrolizidine alkaloids in honey. Like all chemicals 
they also have the potential to disperse into the environment 
and pollute. Probably the most prominent environmental 
example is cyanotoxins, which are produced by cyanobacteria 
in harmful algae blooms (HABs) in surface water. Natural 
toxins are also added to man-made products, such as 
paint – therefore can pollute down the same pathways as the 
synthetic chemicals in these products.
HABs, an increase in concentration of algal species that 
produce toxins, occur in coastal and inland waterways, and 
are increasing in frequency and magnitude.35 They are often 
the result of invasive species, or species that take advantage 
of changed natural environments (temperature changes, 
nutrient enrichment, droughts etc.) The HABs produce 
species-speciic toxins, such as cyanotoxins. Human exposure 
can come from ingestion of contaminated ish, shellish, and 
drinking water; inhalation; or dermal contact. Health impacts 
vary widely, based on the speciic toxin.36 Another example 
of a potential biological pollutant in England is the chemical 
ptaquiloside, produced by bracken. This is a potential 
human genotoxic carcinogen – but there are a number of 
uncertainties around the risk and notably around the level of 
exposure to the public.37
There are currently still many questions about the nature 
of health impacts of natural toxins, with the ield perhaps 
many years behind our imperfect knowledge of synthetic 
chemicals. Compared with synthetic chemicals, sources of 
contamination are much less understood and tend to be 
located more “remotely” from current monitoring samplers. 
Toxicity is also more frequently genotoxic, with the potential 
human health effects currently hard to quantify. Meanwhile, 
given the formation/release in and into the environment 
is constant but with degradation (although varying in rate 
depending on ambient conditions), it is hard to quantify the 
amounts in the environment using our traditional schemes. 
That said, exposures are likely very low – although perhaps 
heterogeneous. Wider advances in monitoring chemicals, 
such as the NORMAN database (http://www.norman-
network.net/) – which will allow us to screen chemicals with 
potential effects on human health) – will help our response to 
these natural toxins, as well as to synthetic chemicals. 
Box 2 Bioaerosols
Timothy W Gant and Emma Marczylo, Public 
Health England
Increasing populations and demands for food at lower 
cost are having an effect on the way farming and food 
production are carried out. In particular there has been a 
shift towards consolidated high density farming operations 
called intensive farms. These units generate biological and 
chemical emissions, both from the unit and the waste 
generated. At the opposite end of the product life there 
is disposal. With the decreased desire for landill, more 
organic matter is being composted in large facilities. Both 
of these can release bacterial and fungal spores, with 
fungal spores being more predominate from composting 
operations. These could have an effect on health, 
particularly for the development of immune diseases such 
as asthma.
For intensive farming sites there is evidence of health 
effects on workers but only limited evidence for health 
effects in the general population. For composting, there is 
some evidence of a health effect for those living close to 
sites. The same applies for the development of asthma in 
children living near to intensive farming sites.* Conversely 
there could be health beneits. The so-called ‘hygiene 
hypothesis’ states that early life exposure to the type of 
biological agents that could be associated with intensive 
farming sites and composting sites could stop the immune 
system being unduly reactive later in life that could lead to 
immune disease. There is little evidence for this possible 
beneit from composting sites and only very limited 
evidence from intensive farming sites.
Further work must investigate the possible links between 
intensive farming and composting sites, and effects 
on health (beneicial or adverse). This will involve the 
development of better assays to detect the microbial 
species associated with these facilities. Many of the 
traditional methods for detecting biological species are 
limited and not discriminatory. Modern molecular methods 
must better characterise the biological exposure from 
these facilities and link these data epidemiologically to 
health outcomes on small geographical scales. 
*  Int J of Hygiene & Environmental Health https://doi.org/10.1016/j.ijheh.2017.10.019
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Impacts of future change on 
the health risks of pollutants
This section is authored by 
Alistair Boxall, University of York
Introduction
England is changing: over the next century alterations are 
predicted in climate, land-use, demographics, physico-
chemical properties of the environment (for example 
acidiication), water availability and the degree of 
urbanisation. Global climate change (GCC), for example, 
is predicted to result in different weather characteristics 
in England. The English population is projected to 
continue growing, reaching over 63 million by 2039.38 The 
population is also getting older, births are continuing to 
outnumber deaths and immigration continues to outnumber 
emigration.38
All of these changes are likely to affect the risks from 
chemicals and other pollutants in the natural environment to 
human health by altering: 
a) the types and quantities of chemicals that are released to, 
or formed in, the environment; 
b) transport, accumulation and fate of chemicals in the 
environment; 
c) sensitivity of humans to a particular contaminant; 
d) human behaviour (for example Figure 4.1)
Below we discuss some of these potential changes in 
exposure and risks, focusing mainly on GCC-drivers which is 
where most work has been done.
Figure 4.1 Potential global climate change (GCC) related and other drivers that will affect the risks of pollutants 
to human health in the UK in the future 
Source Adapted from Boxall et al.
Future changes in climate will impact chemical usage patterns 
and the amounts used, as well as how chemicals are formed 
in the natural environment and even alter exposure to existing 
chemicals. For example:
  For pesticides, biocides and pharmaceuticals, use will likely 
increase due to changing disease and pest pressures (in 
addition to increases due to demographic changes).39,40
  As the generation of many natural toxins (for example 
algal, fungal and phyto-toxins) is partly governed by 
temperature and moisture, GCC will affect the rates of 
formation of these substances in the environment as well 
as their geographical distribution. 
  For legacy contaminants, such as mercury, that have been 
released into the environment in the past and reside in soil 
and sediments, GCC may alter the environment in such a 
way that the contaminant can be released more rapidly.41
As well as the direct impacts of GCC on pollutants (more 
below), our response will also have impacts on other 
pollutants. For some chemical contaminants there may be a 
reduction in emissions to the environment. As many fossil-
fuel combustion processes that generate greenhouse gases 
also emit other harmful air pollutants, decreases in fossil fuel 
use, resulting from greenhouse gas mitigation policies, will 
reduce ground-level air pollution by particulate matter and 
ozone in urban areas.41 Conversely, shifts to some types of 
biofuels may increase levels of air pollution in rural areas.
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GCC and pollutant pathways
Transport pathways for chemicals will be affected by changes 
in climate conditions which will affect human exposure.42 
Aerial transport of chemicals, for example, is dependent on 
the surface temperature, air temperature and wind speed, 
all of which are predicted to change as a result of climate 
change. Increases in temperature resulting from GCC will 
result in increased volatilisation: this will increase long-range 
transport of persistent organic chemicals, such as PCBs and 
dioxins, and local bystander exposure to chemicals such as 
pesticides.41 Increases in the occurrence of extreme weather 
events, such as loods and droughts will alter the mobility of 
contaminants, providing pathways by which chemicals can 
move from contaminated areas such as contaminated land 
sites and sediments to uncontaminated areas.
On the land, alterations in soil characteristics such as 
reductions in soil organic carbon content, increases in 
dustiness and changes in soil hydrology will alter how 
contaminants are sequestered in soil systems and transported 
around rural catchments.39 The dilution potential of 
contaminants in rivers and streams in the UK will also 
change.43 In agricultural areas, changes in irrigation practices 
and more reliance on re-use of wastewater, in response to 
GCC, could also move contaminants from waterbodies and 
sewer systems onto land. 
GCC and pollutant fate
As well as affecting environmental transport processes, GCC 
will also alter the fate of chemicals. Increases in temperature 
and changes in moisture content are likely to alter the 
persistence of chemicals.43 Biodegradation is generally 
faster at higher temperatures and moisture contents, so 
faster degradation of organic chemicals would be expected 
in hotter and wetter regions. Rates of photolysis are also 
expected to increase in some regions due to reduced cloud 
cover meaning that photosensitive chemicals will be exposed 
to higher intensities of UV light. All of these different changes 
in fate and transport can have both positive and negative 
implications for contamination of air, surface waters, soils, 
food and drinking water supplies and air and hence human 
exposure. The relative changes in exposure will likely vary 
depending on region and the physico-chemical properties of 
the chemical itself. 
Human vulnerability
Human vulnerability to pollutant exposure will be altered.44 
Heat makes humans more vulnerable to adverse effects 
of air pollutants, such as ozone and PM
10
, so anticipated 
temperature increases under GCC could increase sensitivity 
to aerial contaminants. Chemical exposure may also make 
humans more vulnerable to GCC-driven changes, for example 
impairment of the human immune system resulting from 
chemical exposure could increase vulnerability to vector-
borne diseases which are predicted to increase under GCC. 
Human behaviour will also be affected by GCC and this will 
have implications for exposure. 
Summary
Overall, human exposure and sensitivity to pollutants will be 
altered in the future. In some instances, these alterations will 
have a positive impact on exposure and health while in others 
health impacts may be exacerbated. We therefore urgently 
need to establish how exposures of pollutants of potential 
concern could change under different future scenarios and 
to use the results of such analyses to identify potential 
interventions to reduce the health impacts.
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Box 3 Pollution and the weather
Dr Matthew Hort, Met Ofice
The gases and particulates that make up ‘air pollution’ 
originate from sources as diverse as transport, industry, 
agriculture and the natural environment. These sources are 
also spread out geographically across our cities, countries 
and the world. Pollution though does not stay located at 
its source, as once in the atmosphere it is blown, mixed, 
diluted, removed and reacts with, amongst other things, 
the wind, humidity, clouds, rain and other chemical 
compounds. 
The weather we experience knows no borders and the 
winds, systems, and storms evolve, grow and diminish 
perpetually in a continuum spanning from the local street 
to the world. Therefore, chemicals and particulates once 
in the atmosphere can potentially also be transported 
over distances ranging from a few millimetres to 1000s in 
km. The transport by the atmosphere also brings together 
and enables interactions and reactions of and between 
the gases and particulates. While this is a universal 
phenomenon it can perhaps be appreciated more easily 
when we think about speciic events: The eruption of the 
Icelandic volcano in 2014 that resulted in volcanic gases, 
including Sulphur Dioxide which then created sulphate 
particles, spreading across Northern Europe; the presence 
of ine sand from the Sahara on our cars that has been 
blown all the way from North Africa before being removed 
from the atmosphere by rain; the intermittent smell of a 
domestic wood ire on the street or in our gardens; and of 
course, the clear increase in trafic ‘fumes’ as we approach 
major roads and junctions.
This means that the causes of air pollution at a speciic 
location can be: predominantly located far away; be an 
even mix of near and far sources or be predominantly due 
to local emitters. Even in our cities, while the pollution can 
be dominated by local trafic emissions it still contains, 
often signiicant, elements from sources across the rest of 
the country, shipping in the surrounding waters, the wider 
continent and also the rest of the northern hemisphere. 
As such, while it is often correct to focus on local sources 
for local effects, it is however wrong to do this to the 
exclusion of considering the contribution and impact 
from the wider geographical area. The meteorology 
and dispersion after all follow the rules of physics and 
chemistry rather than administrative or societal boundaries.
Epigenetic changes and 
the environment
This section is authored by 
Paolo Vineis, Imperial College London
Environmental changes of the past have had consequences 
on the genetic characteristics of certain populations, such 
as selecting gene variants. For example, the migrations from 
the Fertile Crescent of the Middle East to Northern Europe 
(between 5,000 and 10,000 years ago) led to selection 
among the new settlers of the northern countries of the 
traits for tolerance to lactose and the diffusion of fair skin. 
Both mutations emerged in all likelihood to make up for the 
deiciency of Vitamin D, due to reduced exposure to the sun 
in northern countries. These adaptations appeared through 
selection of favourable genetic mutations in the migrant 
populations. 
It is unlikely, however, that slow changes in the genetic make-
up of populations, that is, in the DNA sequence, dominated 
the response to rapid changes linked to globalisation (for 
example in diet). It was likely due to faster epigenetic 
changes, which are only now beginning to be understood 
in detail. These are functional changes, in how the DNA 
is expressed – or more simply used – which are reversible 
and transmissible from one cell to its daughters. They are 
not structural changes, such as in the sequence of the DNA 
bases.
To give an example of how the environment impacts on 
one type of epigenetic change; methylation is a change, the 
binding of a molecule, to the DNA that affects how it is used 
in a cell. Work is examining the impact of air pollution on 
the methylome, a record of all of these methylation changes. 
Long-term exposure to air pollution has been associated 
with several adverse health effects including cardiovascular, 
respiratory diseases and cancers. However, underlying 
molecular alterations remain unclear. This work investigates 
the effects of long-term exposure to air pollutants on DNA 
methylation at functional regions (elements of the genome 
known to code for proteins) and at a certain recurring DNA 
sequence (CpG sites) that is methylated differently at the 
same site in different human tissue, with this methylation 
associated with disease. Findings suggest that global 
hypomethylation (the absence of this methyl molecule 
binding) is associated with air pollution. Further, methylation 
in both the genes and these CpG sites are mostly affected by 
exposure to NO2 and NOx. Previously, hypomethylation has 
been associated with genetic instability, greater probability of 
mutations and increased risk of disease.
The investigation of epigenetic changes is believed to be one 
of the most promising ields of research on the mechanisms 
that explain the impacts of environmental changes – 
including from pollution – on health.
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Box 4  Mutational signatures – a record of 
environmental exposure?
David Phillips, King’s College London
Whole genome sequencing of human tumours has 
revealed distinct patterns of mutation that hint at the 
causative origins of cancer. Some of these signatures can 
be attributed to environmental causative agents, while 
others suggest defects in cellular processes that maintain 
the integrity of the genome. A large proportion of the 
signatures are, as yet, uncharacterised.
Mutational signatures can be generated experimentally by 
exposing cells to mutagens. In cancers for which tobacco 
smoking confers an elevated risk, smoking is associated 
with increased mutation burdens of multiple different 
mutational signatures, which contribute to different 
extents in different tissues. One of these signatures, mainly 
found in tissues directly exposed to tobacco smoke, is 
attributable to misreplication of DNA damage caused by 
tobacco carcinogens as it closely matches the signature 
induced in cells by exposure to benzo[a]pyrene, a tobacco 
carcinogen. Others likely relect indirect activation of 
DNA editing and of an endogenous clock-like mutational 
process.
Some other cancers also have mutational signatures 
indicative of an environmental exposure: alatoxin in liver 
cancer, aristolochic acid in urothelial cancer, ultraviolet 
radiation in melanoma. Air pollution contains a complex 
mixture of mutagenic carcinogens. Whole genome 
sequencing of tumours attributed to air pollution may yet 
reveal a characteristic mutation signature or signatures 
linking their causation to the environmental carcinogens 
present in urban air.
Advances in epidemiology 
This section is authored by 
Giovanni Leonardi (Public Health England); 
Tony Fletcher (LSHTM)
Addressing pollution needs a new epidemiology that 
integrates measurements from across pollution-relevant 
domains, to human domains. If planning ahead for which 
chemicals would be safe for society to use, regulatory 
toxicology has a clear role to play, however once people are 
unfortunately exposed, epidemiology can have a crucial role. 
Indication of the value of integrating measurements from 
several pollution domains using epidemiology has come from 
several recent results. These include the recognition and 
quantiication of effects of several environmental exposures 
on (1) growth and physical development; (2) behavioural and 
cognitive development; (3) asthma and allergies; (4) sexual 
and reproductive development. 
Both toxicology and epidemiology can provide some 
integration, but have often failed to include information to 
provide quantitative estimation of parameters suficiently 
relevant to a societal level capacity to intervene. The irst 
failure is to ignore population level distribution of beneits 
and hazards attributable to a chemical compound, mixture, 
or other environmental factor, the second is to address 
these aspects by exceedingly weak methods, inadequate 
to reach conclusions about either causal relationships or 
relevant interventions. In anticipating future challenges that 
do not allow time for a prolonged and laborious examination 
of overlapping and conlicting factors over decades, 
epidemiology has the potential to provide valuable and 
quantitative indication of the value of an intervention.
Epidemiology is not a tool or method for public health; it is 
a science essential to public health.45 Non-communicable 
disease (NCD) that has been caused by pollution exposure, 
and for which preventive interventions exist, would not 
be acted upon in the absence of epidemiologically-based 
assessment of population risks and beneits. This applies 
to pollutants too. This may be counterintuitive when 
epidemiology has often been viliied in the media for 
proposing implausible and conlicting interpretations of 
non-communicable disease. This supposed limitation of 
epidemiology may be attributed to the general weakness 
of a science process that does not recognise the beneits of 
population thinking when addressing population-level issues, 
more than to intrinsic deiciencies of either epidemiology 
or the media. Lack of recognition of the essential value 
of population thinking may be more an issue of general 
culture and education than technical competence in any 
given discipline of science. In any case, epidemiologists 
have produced indings of unique value to understanding 
and prevention of non-communicable disease, when clear 
high exposure groups could be deined, as in the example 
of smoking and asbestos. Even when pollutant exposure 
has been lower and more widespread, such as in the case 
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of air pollution, epidemiology has managed to document 
health impacts. So, it is expected that epidemiologists will be 
capable of producing other indings of comparable value on 
other themes such as the challenges summarised throughout 
this report, if adequately trained and supported. In the future, 
a population-level assessment of health risk will be helpful 
whether we consider near-term knowledge needs (ive years) 
such as neurological and other emerging health effects 
of air pollution and transport, health impacts of airport 
(and other transport hub) noise, health impacts of waste 
management approaches such as incinerators and landill 
sites, or longer term needs (up to 20 years) where additional 
foreseeable developments include investigation of potential 
health impacts of new energy sources (for example shale gas 
extraction, small modular nuclear reactors), of light from a 
variety of sources, around current and legacy industrial sites, 
intensive farming practices, or simply in response to potential 
needs to revisit issues such as childhood cancer around 
nuclear sites, power lines, Camelford** etc.
Typically, success in epidemiology in these themes has 
required careful assessment of environmental exposure 
pathways and burden of socio-economic and other 
confounding, and efforts to conduct individual level 
longitudinal studies as well as ecological and cross-sectional 
studies before coming to a conclusion on any topic. Examples 
include results on endocrine effects of persistent pollutant 
** In July 1988, 20 tonnes of aluminium sulphate entered the water supply of 20,000 residents of the Camelford area of Cornwall following accidental contamination. This is considered the largest 
accidental water contamination in UK history.
PFOA and other luoridated compounds, neurological effects 
of DDT and other chlorinated compounds, and the increasing 
recognition of the inter-generational effects of pollutants and 
other environmental stressors by analysis of birth cohort as 
well as adult cohort studies.
To characterise effective, evidence-based potential 
interventions to reduce NCD health burden attributable to 
pollution, epidemiology will be needed as well. This was 
demonstrated by the experience of Environmental Public 
Health Tracking (EPHT) programmes in the US and elsewhere, 
where evaluation of health beneits of complex interventions 
could be documented by consortia that included agencies 
responsible for interventions as well as epidemiologists (see 
Box 6, Chapter 8). Integration in EPHT of information on a 
new generation of biomarkers of exposure and disease risk, 
signiicantly enriched by mechanistic information, seems 
feasible.46
In conclusion, integration of epidemiology with toxicology is 
likely needed to design valid studies of potential harm of new 
and emerging pollutants, and integration of epidemiology 
with sciences adopted by those resourcing interventions is 
likely needed to design valid studies evaluating beneits of 
interventions to prevent NCD.
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Box 5 A breath of fresh air: Novel approaches to behaviour change
Carolin Reiner, Michael Hallsworth, Toby Park, Elisabeth Costa of the Behavioural Insights Team
Every day we make decisions that directly affect the air 
quality around us – be it our commute, our choice of car, or 
the way we heat and light our homes. Cumulatively, these 
decisions have large environmental implications. In other 
words: improving air quality requires changes in behaviour, 
and therefore a more sophisticated account of human 
behaviour will allow us to make better policy. Behavioural 
insights can help provide this more sophisticated account. 
Consequently, behavioural insights can either suggest 
new policy options and new kinds of interventions, or 
improve existing policy options. In terms of new kinds of 
policy interventions, a recent study where Virgin Atlantic 
pilots were encouraged to ly in a more fuel-eficient way, 
demonstrates how behavioural insights can successfully 
reduce emissions.i All 355 pilots in the trial were aware their 
emissions were being monitored, and this fact alone was 
enough to increase their fuel eficiency. Some pilots also 
received behaviourally informed “interventions”, such as 
personal emission targets and feedback on their respective 
performance, leading to even greater reductions in 
emissions. Overall, the experiment saved 6,828 metric tons 
of fuel, which amounts to 21,507 tons of carbon dioxide 
not emitted.ii
There is great potential for similar interventions to reduce 
road vehicle emissions in the UK. For example, there is a 
growing trend among business leet owners to use in-
vehicle telematics to monitor driving style, with insurance 
companies also starting to use the technology to assess 
driving safety and risk. While the awareness of being 
observed is often enough to change behaviour, the use of 
telematics also opens up possibilities for interventions such 
as in-vehicle prompts about driving behaviour, tailored 
fuel consumption reports, the salient highlighting of cost 
savings, and making social comparisons with more eficient 
drivers. The latter idea is analogous to successful work by 
Opower, whose home energy bills have been shown to 
reduce energy consumption by comparing households’ 
energy consumption to their more eficient neighbours.iii 
Similarly, this social comparison could be applied to reduce 
air pollution.
Behavioural insights can also be used to improve existing 
policy options, like incentives structures used to increase 
the uptake of a public service or a recommended product, 
such as low or zero emission vehicles. Scrappage schemes, 
punitive taxes on more polluting vehicles, or changes to 
fuel duty are such possible incentives under consideration, 
and are examples where behavioural insights can be used 
to structure incentives for maximum impact. For example, 
we tend to be loss averse (being more motivated by a loss 
than by an equivalent gain); we often overweight small 
probabilities (meaning lotteries and prize draws can be more 
powerful than lat incentives); and we tend to discount the 
future (meaning upfront rewards are more motivating than 
delayed ones, and delayed costs are less off-putting than 
immediate ones). Speciically, for instance, we could make 
scrappage schemes more salient by introducing a prize 
draw for everyone who signs up and thereby encourage the 
uptake of low or zero emission vehicles.
New ‘behavioural’ policy interventions like setting targets 
to steer driving behaviour are easy to implement and more 
affordable than traditional policy levers like regulations 
(for example the diesel ban), and can also improve the 
effectiveness of existing policies like a scrappage scheme. 
Their cost-effective nature renders behavioural insights 
interventions easily scalable and can therefore substantially 
shift behaviours to clean up the air we breathe.
References
i Gosnellet et al. (2016). Working Paper (22316). National Bureau of Economic Research 
ii Lambert et al. (2016). https://www.virginatlantic.com/content/dam/vaa/documents/footer/
sustainability/VAA_Captains_Study_Summary_FINAL_170616.pdf 
iii Olig & Sierzhula (2016) Evaluation Report. Navigant Consulting.
Chapter title
Annual Report of the Chief Medical Oficer 2017, Health Impacts of All Pollution – what do we know? Chapter 4 page 14
Chapter 4
Suggestions for policy makers
This section was authored by Alistair Boxall and Andrew R H 
Dalton. 
While the links between many environmental pollutants and 
human health are well established, our overall understanding 
of the overall impacts of environmental pollution on human 
health is actually quite limited. This is because:
  we only monitor a handful of the 1000’s of chemical, 
physical and biological pollutants that an individual will be 
exposed to over their life time; 
  even for pollutants where we have knowledge on 
exposure, we have a very limited understanding of the 
effects – particularly for pollutants where exposure is low 
but occurs throughout an individual’s life time; and 
  we have limited understanding of the combined effects of 
multiple exposures to a number of pollutants.
These knowledge gaps could be addressed by:
  The development and application of prioritisation 
methodologies to identify the ‘unknown’ pollutants 
of greatest concern to the UK population and which 
therefore require further testing and monitoring. This will 
likely need much better sharing of knowledge and data 
across different sectors.
  The extension of current monitoring systems (for example 
for water and air quality) to consider a much wider range 
of pollutants and to generate exposure data at much more 
detailed spatial and temporal resolutions allowing us to 
better establish what different populations are exposed 
to throughout their day-to-day lives. The introduction of 
environmental specimen banks would allow us to look 
back in time as new pollution issues become apparent;
  New models for predicting exposure of individuals to 
different pollutants in different regions of the country and 
across a range of timescales;
  The application of new biomonitoring approaches (for 
example ‘omics’ – see box) and technologies (for example 
sensor networks and crowdsourcing of data) to develop 
information on how the health of individuals varies across 
space and time.
By combining information for these new systems for 
monitoring and modelling the exposure and effects of 
pollutants on the human population with approaches for 
analysis of ‘big data’ we should begin to be able to generate 
a much better understanding of the impacts of the plethora 
of the environmental pollutants that we are exposed to on 
our health meaning that interventions can be focused on 
those pollution threats that really matter.
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Summary of key points 
Interventions to reduce pollution have the potential to 
increase social welfare through improvements in health, 
social and economic outcomes. This potential has been 
shown in a range of economic analyses focusing on speciic 
interventions. In this chapter we present evidence from 
studies focusing on the health impacts of environmental 
interventions that have been evaluated from an economic 
perspective. Overall, this body of evidence is strongly 
suggestive of beneicial welfare impacts from most 
interventions. However, there remains signiicant scope for 
expanding and strengthening the current evidence base in 
order to provide clearer guidance to policy makers in policy 
design and investment decisions. Salient points made in this 
chapter include:
  England has successfully managed to “decouple” trends 
of economic growth and polluting emissions, achieving 
reductions in emissions of a large range of pollutants with 
an expanding economy. However, the detrimental health 
impacts of current levels of pollution are still large, as 
are the potential beneits of taking more incisive actions 
against pollution.
  Economic analysis approaches typically applied in the 
appraisal of environmental interventions are at odds 
with those prevailing in the health care domain. A gold-
standard economic evaluation approach in the area of 
environmental health interventions should take a societal 
perspective and aim at assessing overall impacts on 
social welfare. Available evidence neglecting these key 
components likely underestimates the net beneit of 
pollution reduction measures. 
  Research priorities should now include the evaluation of 
the societal beneits of measures to address pollution 
in order to justify economically beneicial interventions 
that reduce individuals’ pollution exposure or remove the 
source of emissions. 
Introduction and background
Understanding the consequences of pollution requires a 
multi-disciplinary approach, and the perspectives of multiple 
stakeholders must be accounted for in designing effective 
solutions. Economics can play a crucial role in understanding 
individual behaviours – how individuals respond to different 
types of incentives – and in assessing the economic impacts 
of interventions to curb pollution. Pollution is often viewed in 
economics as a negative externality of an activity, particularly 
for health and the environment, yet the economic output 
generated by the underlying activity contributes to increasing 
welfare. Economic analysis applies to this problem through 
two principles: (a) eficiency, i.e. the marginal (incremental) 
social beneits of an activity must always exceed the marginal 
social costs involved (e.g. from pollution); and, (b) equity, i.e. 
if different subjects enjoy the beneits of the activity and bear 
the costs involved, some form of redistribution is required.
Pollution has been perceived by some as a necessary evil 
on the way to prosperity and economic development. The 
economic hypothesis linking growth and pollution has 
been portrayed as an inverted U-shape, referred to as the 
“environmental Kuznets curve”, relecting the observation 
that some emissions tend to increase in parallel with 
economic growth up to a certain level of income, until they 
peak and start decreasing as income grows further. This 
concept applies in different ways to different countries and 
types of emissions.1-3 The key principle is the existence of 
a turning point, at which the “decoupling” of emissions 
and economic growth happens, with emissions starting to 
increase at a slower pace than economic growth (relative 
decoupling) and eventually decreasing with further economic 
growth (absolute decoupling). 
A DEFRA assessment showed that absolute decoupling of 
emissions of a wide range of pollutants has been achieved 
in the United Kingdom since 1990, including CO
2
, which is 
typically less amenable to decoupling.4 While population 
and consumption increases are typically the strongest drivers 
increasing emissions, changes in production technology 
and in the mix of products consumed are typical drivers 
acting in the opposite direction. However, the Lancet 
Commission on Pollution and Health has warned against 
simplistic interpretations of the Kuznets curve, which may 
lead to complacency about pollution on the assumption 
that economic development will eventually ix the problem.5 
Achieving the decoupling of economic growth and 
emissions requires effective environmental policies, including 
appropriate forms of regulation and incentives for the use of 
non-polluting technology and energy sources. Pollution is a 
hindrance to further economic growth6 and reducing levels of 
pollution has beneicial impacts on the economy. In the case 
of air pollution, each dollar invested in control measures has 
been estimated to yield economic beneits of about $30 US.5
Evidence of the balance between the costs and the beneits 
of interventions is essential to the design and implementation 
of effective and eficient policies. This helps policy makers 
to understand not only the full extent of the consequences 
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of those policies but also the critical uncertainties around 
policy impacts and future pollution scenarios.6,7 Given the 
established and important health impacts of pollution, a 
sound economic evaluation of an intervention to reduce 
exposure to or emissions of pollution should include an 
assessment of the value of the health beneits of the reduced 
exposure and of the possible impacts on the demand for 
health and social care. Ideally, a proper economic evaluation 
should also account for the indirect effects of pollution, 
namely the productivity loss and the cost to the ecosystem. 
The aims of this chapter are: (1) to review the most robust 
evidence from economic evaluations of interventions to 
reduce pollution, or exposure to pollution, which have duly 
accounted for the health consequences of such actions; 
and, (2) to highlight interventions that have been associated 
with favourable health and economic impacts. In the rest of 
the chapter, we present the indings of a literature review* 
designed to identify comprehensive economic evaluations of 
policy interventions aimed at reducing pollution in the UK, or 
in countries at a comparable level of economic development. 
We also provide an overview of the main types of policy 
interventions that have been implemented and evaluated to 
reduce pollution and its impacts on mortality and morbidity.
* See Appendix 2 of this report (literature review) for more details.
Different types of economic 
evaluation 
Economic analyses of environmental interventions cut across 
two ields (health and environment), which typically adopt 
different evaluation approaches. In health economics, the 
focus is traditionally on how effectively health care resources 
can be used to improve the health of individuals and 
populations, typically through cost-effectiveness analysis. In 
environmental economics, a welfarist cost-beneit analysis 
approach prevails, aimed at assessing whether interventions 
have an overall positive impact on social welfare. 
A gold-standard economic evaluation approach in the area 
of environmental health interventions would typically take a 
societal perspective, in order to account for the broad range 
of consequences that may accrue to different subjects, in 
different time frames, and with different levels of uncertainty; 
and would aim at assessing overall impacts on social welfare 
resulting from the intervention. However, many economic 
evaluations of environmental policy interventions account for 
only some of the wide-ranging impacts (health, economic, 
social, environmental) of such interventions. As a result, the 
net beneits of interventions calculated in different studies are 
often not directly comparable to each other.
The impact of an intervention is either assessed directly by 
comparing the observed pre- and post-experiment outcomes 
(cf. Box 1 for an example), or derived or simulated using an 
impact pathway approach (IPA8). IPA combines different 
sources of information and model estimates. In a typical IPA 
study, one quantiies the change in emissions associated 
with the intervention, applies a dispersion model, relies 
on concentration-response functions to derive the health 
impacts, and translates the effects into a monetary value. 
Depending on the objective of the analysis, this approach 
may also cover non-health impacts such as changes in 
lifestyle, or environmental consequences. 
Health impact assessment (HIA) methods, i.e. IPA 
focusing on health impacts, have been used to document 
the wide and complex impacts of pollution on health and 
mortality (e.g.9-12), but individual studies often assess only 
selected dimensions of those impacts. Assessments also 
provide estimates with large margins of uncertainty, due to 
the complexity of the relationship between environmental 
exposures and health.13,14 Outcomes in HIA can be expressed 
in different metrics and guidance is lacking on how to select 
the most appropriate metric in a speciic context.11
Monetisation of health impacts
In order for health impacts to be taken into account in an 
economic evaluation, they have to be expressed in a unit 
comparable to the costs of the intervention. The objective 
of this section is to review the main methods available to 
monetise health impacts. Table 5.1 summarises the main 
valuation methods. Monetary values offer signiicant 
advantages over in-kind outcome measures. They can 
Chapter title
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summarise multi-dimensional outcomes (including non-health 
outcomes) into a single metric, which is the same metric used 
to assess costs in economic evaluations.
Table 2.1 Summary of main monetisation methods
Health economic technique Description Pros and cons
Unit costs This approach values each unit 
that affects health outcomes, for 
example healthcare resources to treat 
a condition.
It costs individually each aspect, yet not 
all the unit costs are always available 
(e.g. the cost of treating all the diseases 
affected by pollution such as the cost of 
depression)
Willingness-to-pay (WTP) Maximum monetary value that 
individuals are prepared to pay for 
something such as the removal of 
pollution exposure, or noise from trafic. 
This measure is typically extracted from 
surveys. 
It provides a holistic igure that 
cover the direct and indirect costs as 
perceived by the payer. 
However, it is context speciic and lacks 
clarity on what is and is not accounted 
for. It also depends on the individuals’ 
ability to pay and it may not be 
representative of the overall population. 
Value of a Statistical Life (VSL) It is the total WTP of a population to 
save one statistical life, or in other 
words, the risk of death. 
It is often misinterpreted as it does not 
refer to the economic valuation of the 
death of a speciic individual.
From an economic perspective, health outcomes can be 
valued along multiple dimensions. These include the health 
care costs involved, the productivity losses incurred, and also 
intangible costs such as the pain and suffering associated 
with a disease. A simple valuation of health outcomes can 
involve the costing of healthcare associated with the relevant 
health outcomes. For example, if pollution is affecting the 
number of asthma cases, this health impact can be translated 
into the healthcare cost of treating these additional cases. 
Yet, this approach is limited when it comes to the costs of 
intangible direct and indirect health impacts such as mortality 
and loss in productivity. The public health literature values 
premature mortality at about 30,000£ a year.
The willingness-to-pay (WTP) approach addresses some 
of these limitations and is often used to have a price of non-
market goods such as pollution. The WTP is the maximum 
price that an individual is willing to pay, typically here to 
avoid the consequences of pollution exposure. Although 
this measure is abstract and varies by participant (e.g. as 
a function of income, or the nature of health risks), it has 
the beneit of capturing some of the less tangible costs 
and indirect impacts, such as the value placed on a cleaner 
home.15 The main empirical approaches for the elicitation of 
such values are contingent valuation, revealed preferences, 
and human-capital valuation. The contingent valuation 
method requires the participants to state their willingness 
to pay contingent on the hypothetical provision or removal 
of a good or service. It is captured through appropriately 
designed surveys. The revealed preferences method requires 
observational data on price responses, or preferences can 
be elicited by offering survey participants different trade-
offs (e.g. wage/risk trade-offs in the labour market). The 
main limitation of these methods is that they do not capture 
unknown risks to the individuals. For example, if individuals 
do not know or understand that pollution is harmful, their 
WTP will be low. Finally, the human capital evaluations proxy 
the value of health improvements as the difference between 
the decreased consumption of health care and the increased 
production, typically based on earning.16
Aggregate WTP can be used to derive the value of a 
statistical life (VSL), which represents the sum of what a 
population would pay to remove a speciic risk. A number of 
reviews have been undertaken of monetary values reported 
for a statistical life or for particular health risk reductions 
(e.g. Viscusi, 1992). These have consistently shown large 
ranges of variation, but also some clearly identiiable 
patterns (by valuation approach, individual characteristics, 
or characteristics of health risks). The problem of identifying 
a monetary value for a statistical life can be viewed as the 
derivation of a demand curve for health, in which different 
levels of willingness to pay are linked to speciic health 
risk reductions. The use of WTP values in international 
comparisons means that estimates of the cost associated 
with pollution tend to be higher in high-income countries, 
but smaller as a proportion of income compared to low- and 
middle-income countries.17
In a world with limited resources, and where choices must 
be made on priorities for resource use, welfare economics 
offers a systematic approach based on a simple logic. Welfare 
economics is concerned with formulating and justifying 
propositions by which alternatives may be ranked.18 The 
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starting point of welfare economics is individual utilities (or 
wellbeing), and the inal aim is achieving a social maximum 
welfare derived from individual desires and preferences.19 
Prioritising effective interventions in welfare economics is 
made easier by comparing the net beneits of interventions. 
The algebraic difference between the beneits and costs is 
the net value of the intervention, and a positive net present 
value implies an eficient use of resources from an economic 
perspective. However, applying this logic does not leave 
much room for judgements on the distributional implications 
of alternative allocations generally, although the use of 
equity weights is possible. The ranking of alternatives can be 
achieved using cost-effectiveness or cost-beneit analysis. 
The health economic evaluation literature in health care 
settings often relies on Cost-Effectiveness analysis(CEA). 
CEA takes the perspective of an identiied decision maker, 
typically a health care provider, and adopts a narrow view 
on the direct beneits and costs of health care interventions. 
Beneits are measured in natural units (e.g. survival rates, 
life expectancy, life years gained, etc.). The normative nature 
of CEA remains conined to the maximisation of a speciied 
objective function (e.g. aggregate quality adjusted life 
expectancy*) within a budget constraint. CEA ratios for a 
comprehensive series of (non-mutually exclusive) interventions 
that compete for the same pool of resources and then 
compared in a CE league table. Interventions with the 
lowest CE ratios are in principle selected as eficient uses of 
existing resources.
Supporting policy makers who have to ultimately choose 
interventions across a range of options with different 
health outcome beneits is made easier by comparing the 
beneits and costs translated into monetary units. Cost-
Beneit analysis (CBA) has its theoretical basis in welfare 
economics, whereas CE analysis retains a weaker link with 
economic theory. A simple CBA compares the direct cost 
of the intervention, and translates the health impact into a 
monetary value. This method is appropriate if most of the 
beneits are expected to be captured by health outcomes. 
However, if there could be large indirect impact, the true 
costs and beneits are likely to be much larger once the 
indirect impacts are accounted for. 
A few authors are referring to “extended Cost-Beneit” 
analysis to include hidden and external costs not normally 
account for in decision making.20 But due to the lack of data, 
this is rather a narrative than a summary igure.
Societal and environmental impact
The regulation of economic activities that generate pollution 
is complex because of the extent of the externalities involved, 
including wider societal and environmental impacts. Societal 
impacts include the life-long consequences of in utero 
exposure21 and low birth weight22, the cost on children’s 
cognitive development23,24, land value, and damage to 
* The pharmaeconomy literature would refer to cost-utility analysis when the quality of life is taken into account. 
properties (e.g. crops), or changes to the provision of public 
goods (e.g. overcrowded public transports) just to name 
a few. The impact pathways are virtually unlimited for 
many pollutants. Signiicant progress has been made in 
the estimation of a social cost of carbon25, but there is no 
systematic approach for estimating the economic burden of 
other pollutants affecting primarily health, and some impacts 
may not even be quantiiable.26
Policy interventions to reduce a speciic source of emissions 
often generate additional impacts beyond their primary 
target. For example, trafic calming measures have the 
potential to generate “co-beneits” in the form of an increase 
in physical activity.27 Greenhouse gas reduction policies 
have the potential to affect emissions of other pollutants, 
negatively or positively, which could have an impact on health 
outcomes. Other co-beneits comprise reductions in energy 
bills when installing more environment-friendly boilers, or 
healthier food products when switching to less polluting 
agricultural production process.28 Economic evaluations of 
environmental interventions should take these beneits into 
account, as well as possible unintended negative impacts.29 
In economic evaluations, if certain cost cannot be estimated, 
their value is implicitly assumed to be zero. This suggests 
that many evaluations systematically underestimate the 
economic costs of pollution, and therefore the beneits of 
interventions.30
Comparing the different evaluations 
It is a clear that a complete CBA accounting for a complete 
societal impact, including the short- and long-term effects is 
not realistic due to the lack of data to quantify and monetise 
all the relevant aspects. Therefore, all existing CBAs have 
limitations: they rely on different hypothesis to depict a 
complete picture of the costs and beneits of an intervention. 
Even comparing CBAs focusing solely on health beneits is 
made dificult by the variety of ways health impacts can be 
monetised.31
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Different types of interventions
* For example, a policy aiming at reducing individual exposure by providing them with their individual levels of exposure through an app primarily falls into exposure reduction as some individuals will 
take different routes to be less exposed. However, a co-beneit of this policy could be that some individuals decide not to drive to work any more to be less exposed to trafic emissions, and as a result, 
the policy will achieve an emission reduction. 
Policy interventions to reduce pollution have been in 
place for decades32, but were often not the subject of an 
economic evaluation to assess their direct and indirect costs 
and beneits. We describe here the types of interventions 
that have been analysed in the literature from an economic 
perspective. Most of the evidence focuses on air quality 
intervention, but we also review other types of environmental 
interventions when available. We classiied interventions 
into three categories: pollution exposure reduction, emission 
reduction, and emission removal. In practice measures rarely 
fall strictly into one category only as they may also come 
with some co-beneits that fall into different categories (see 
Figure 5.1),* but we review interventions focusing on their 
main objective.
Figure 5.1 Main types of policy interventions to reduce pollution exposure
Source Laure de Preux
Exposure reduction encompasses all types of actions that 
do not address the source of emissions, but the individuals’ 
exposure levels. Often, it can be adopted in the short-run, 
when more time is needed to reduce or remove the source 
of pollution, or when changes in the environment are not 
immediate. Exposure reduction is relatively easy to achieve 
when pollutants are conined into a speciic location.
A more concrete step toward an emission free environment 
is an emission reduction at the source. It can be achieved 
by reducing the activity emitting, or improving the quality of 
the emissions. The former is often achieved by a change in 
behaviour, whereas the latter implies a more eficient process 
in place.
Finally, emission removal requires a complete stop of the 
source of emissions, which is not necessarily achievable in 
the short-run, or would be but at a very high cost. Given that 
there is no healthy level of pollution, emission removal should 
be the ultimate long-term goal. 
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The main sources of pollutions and their associated costs
*  COMEAP does however suggest a methodology to translate life-year into cost.
**  In other words, the effect is not linear. 
***  Box 2 discusses the discrepancy between the current UK limits and those recommended by WHO. 
**** Willingness-to-pay is extracted from a value of a statistical life. 
***** The authors’ only account of respiratory and cardiac diseases. 
Pollution has been associated with increases in morbidity 
in some non-communicable diseases, in particular chronic 
conditions, and excess mortality. The Committee on the 
Medical Effects of Air Pollutants (COMEAP) advises the 
government on all matters concerning the health effects 
of air pollutants, and have estimated the impact of long-
term exposure to air pollution on chronic bronchitis, the 
mortality effects and cardiovascular disease related to long-
term exposure to air pollution, yet they do not provide cost 
estimates of pollution on health and welfare.33,34,* Estimates 
of the morbidity and societal costs associated with pollution 
are limited, although they represent the largest share of the 
economic burden as looking after individuals with different 
morbidities is costly.
The cost impact estimates for various types of pollutants vary 
greatly. The dificulty in comparing different igures from 
the literature comes from the fact that pollutants as well as 
sources of emissions differ between the different studies. 
Furthermore, the effect depends on the pollution reference 
level or speciic change analysed. The effect of a small change 
in pollution levels is not necessarily proportional to a large 
change.** In addition, the health or societal burden estimates 
do not necessarily capture all the direct and indirect effects. 
The different examples chosen below illustrate the magnitude 
of the impacts distinguishing between the health associated 
costs and the overall burden for the society. The igures 
are not directly comparable as they cover different aspects, 
estimate the inputs in different ways, and express the results 
in different units. The Methodology for Cost-Beneit analysis 
for the Clean Air for Europe (CAFE) programme illustrates the 
limitations explicitly in this type of exercise.35-37
Air quality is currently at the centre of attention. In the UK, 
exposure to particulate matter has been associated with a 
reduction of six months of average live expectancy, and a 
related cost of £16 billion a year.38 The Lancet Commission 
on pollution and health estimates the current cost of ambient 
and household air pollution at 117.30 billion 2015 US dollars 
in the UK.5 In London only, PM
2.5
 and NO
2
 in 2010 have an 
associated mortality burden of £1.4 billion and £2.3 billion in 
2014 prices, respectively. The number of hospital admissions 
in London associated with these two pollutants were 2,732 
and 419, respectively.39 Trafic has been estimated to cost to 
the society 0.01-0.09€/km (0.02-0.41€/km for 1996 cars or 
older) in France.40
The Aphekom project estimates the cost of a decrease in air 
pollutant levels to the WHO air quality guidelines in terms of 
particulates and ozone.*** The authors use a HIA approach 
and monetise the mortality**** effect using a willingness-to-
pay approach and the morbidity***** cost using the cost-of-
illness. The estimated monetary gain is €31 billion annually 
over 25 European cities estimated over 2004-2006.41 In 
London, if the beneits of current and planned policies deliver 
the reductions they are anticipated to, life expectancy would 
increase by six months.42
Air pollution is not the only type of exposure. The Lancet 
Commission estimated the cost of lead exposure in the UK 
at 17.76 billion US dollars, and unsafe water sources to cost 
13.23 billion US dollars in the UK only.5 Coal-ired power 
stations are believed to cause 1,600 premature deaths per 
year, and cost £1.1 to 3.1 billion per year to the society.43 This 
is to give a sense of the magnitude of the problem. 
The health and societal costs of pollution are unarguably 
high. Yet, given that each estimate is context speciic, there 
is a lack of a range of estimates using the same methodology 
that allow them to be used in economic evaluation. As a 
result, very few studies have been able to account for them in 
a comprehensive CBA allowing us to compare the net societal 
beneits of different interventions.44 We discuss three broad 
categories of interventions to reduce pollution and present 
in more details, when available, the net beneits of some 
speciic interventions.
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How to address pollution? 
* Website of the London Air Quality Network (LAQN). http://www.londonair.org.uk/LondonAir/Default.aspx 
** The World Health Organization has developed a Health Economic Assessment Tool (HEAT) to measure the beneits of walking and cycling (World Health Organization, “Health economic assessment 
tools (HEAT) for walking and for cycling – Methods and user guide, 2014 update,” 2014.). For example in Brighton and Hove, the tool estimated that 30% increase in the number of cyclists during 
2007-2010 was associated with a mean annual beneit averaged across 10 years of £220,115, but these estimates to do not take into account exposure to pollution. 
Pollution exposure reduction measures 
A irst set of interventions to mitigate the health impacts of 
pollution involves reducing levels of exposure to it. Exposure 
reduction requires a good understanding and measurement 
of the spread of pollution in the relevant media (e.g. air, 
water, ground), as well as effective communication to the 
public. Therefore, exposure reduction often starts with 
an appropriate monitoring system, the design of which 
will depend on the source of pollution and speciicity of 
the pollutant (e.g. water pollution from fertilisers used in 
agriculture is often assessed fortnightly or monthly only45). 
The sampling process to monitor pollutants is normally 
designed to optimise costs and beneits, as measurements 
can be expensive (e.g. in the case of milk dioxin monitoring46) 
and need to be justiied by their beneits. 
Air quality monitoring is the most common. Air quality 
monitoring technology has improved signiicantly over 
the last decade; it has become cheaper, smaller and more 
reliable. Portable and affordable devices are now available 
to the public, although their precision varies greatly. 
Furthermore, air quality networks with continuous monitoring 
such as the London Air Quality Network (LAQN)* are 
now accessible to all free-of-charge and increase people’s 
awareness of air quality in their local area. The information 
from these networks can also be combined with mobile 
phones’ geographical information47 to estimate people’s 
exposure to pollution without carrying monitoring devices. 
Although monitoring is a key element to evaluate the air 
quality, identify problems, and support changes with factual 
information, the Royal Borough of Kensington and Chelsea 
has closed or removed from the LAQN seven out of its 
nine monitoring stations in October 2017. Monitoring is a 
cornerstone in air quality improvement, and this decision 
goes against the evidence reviewed in this chapter. 
However, in order to be beneicial, monitoring needs to be 
complemented by additional information such as overall 
indicators that are meaningful to the user (e.g. a colour 
scheme that translates pollution metrics for non-expert into 
recommendations), alerts of high pollution levels, or practical 
suggestions to avoid or reduce exposure (e.g. alternative 
commuting routes). Alerts are effective in informing the 
public about peaks of pollution48,49 but had no clear impact 
on hospital admissions in a study based in Southampton.50 In 
the case of smog alerts in California, individuals responded to 
the information, although the effect was mostly limited to the 
irst day of the alerts when there were consecutive days of 
high pollution. As the cost of substituting activities between 
days increases over time51, alerts would not be effective in 
case of numerous and repeated peaks. Walking or cycling 
along a street with low trafic can reduce exposure to some 
pollutants.52 Mobile phone apps that propose alternative 
routes to individuals using active transport are becoming 
increasingly popular.** However, the success of these 
alternatives could be limited by the existing infrastructure in 
some cities where walkable routes are limited.53. In the future, 
we should see a more dynamic and personal use of alerts by 
combining individual exposure and needs (e.g. information 
on when to take or increase respiratory drugs on the way to 
school.54). 
When the source of emissions cannot be modiied, 
retroitting air ilters to the source of emissions can be an 
effective solution. The Washington State clean school bus 
program provided $5 million in annual funding for 2003–
2008 for retroitting old diesel buses, and a conservative 
beneit–cost ratio was estimated between 7:1 and 16:1, 
equivalent to a net present value of children’s health beneits 
between 424,000 and 989,000 dollars per adopter school 
district55 (this study is further detailed in Box 1). Stevens et 
al. considered retroitting old cars in Mexico City with either 
type of diesel particulate ilter or an oxidation catalyst, and 
ind positive net beneits. At current prices (2010), retroit 
with an oxidation catalyst provided greatest net beneits. 
However, the authors suggest “as capital costs decrease, 
retroit with diesel particulate ilters is expected to provide 
greater net beneits”.56 Some authors have modelled building 
ventilation and retroitting homes according to certain 
standards to reduce indoor exposure to outdoor PM
2.5
 
using enhanced iltration among others leads to positive 
net health beneits 57,58 but empirical evidence is lacking. 
Others have modelled the optimal ventilation rates to radon, 
while accounting for the increase in heating cost and have 
concluded that periodic ventilation in this context should be 
preferred over a continuous one, but no health impacts have 
been assessed.59
Many more alternatives have been suggested to reduce 
existing pollution levels, such as planting trees and shrubs60, 
optimal ventilation routines to address various sorts of 
pollutants but formal economic impact assessments 
accounting for the health impacts are not available. 
Indoor air pollution is also a health hazard, but cost-beneit 
analyses of interventions to improve health outcomes in 
this context are limited. A study from the Department for 
Communities and Local Government published in 2009 inds 
that carbon monoxide caused the poisoning of about 80 
individuals in a year in England and Wales, but based on a 
cost-beneit analysis, the authors found that the installation 
of CO detectors alongside new gas appliances (already 
incorporating secondary safety systems) comes at a very 
favourable cost-beneit ratio (except in the case of solid 
fuel).61 A model of indoor air ventilation and iltration has 
been developed by the EU-funded HEALTHVENT project. 
Their analysis shows a potential for a signiicant health risk 
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reduction, but the beneits have not been compared to the 
interventions’ costs.62 
Pollution reduction measures
A reduction of pollution can be achieved at very different 
costs and levels of effectiveness depending on the policy 
instruments. One way to reduce pollution is through 
economic incentives that promote more environmentally 
friendly choices of products or behaviour. A irst step 
towards a reduction in pollution is to inform the public of the 
consequences of their choices and offer them alternatives. 
For example, a reduction in trafic-related emissions can 
be achieved by encouraging commuters to choose greener 
transport, such as cycling and walking, by developing 
appropriate infrastructure in cities. An evaluation of New York 
City’s bicycle lanes programme* accounting for a reduced risk 
of injury, additional physical activity, and reduced pollution 
resulted in an incremental cost-effectiveness ratio of $1,297/
QALY gained compared to the status quo.63 Active travel 
also increases pollution exposure, but scientists show that 
cycling and walking only become harmful after 1 hour and 
15 minutes, or 10 hours and 30 minutes per day respectively 
in high background PM
2.5
 levels.64 Of people using different 
transport modes, pedestrians are the least exposed.65 With 
rising concerns about obesity levels, the co-beneits of a more 
active lifestyle are also often included in analyses66,67 but only 
limited evidence exists on the success of such initiatives.68 
An OECD analysis of various voluntary approaches concludes 
that their effectiveness is still unclear69, but these voluntary 
programmes are dificult to assess due to the myriad of 
schemes that may overlap, the lack of adequate data on their 
adoption or their environmental impact, and the estimation 
of the counterfactual scenario.70 
Informing the public and promoting greener alternatives 
is often a low cost policy option**, which does not require 
monitoring and sanctions in the case of non-compliance. 
On the other hand, regulation comes generally at a cost for 
governments. Traditional “command-and-control” (CaC) 
policies based on regulation typically target three aspects 
of pollution: the direct emission target, the concentration 
of pollutant in a speciic environment, and the technology 
standard.71 Direct emission standards are deined as a 
certain level per quantity and/or unit of time, and a certain 
quantity is meant to never be exceeded by the source of 
pollution. Ambient pollution standards specify a maximum 
concentration level, such as the Directive of the European 
Parliament and of the Council on ambient air quality and 
cleaner air for Europe drawn up in 2008.32 Targets cannot be 
enforced directly and monitoring of the different sources is 
necessary to achieve the targets. Setting emissions standards 
does not necessarily guarantee meeting ambient standards, 
and vice versa due among others to meteorological and 
hydrological phenomena.71 Human decision also plays a role 
* 45.5 miles of bike lanes constructed in 2015 at a cost of $8,109,511.47.
** This is assuming that providing it does not require massive investment to change an existing infrastructure.
in the inal concentration of pollution. For example in the 
case of car emission standards, the overall number of vehicles 
on the road will affect ambient air quality. 
Low emission zones (LEZ) and new Ultra Low Emissions Zone 
(ULEZ) are examples of trafic control measures based on 
technology standards. Vehicles may only enter the relevant 
Zone if they do not exceed a certain emission threshold, but 
the mileage they can do within these zones is unlimited. 
These measures are considered to be the strictest trafic 
regulations to contain PM
10 
pollution.32 LEZs have been 
implemented in different cities (e.g. in Munich72, Tokyo, 
Rome, Sweden73,74), and are due to be expanded in the 
future. An economic evaluation of the West Yorkshire Low 
Emission Zone Feasibility Study, where pre-EURO 4 buses 
and Heavy Goods Vehicles (HGVs) were upgraded to EURO 
6 by 2016, generated an annual beneit of £2.08 million 
and a one-off beneit of £3.3 million compared with a 
one-off implementation cost of £6.3 million.75 The London 
LEZ (Congestion Charge Zone) was associated with some 
improvements in air pollution but modest health gains, 
but their causal link with the LEZ has been questioned 
due to other trafic interventions being implemented 
simultaneously.74,76 DEFRA has modelled in detail the societal 
cost and beneits of different pollution reduction measures, 
including, among others, retroitting vehicles with pollution 
ilters, LEZs and road pricing. Their indings show large 
net beneits from measures to reduce particulate matter, 
particularly those generating larger reductions, but not from 
measures to reduce ozone.77,78 A model-based study of the 
Stockholm LEZ shows larger beneits79 than the London 
study, and a cost-beneit evaluation of the scheme shows a 
signiicant social surplus, with investment and start-up costs 
offset by the value of social beneits in around four years.80
CaC policies have many drawbacks. First, establishing 
standards is dificult as it requires, ideally, a good 
understanding of the beneits and costs involved in order 
to anticipate the impacts of alternative standards. Second, 
regulatory policies do not encourage further improvement 
once the pollution level is contained within the set limit. 
Third, regulation does not account for differences in the 
marginal cost of abatement between individuals or irms. 
Fourth, unregulated zones are likely to see a surge in 
pollution, and this is never explicitly documented. The 
example provided in Box 2 further illustrates the dificulties 
involved in implementing standards.
Market-based policies are the main alternatives to CaC 
measures. The former are policies that “encourage behaviour 
through market signals rather than through explicit directives 
regarding pollution control levels or methods”.39, p. 19 Examples 
include taxes, subsides or tradable permits. 
SO
2
 levels have dramatically reduced over the last 30 years 
in the U.S., however it is unclear which policy can be held 
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responsible for this decline. Greenstone82 evaluated impacts 
of the U.S. Clean Air Act (1970) over 30 years and found 
that the legislation classifying counties into attainment and 
nonattainment categories appears to have had little effect 
on the observed overall reduction in SO
2
. The U.S. Clean Air 
Act Amendments enacted the Acid Rain Program (ARP) in 
1990. Two chemicals are largely responsible for acidifying 
deposition, sulfur dioxide (SO
2
) and nitrogen oxides (NO
x
). 
The ARP established a permanent cap on SO
2
 emissions to 
be achieved with an emission market.* Chestnut and Mills 
report health and environmental beneits over $100 billion 
annually for 2010, compared to $3 billion annual costs, 
respectively, accounting for both SO
2
 and NO
x
 reductions.83 
Similar systems are costly to implement84, but their beneits 
may largely outweigh the costs involved once health and 
environmental beneits are fully accounted for.85 More 
generally, the U.S. Clean Air Act passed in 1970 has been 
associated with a 70% reduction in the concentration of 
six common air pollutants while GDP has increased by 
almost 250%.86 Its associated reduction in total suspended 
particulates led to a “one percent decline in total suspended 
particulates [that] results in a 0.5 percent decline in the infant 
mortality rate. Most of these effects are driven by a reduction 
in deaths occurring within one month of birth, suggesting 
that foetal exposure is a potential biological pathway”.87 
However, in the long-run, the associated decrease in 
particulates had little effect on adult or elderly mortality.88 
The European Union has also implemented regulations on 
acidiication, but the transboundary nature of acid rain 
means that different stakeholders have different interests 
in its regulation. The UK has much of its population at risk, 
and therefore has much to gain from it.89 A recent review 
concludes that “the large reduction of sulphur emissions in 
both Europe and the United States have resulted in beneits 
that signiicantly outweigh the costs” when health effects are 
accounted for.90
Desulfurization of power plants in Germany was studied by 
Luechinger to identify the impact of a reduction in SO
2
 in a 
natural experiment framework. The study shows an annual 
gain of 826–1460 infant lives. The lowest health beneit 
estimate of $50 per household per year (the highest estimate 
is $343) compares favourably with compliance costs ranging 
between $33 to $165 per household per year.91 Several 
items of legislation have been passed over the last 40 years 
in the UK to reduce SO
2
, NO
x
, or NH
3
. At the same time, 
downward trends have been observed for those pollutants92, 
but that legislation has not been evaluated in a cost-beneit 
framework.
Household indoor air quality can also be improved by 
pollution reduction measures. Replacing old boilers has been 
showed to have a payback period of four to nine years. 
This is a cost-effective intervention to address fuel poverty 
but also has air quality co-beneits by reducing NOx and 
* The ARP also regulated nitrogen oxides (NOx) emissions but in a different way. 
CO2 emissions.42 A review focusing on asthma concludes 
that a strategy of reducing exposures to both allergens and 
pesticides (“integrated pest management” – IPM) is two or 
three times more expensive than other alternatives.93 Fabian 
et al. ind that “interventions such as IPM and repairing 
kitchen exhaust fans led to 7–12% reductions in serious 
asthma events with 1–3 year payback periods”.94 Radon 
remediation programmes in the UK are effective, although 
the effectiveness varies with the concentration of radon in 
communities95, yet the “current strategy employed in the UK 
is failing to target those most at risk”.95
Agriculture produces a large share of all polluting emissions. 
Ammonia (NH3), for example, comes largely from agricultural 
sources. Ammonia converts into acidifying compounds and 
also contributes to eutrophication.81 McCubbin et al. consider 
livestock management to reduce ammonia emissions in the 
U.S. through diet optimisation, animal housing practices, 
animal waste storage, and land application of manure. Their 
analysis suggests that “a 10% reduction in livestock ammonia 
emissions can lead to over $4 billion annually in particulate-
related health beneits”.81, p.1141 
Schucht et al. compare the costs and health beneits of 
reducing PM
2.5 
and ozone concentrations in Europe at the 
2050 horizon in order to limit the global temperature increase 
to 2˚C by the end of the century. Health beneits include 
reduced mortality, morbidity and the associated care, and 
are monetised using willingness-to-pay and value-of-life-year 
approaches. The study concludes that the “health co-beneits 
from the ambitious climate policy will at least cover 75%, and 
may in fact amount to more than 450% of the additional net 
aggregate air pollution mitigation and climate policy costs”.97
Accounting for further co-beneit of these policies, such as 
increased physical activity, would make the net beneit of 
these interventions even larger.
Withdrawing pollution measures 
The Clean Air Act of 1956 passed in response of the Great 
London Smog is an example of a ban on certain types of 
smoke fuels in some speciic areas and it successfully solved 
the problem of SO
2
. The Act imposed bans on various 
pollutants such as aerosol sprays. However, more recent 
policies on air quality have been less impactful. 
Many experts claim that a ban on cars in busy cities may 
be the only way to tackle pollution, although this scenario 
has not been evaluated from an economic perspective. 
Diesel vehicles are responsible for a large share of pollution 
and even electric cars, which do not emit NO
2
, generate 
particle emissions through tyre, brake disc, and road surface 
wear.98 As electric cars are on average heavier, they generate 
more non-exhaust particulates.99 Furthermore, electricity 
generation is often not a clean process.100 A study comparing 
electric and gasoline vehicles, and accounting for type of 
electricity generation as well as the short- and
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long-term, local and global impacts*, found that 90% of 
local environmental externalities from driving vehicles are 
simply displaced elsewhere by driving electric cars, although 
it may be a temporary solution in heavy polluted cities and 
arguably a way of mitigating health impacts.101 The authors 
combine a model of vehicle choice, econometrics and an 
integrated assessment model, and illustrate the heterogeneity 
in the environmental beneits. A city suffering from large 
damages from gasoline but provided with a clean energy 
grid can beneit from a move to electric cars. The authors 
estimate the average value of a subsidy across the US, based 
on the economic principle that “subsidy should be equal 
to the difference in lifetime damages between an electric 
vehicle and a gasoline vehicle”101, p. 3701 and conclude that, 
on average, the most eficient policy would rather be a 
tax on polluting vehicles. This illustrates that in high-trafic 
areas electric cars may improve local air quality, but are not 
a panacea.102 
Lead exposure has been signiicantly reduced over the last 
years decades thanks to the bans on leaded fuels, paint and 
plumbing among others in many countries.93 Nevertheless, 
lead is still present in the environment, in particular in 
houses that were built when lead-based paint was still 
permitted. Gould estimated that “each dollar invested in 
lead paint hazard control results in a return of $17–$221, or 
net savings of $181–269 billion” in 2006 prices in the US 
when accounting for medical expenditures and individual’s 
revenue loss.103
* The model includes human health, crop and timber yields, degradation of buildings and material, and reduced visibility and recreation.
Conclusions 
In this chapter, we have presented evidence that illustrates 
the magnitude of the net beneits of the main types of 
interventions available to mitigate the health impacts of 
pollution. A systematic direct comparison of interventions 
is not possible due primarily to the variety of beneits 
considered and the heterogeneity of methods adopted in 
the valuation of health and resource impacts. However, 
some examples exist of studies using consistent approaches 
to comparatively assess the impacts of wide ranges of 
interventions, such as an OECD study undertaken by Hunt.78
Two points emerge clearly from the evidence reviewed. First, 
studies assessing a more comprehensive range of impacts 
of interventions to reduce pollution show larger societal 
values. Second, there is signiicant scope for expanding and 
improving the existing evidence base on the value of many 
interventions, in order to better support the design and 
implementation of appropriate policies. 
This chapter provides an overview of the impacts and value 
of existing interventions that have been evaluated, but it 
does not cover the potential of future policies to reduce 
pollution. The success of future policies will rely on a 
combination of public engagement and very strict policies 
to signiicantly reduce current and future levels of pollution. 
Modest interventions such taxing idling cars have to be put 
in place now, and enforced, but more permanent behavioural 
changes will be achieved with a better infrastructure. For 
example, encouraging greener transport choices will be 
effective with further infrastructure development and 
information campaigns, for instance to improve public 
perceptions around the safety of cycling in urban areas.104,105
It is legitimate to expect the overall cost of pollution, and 
thus the overall beneits of interventions, to be signiicantly 
larger than those identiied in many existing studies. Several 
facts can support this claim. First, only few studies account 
for the cost associated with the impact of pollution on 
morbidity, a major driver of health care and welfare costs, 
and consider exclusively mortality. Second, most studies 
focus on individual pollutants and neglect the effects of a 
simultaneous exposure to multiple pollutants106, as well as 
the spill-over effects (positive or negative) of interventions 
to reduce one pollutant on other pollutants.107 Third, 
disentangling the effects of short- and long-term exposures 
is dificult in empirical studies. Studies tend to take one or 
the other perspective, and therefore underestimate overall 
effects. Fourth, if some people adapt their behaviour 
based on their awareness of pollution, the societal welfare 
costs of pollution are likely to be underestimated.108,109 
For example, Moretti and Neidell110 estimated the cost of 
“avoidance behaviour” to be between 25% and 80% of the 
total cost of hospitalisations due to ozone in Los Angeles. 
Finally, technological innovation is rapidly improving energy 
eficiency and resource use, suggesting that analyses that do 
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not account for innovation prospects may overstate future 
policy implementation costs.111 
When more regulations as well as more stringent regulations 
seem the obvious and right things to do from a public health 
perspective, one of the consequence of Brexit will be that 
most of the environmental legislation will cease to apply 
when the UK leaves the EEA.112
A lot of attention has been given to air pollution from trafic 
as it is a major component of ambient air quality, but other 
sources of emissions such as the manufacturing sector, or 
electricity generation should not be forgotten. Furthermore, 
home, school and ofice environments are where most of the 
time is spent and more evaluation of simple measures should 
be supported in order to prioritise interventions.113
Authors’ suggestions for 
policy makers 
  Better monitoring of pollution, and processes in place 
to access, use and analyse the data. This is an essential 
aspect for assessing the current situation, and better 
evaluating interventions in the future. The cost of monitors 
has decreased signiicantly over time, but installation and 
maintenance remain an issue.114 Whereas the objective 
is the individuals’ exposure, technology has permitted to 
proxy exposure with precise individual’s travel trackers115, 
and pollution dispersion models allows us to have an 
estimate of individual’s exposure. Yet, even if air quality 
monitors are leading at the moment, air quality has many 
components and more efforts should be done to measure 
the various pollutants harmful to health. 
  The UK should adopt temporary and long-term measures, 
as well as implement local and national changes. 
Mitigation polices should not be considered in place of 
pollution reduction or removal. Mitigation should be put 
in place now, reduction and removal is essential to support 
a healthy population and should be implemented as early 
as possible. For example, retroitting taxis is a beneicial 
intervention, but should be implement in conjunction to 
more radical and long-term changes such as Ultra-Low 
Emission Zones (ULEZ) across the cities.39 ULEZ is certainly 
a more stringent measure, but it is implemented with 
exemptions and unlikely to be suficient to reduce trafic 
more permanently. Allowed vehicles in the zone will still 
be polluting and trafic can be expected to be reduced 
for a while as the highly polluting cars are replaced by less 
polluting cars. Permanent solutions will have to shift trafic 
to other type of transport (e.g. goods delivered at night 
by tube in central London). A more global, and permanent 
perspective should not be omitted. For example, it is 
not clear how the ULEZ will impact its neighbourhood 
regions, a broader perspective needs to adopted when 
implementing these changes. 
  Lacks of monetised health impacts that can be accounted 
for in economic evaluation by no mean justify the use of 
a missing value in these assessments. The health literature 
is clear on the impact of environment on health, and if an 
intervention improves the individuals’ hazard exposure, the 
health beneits and co-beneits, as well as the spill-over 
effects should be account for by some values different 
from zero. While more work needs to be done to develop 
a societal cost of pollution that could be used in policy 
analysis, some simple alternatives such as updated DALYs 
for conditions linked with environmental exposure would 
greatly improve the comprehensiveness of the evaluation.116
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Box 1  Retroitting old buses to improve 
children’s pollution exposure – A 
state-of-the-art economic evaluation
A robust approach to assess the beneit of an intervention 
is to compare outcomes before and after the change, while 
taking into account any other factor that could bias the 
result. Beatty and Shimshack55 implement a state-of-the-
art evaluation of a local reduction programme that retroits 
diesel school buses with aggressive pollution control 
technologies in the state of Washington (USA). School 
buses can pollute twice as much as the average tractor-
trailer truck.117, especially in residential areas where they 
collect children, and interventions to make them cleaner 
can lead to signiicant health beneits. A large proportion 
of children use school buses to travel long distances and 
remain exposed to high levels of pollutants inside the cabin 
throughout their journeys. 
The study combined detailed data on bus retroit (about 
4,000 buses in 53 school districts) with morbidity 
(individual inpatient discharges, including the patient’s zip 
code and diagnosis), demographic and weather data. 
A careful analysis of the scheme was required to exclude a 
possible selection effect, for example due to differences in 
underlying morbidity levels between the districts covered 
by the scheme and those not covered. The authors used 
a difference-in-differences design to account for pre-
existing trends and unobserved heterogeneity between the 
districts (adopters vs. non-adopters of the retroits). They 
also exploited the time differences in retroit adoption 
between the districts, and control for a wide range of 
socio-demographic characteristics, such as per capita 
income, racial mix, and school-staff-per-student ratio. 
However, their estimates had to rely on the assumption 
that the health trends of the adopters would have been 
the same as the non-adopters had they not implemented 
the programme. 
Annual health care savings per district due to reduced 
inpatient episodes of bronchitis, asthma, pleurisy and 
pneumonia, following the adoption of ilters on school 
buses were estimated between $54,900 and $128,100. 
The net present value of the programme was between 
$424,000 and $989,000 per district, without even 
accounting for long-term beneits from reductions in 
chronic sequelae and non-respiratory diseases. 
An interesting feature of Beatty and Shimshack’s study is 
that the authors did not have to estimate the impact of the 
programme on local air pollution levels in order to assess 
the health beneits of the intervention. They exploited a 
natural experiment offered by the fast introduction of the 
programme in order to estimate health impacts directly, 
with no knowledge or assumption on pollution levels.
Box 2  Establishing pollution thresholds 
based on a “Less-is-More” principle 
Command-and-Control policies to reduce pollution levels 
often impose a technology standard, or an emission limit. 
The dificulties are that, not only the value limit needs to 
be established, but also the period of time over which 
the measurement applies. Optimal measures are not 
straightforward to establish as the government never has 
perfect information on the effects of different thresholds, 
and even less on wider societal impacts. In the case of 
pollution, a simple principle applies: the less, the better. In 
other words, there is no healthy level of pollution. 
The above principle applies, for instance, to particulate 
matter (e.g. PM
10
, PM
2.5
), which represent a health 
hazard whether they are constant or observed in high 
concentrations over a short period of time.118 However, 
the approaches to particulate matter taken by regulators 
in different jurisdictions have been fairly heterogeneous. 
Not only the “US EPA National Ambient Air Quality 
Standards for PM
2.5 
are lower than the EU limit values” but 
also the “EU requirements for assessing compliance with 
the Limit Value for PM
2.5 
are not more stringent than the 
US EPA requirements for assessing compliance with the 
annual and 24-hour PM
2.5 
National Ambient Air Quality 
Standards”.119 p. 6425 Compliance with particulate matter 
threshold values is challenging not only for the UK, but 
also for 24 other EU Member States.120
Also the EU requirements have been found to be poorly 
aligned with current scientiic evidence.118 In the case of 
particulates, they are roughly 2.5 times higher than the 
levels recommended by the WHO in 2005.121 Pollution in 
London is above WHO limits for particulate matter and 
NO
2
. Levels of NO
2 
exceed also EU thresholds and are not 
expected to fall below the latter until at least 2025.121 
Environmental groups won two legal challenges against 
the UK government in 2017.122 There is now enough 
evidence to know that less is more and this principle 
should be applied consistently in government policy.
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Box 3  Avoidance behaviour and self-
selection
While there is no evidence of adaptation to pollution, there 
is some evidence of avoidance behaviour, that is people 
substituting their intended activities with different ones 
in order to reduce their exposure to pollution. Examples 
include the substitution of outdoor with indoor activities 
when air pollution levels are expected to be especially 
high, or moving more permanently to residential locations 
with lower pollution levels. 
Smog alerts were found to signiicantly reduce attendance 
at outdoor facilities.108 Bottled water purchases were found 
to increase by about 22% after public communications 
about tap water contamination levels exceeding safety 
thresholds.116 But responses to alerts are heterogeneous. In 
the United States, White and more educated mothers were 
found to respond more rapidly to information about toxic 
exposures for children, and were more likely to avoid those 
exposures.123,124,125 
Studies that do not account for the impact of avoidance 
behaviour on people’s health are likely to underestimate 
the welfare costs of pollution.
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Summary 
Pollution is unequally distributed and contributes to health 
inequalities.
Pollution-related health inequalities exist for various reasons. 
Pollution sources can be concentrated in particular areas, 
once in the environment pollution may accumulate and 
disperse unevenly, and some people can be more susceptible 
to the health effects of being exposed to pollution than 
others.
There are strong geographical differences in the occurrence 
and concentration of pollutants. Analysis shows that these 
patterns, which vary by pollutant type, are related to 
measures of socioeconomic status, with pollution sources and 
higher concentrations of ambient pollution typically found in 
more socially disadvantaged areas.
The evidence of how pollution sources and concentrations 
vary with other socio-demographic variables, including 
ethnicity, is less substantial and consistent. How unequal 
patterns of pollution exposure relate to health inequalities 
is complex. Poor health status, adverse health behaviours, 
multiple environmental exposures and psychosocial stress are 
more prevalent in lower socioeconomic groups. These factors 
may mean that pollution exposure has greater impacts on the 
health of these groups, a so-called ‘triple jeopardy’ effect.
These relationships have been most substantially examined 
for air quality. UK studies provide tentative evidence of 
differences in susceptibility affecting health outcomes 
from air pollution exposure. International studies are more 
conclusive that these effects exist.
Options to intervene in the relationship between pollution 
and health inequalities include proactive assessment of the 
distributional effects of plans and policies to inform decision-
making; targeting measures on ‘pollution-poverty hotspots’; 
and supporting community involvement in pollution 
monitoring and mitigation. 
Background 
Addressing health inequalities is a long-standing priority of 
the UK government1, with speciic duties on the Secretary 
of State for Health and health care providers laid out under 
the Health and Social Care Act 2012. Not only are health 
inequalities, as the Marmot report stated, “a matter of 
life and death, of health and sickness, of well-being and 
misery”2, but they are also a signiicant detriment to realising 
employment and other life-opportunities, with consequences 
that ‘spill-over’ for all of society, including increased 
healthcare and welfare expenditure.3 In England, health and 
well-being indicators repeatedly reveal signiicant differences 
between population groups in socio-economic and other 
terms, such that life expectancy, serious illness and many 
other detriments to wellbeing are distributed regressively 
along social gradients.2 p.10 Across local authorities in England 
there are large inequities in life expectancy at birth. It is 
highest in Kensington and Chelsea for boys (83.3 years) and 
Chiltern for girls (86.7 years), compared with Blackpool for 
boys (74.7 years) and Middlesbrough for girls (79.8 years).4 
The social gradient in health in England has also worsened 
signiicantly over the past 30 years.
Health inequalities are deined by Public Health England as 
‘systematic, avoidable and unjust differences in health and 
wellbeing between different groups of people’.5 p. 41 The 
impact of pollution on health, the concern of this chapter, 
has the potential to be differentiated between groups of 
people in systematic, avoidable and unjust ways, exacerbating 
underlying inequalities in a number of harmful non-
communicable diseases.
While there are complexities involved in making deinitive 
assessments of the patterns and consequences of 
pollution inequalities, evidence indicates that poorer and 
disadvantaged groups in society are often systematically 
exposed to higher levels of pollution and that they may be 
more susceptible to the impacts of that pollution. Differences 
in pollution impacts on health can therefore be both a cause 
of health inequalities and a consequence of them, and in 
both respects argued to be both avoidable and unjust. 
To further compound patterns of injustice, evidence from 
‘polluter pays’ analyses show that those most at risk of health 
impacts from pollution are typically far less involved in its 
production6-8: least responsible, but potentially most at harm. 
The notion of environmental justice is widely used to capture 
these concerns9,10 (see Box 1).
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Box 1 Environmental Justice
In the US in particular, environmental justice has become 
the focus of a substantial body of activism, research 
and policy activity. Over the past 30 years, attention has 
been given to differences in pollution burdens between 
population groups deined in racial, socio-economic 
and other terms.10-12 Activists argue that various forms 
of environmental discrimination exist which need to 
be addressed by regulatory bodies such as the US 
Environmental Protection Agency, and government policy 
has since 1994 made environmental justice part of the 
mission of all Federal agencies. In the UK there is a less 
established environmental justice agenda, although the 
research base is developing and both non-government 
organisations13-15 and different parts of government16-19 
have made some steps towards investigating the 
relationship between environmental and health 
inequalities. Air pollution has been the primary focus, but 
by no means the only one.20-22 Whilst most attention is 
typically given to the distribution of exposure and impacts 
between different groups in current populations, questions 
of intergenerational justice can extend to consequences for 
future generations. 
In this chapter we summarise and evaluate key aspects of 
the existing evidence base. Our focus is irst on inequalities 
in patterns of pollution distribution, concentrating in 
particular on the geographical relationships between 
pollution sources and levels and patterns of poverty or 
social deprivation. We then focus on air pollution, the 
subject of most of the existing work, to examine evidence 
of ‘effect modiication’ – how for a given level of pollution 
exposure more deprived and vulnerable population groups 
can suffer stronger health effects than others.
Relating pollution and health 
inequalities
Establishing the nature and detail of relationships between 
pollution and health inequalities is dificult. At each stage 
of the ‘source-pathway-receptor’ sequence there can be 
important differentiations to consider (Figure 6.1). Sources 
of pollution are often concentrated in particular geographic 
areas – due to, for example, the density of trafic or co-
location of multiple industrial sources. Once released, the 
pathways that pollutants follow in the environment can 
mean that they remain or become concentrated in particular 
places, and/or at particular times. The presence of people, 
as receptors, in those places can then be differentiated 
in various ways, in terms of their demographic and social 
characteristics, their patterns of activity over time and space, 
and their susceptibility to harm from the pollutants they are 
exposed to.
There are interactions between multiple pollutants both in 
a place and in peoples’ bodies, which can have potential 
accumulative and synergistic effects.23 There can also 
be synergies between social vulnerabilities, for example 
greater vulnerabilities from being both elderly and socially 
disadvantaged. It is therefore hard to accurately measure 
effects, and further developments in knowledge and 
analytical tools are necessary.
Table 6.1 conveys the scope of UK environmental inequality 
research to date, indicating the analytical approach adopted 
with, on the left, a focus on socio-environmental relationships 
from which impacts on health are inferred, and on the right, 
approaches which explicitly attempt to quantify associated 
health consequences. The coverage is patchy, even though 
the UK arguably has one of the better evidence bases on 
environmental inequality. The majority of studies fall to the 
left of the table, illustrating how environmental inequalities 
and health inequalities research have largely been pursued as 
separate disciplines.
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Figure 6.1 Summary of potential for health inequality across the pollutant source-pathway-receptor model
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Table 6.1 Overview of UK environmental inequalities research by issue and approach, extending beyond 
pollution
Analytical approach Proximity Emission
Area level 
Concentration /
intensity
Concentration 
or dose 
experienced by 
individuals
Health response
Feature of analytical 
approach
Environment metric
Good data availability 
Relatively cheap 
Whole populations 
Health effects inferred 
Little data 
Relatively expensive 
Small samples
Health effects observed
Industrial hazards  
(IPC sites)
999
Landill sites 999
Air quality (NO
x
, ine 
particulates)
99 999 9 9
Surface water quality 9
Potable water quality 9
Noise 9
Radon 9
Electro-magnetic 
radiation
9
Flood hazard 99
Woodland‡ 9
Parks /other green 
space‡
99
‘Blue space’*‡ 9
Multiple /cumulative 99 9
99 – Most research, At least one study
* Health-enabling spaces where water is at the centre
‡ Hypothesis that deprived groups have least access to health enabler
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Inequalities in patterns of  
pollution
The evidence base speciically on pollution inequality has 
been developed through analysis of pre-existing spatially 
disaggregated environmental data against social variables, 
predominantly using various measures of poverty, deprivation 
and socioeconomic status.
Air quality
The most robust evidence relates to air quality. 
Concentrations of nitrogen oxides (NO
x
) and ine particulates 
(PM
10
) display a strong social gradient. For mean annual 
concentration, a U-shaped distribution (Figure 6.2a) has 
been repeatedly found across various studies, as lowest 
concentrations tend to be in more rural areas of medium 
deprivation.7,8,19,24 
Considering only locations where concentration values exceed 
the national air quality standard annual average limit values, 
the U shaped distribution disappears, and a very strong 
gradient is evident (Figure 6.2b). In 2001, of the 2.5 million 
people resident in areas where the annual mean NO
2
 limit 
value was exceeded, over half were in the poorest 20% of 
the population; by 2011 the exceedance population had fallen 
to 0.6 million due to overall improvements in air quality, but 
85% of this population was in the poorest ifth25 (Figure 6.3). 
Studies elsewhere in Europe have varied in geographic 
extent, spatial unit, social metric, atmospheric pollutant, 
and analytical method, yet broadly conirm that the most 
deprived populations experience higher and more health-
threatening environmental exposures.26,27
Figure 6.2a Social distribution of annual average NO
2
 concentration in England, 2001
Note 
i Bars denote 5-95 percentile range, N=8,414. 
ii Each decile represents the average of electoral ward mean NO
2
, measured as an annual mean.
Source Walker G et al.Environmental Quality and Social Deprivation. Phase II: National Analysis of Flood Hazard, IPC Industries 
and Air Quality. The Environment Agency (2003)
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Figure 6.2b Population resident in areas exceeding the annual average legal limit value for NO
2
, by deprivation 
decile, England 2001
Notes
i Annual mean standard is 40 ug/m3, applied as a ward average. 
ii Decile 1 is most deprived. All deciles have 4.9 million people. 
iii 2.51 million people are in an NO
2
 exceedance ward, 5.1% of the population of England.
iv 53% of all person exceedances are in the most deprived quantile.
Source Walker G et al.Environmental Quality and Social Deprivation. Phase II: National Analysis of Flood Hazard, IPC Industries 
and Air Quality. The Environment Agency (2003)
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Figure 6.3 Great Britain population in lower super output areas (LSOAs) where NO
2
 exceeds the 40 μg m3 annual 
average legal limit value
Note
Q1 is the least deprived ifth, Q5 the most deprived ifth. Concentration values are the mean of annual average concentrations 
for LSOAs where NO
2
 concentration >40 μg m3. NB. log-scale
Ethnic minority populations in the UK are also exposed 
to higher concentrations of NO
2
 and PM
10
 but there is no 
indication whether this is a casual link with ethnicity or a facet 
of the socioeconomic status of ethnic minority groups; nor 
is there consensus on the link between ethnic susceptibility 
to air pollution and health.28,29 However, fetuses, babies 
and children are known to be more susceptible to poor air 
quality30 and increased exposure of children in UK national 
small area analyses has been observed for NO
2
7,29
 
but not ine 
particulates.29 Gender has been little studied with respect to 
the social distribution of pollution31, but can be expected to 
become more prominent as environmental inequality analyses 
begin to consider an individualistic perspective better able to 
account for temporal variability in exposure, for example due 
to differences in daily travel patterns.6
Indoor air quality has been less studied, but research in 
the US shows a positive association between deprivation 
and poor indoor air quality (NO
2
, ine particulates, VOCs, 
lead, allergens). Indoor air quality is determined by outdoor 
air quality, indoor pollutant sources and occupant activity, 
and physical features of housing.32 No comparable equity 
research exists for the UK, but it is reasonable to assume a 
similar association, given the strong association of deprivation 
with outdoor air pollution, and smaller, often lower quality 
housing.
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Other pollutants and risks
For other environmental pollutants and risks (Table 6.1) 
evidence exists of a strong association (for England) between 
deprivation and proximity to activities regulated under 
Industrial Pollution Prevention and Control (IPPC) legislation, 
including major industrial and petrochemical sites and 
waste incinerators.33 Site speciic studies are equivocal in 
terms of associated health impacts, whilst at a national level 
health impacts are analysed within the wider context of air 
quality (see below), for which road trafic is the dominant 
source. Landill sites are geographically associated with 
deprivation18,34, although study results are dependent on 
methodological choices35 and not clearly associated with 
elevated health risk.36 In England, exposure to brownield 
land is higher in the north and is associated with spatial 
inequalities in mortality and morbidity both within English 
regions, and between them, although differential brownield 
exposure does not appear to contribute to the north-south 
health divide, probably due to differences in the distribution 
of types of brownield land.37
An analysis of ambient noise emission levels from road 
and rail trafic in Birmingham found a weak relationship 
with deprivation38 but no other UK noise studies exist. 
A systematic international review of noise health effects, 
focused on vulnerable groups, concluded that differentials 
in both physiological and psychological effects were largely 
anecdotal, with subgroup-speciic exposure-effect studies 
needed.39 There are various newer forms of health threats 
from pollution (see Chapter 4 of this report, ‘New horizons’) 
where questions of inequality are yet to be examined. 
Multiple environmental hazards
Environmental inequalities research has also sought to 
understand the social distribution of environmental metrics in 
combination. National and region-speciic analyses show that 
with increasing area deprivation there is a greater likelihood 
of populations being exposed to multiple environmental 
hazards, in terms of both the intensity of a speciic hazard 
(such as the clustering of industrial or waste facilities), and 
local exposure to a multiplicity of hazard types (such as the 
coincidence of industrial hazards, poor air quality and lood 
risk).19,40-42
Environmental inequalities over time
Tracing how environmental inequalities develop over time 
is an important step in understanding how they have 
arisen, but such studies tend to be constrained by a lack 
of small area longitudinal data. However, an analysis of air 
quality change in Britain from 2001-2011 reveals a social 
gradient in environmental change.25 Where air quality has 
improved (falling NO
2
) it does so most quickly in the least 
deprived areas, and where it has worsened (rising PM
10
) it 
does so more quickly in the most deprived areas. This may 
be a consequence of the more polluted initial conditions 
experienced by the more deprived communities (for example 
greater air quality improvement is needed to attain ‘good’ 
air quality than in the less polluted, more afluent areas). 
Overall improvements in air quality should have reduced the 
associated national disease burden, but the social gradient 
(Figure 6.3) implies social inequality in how this beneit is 
distributed.25 This suggests that interventions that reduce 
pollution overall can deliver health gains, but if intended 
to reduce health inequalities, they require more targeted 
interventions (discussed further below).
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Evidence linking air pollution to  
health inequalities
As outlined earlier, the relationship between pollution and 
health inequalities is not just that pollution exposure is 
distributed unevenly between population groups. The second 
mechanism that can act independently or concurrently is that 
of differential susceptibility, in which for the same level of 
pollution, more socially disadvantaged groups – and others 
in the population – can be more vulnerable to exposure than 
high ones. Factors such as poor health status (for example 
COPD, asthma and existing CVD), adverse health behaviours 
(for example smoking and diet), multiple environmental 
exposures (for example occupational) and psychosocial stress 
are more prevalent in lower socioeconomic status groups and 
may act in addition or synergy (that is, as effect modiiers) 
with pollution exposure.
The ‘triple jeopardy’ for disadvantaged groups of irst, higher 
exposure to air pollution, and second a greater burden 
of poor health, may then be further added to by a third 
effect arising from greater susceptibility to the impact of 
pollution.43 These processes have been most investigated 
in relation to air pollution, and are the focus of this section. 
Existing evidence is reviewed, being careful to exclude 
studies that do not formally test differences in susceptibility 
between socioeconomic groups. Studies in many countries 
have considered the role of short- and long-term pollution 
exposure in explaining socioeconomic gradients in health 
outcomes with a plausible aetiological pollution link. 
Health outcomes considered include all-cause and cause-
speciic mortality, respiratory health (for example asthma), 
birth weight, and hospital admissions due to a respiratory 
condition.
International evidence 
Recent global and European studies reviewing the evidence 
that socioeconomic status (SES) modiies the effect of air 
pollution on health, broadly suggest that irrespective of 
differences in exposure, lower SES populations experience 
the greater effects of air pollution. The evidence base is 
particularly strong (number of studies and quality of study 
design) in the United States with a handful of studies in other, 
mostly European, countries.
A systematic review of the international literature found 
lower SES groups were at higher risk of death due to short-
term exposure to particulate matter (PM
10
 and PM
2.5
).44 
Similarly a review of the literature on differential effects of 
ozone-health relations by SES noted evidence of associations 
between ozone exposure and mortality for some (for example 
unemployment and lower occupational status) but not all 
(for example low education and poverty) lower SES groups.45 
Other studies review the evidence relating to particular 
‘vulnerable’ groups. For example, an international review 
found lower socioeconomic status pregnant women are more 
vulnerable to air pollution with an increased risk of having 
a child with low birth weight at term.46 On the other hand, 
another review found limited evidence that the association 
between air pollution and children’s asthma exacerbations 
varied between SES groups.47
UK evidence
Whilst, as already summarised, there is a signiicant body of 
work in the UK documenting socioeconomic inequalities in air 
pollution exposure, few studies have examined whether there 
is a synergistic relationship between SES and air pollution that 
acts to affect health. To date there have been six UK studies 
explicitly addressing this question, another using a composite 
environmental index as the exposure metric (including 
measures of air pollution), and a further Europe-wide study 
that includes UK data (Table 6.2). 
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Table 6.2 Socioeconomic inequalities in air pollution exposure – Europe-wide studies including UK data
Authors 
and year of 
publication
Pollutant(s)
SES 
indicators
Geographical 
unit
Location Population Findings
Wheeler & 
Ben-Shloma 
(2005)48 
NO
2
, SO
2
, 
benzene,
PM
10
Household 
social class
1991 census 
wards
England Participants 
aged 16–79 
in the Health 
Survey for 
England 1995, 
1996, 1997
Differential effect of 
air pollution on lung 
function for males only; 
effect in social classes 
III to V double that in 
social classes I & II.
Briggs et al 
(2008)43 
Road trafic, 
industry, 
electro-
magnetic 
frequency 
radiation, 
disinfection by-
products in
drinking water 
& radon
Index of 
Multiple 
Deprivation 
(& 
constituent 
domains)
3 levels of 
analysis: super 
output areas, 
census wards
& districts
England Full population Some evidence of 
greater risk of poorer 
general health for those 
living in more socially 
disadvantaged areas
Pearce et al 
(2010)42 
Composite 
‘Multiple 
Environmental 
Deprivation 
Index’ including 
of PM
10
, NO
2
, 
SO
2
, and CO, 
plus greenspace
Area-level 
income 
deprivation
10,654 Census 
Area Statistics
Wards
UK-wide Full population Inluence of multiple 
environmental 
deprivation on health 
greater in the least 
income-deprived areas
Jephcote & 
Chen (2012)49 
PM
10
 road-
transport 
emissions
Area-level 
measure 
of social 
deprivation 
(Carstairs 
Index), 
ethnicity
187 Lower Level 
Super Output 
Areas
Leicester Children aged 
0–15
Double-burden of road 
transport emissions 
and social deprivation 
related to children’s 
respiratory health.
Richardson et 
al (2013)50 
PM
10
Mean 
household 
income
268 sub-
national regions 
(NUTS level) 
Europe-
wide
Full population Lower income regions 
more susceptible 
to health effects. 
Restricted to circulatory 
disease mortality in 
Eastern Europe and 
male respiratory 
mortality in Western 
Europe
Halonen et al 
(2016)51 
Trafic pollution 
including 
NO
x
, NO
2
, 
tailpipe 
emissions, PM
2.5
 
and PM
10
Area-level 
measure 
of social 
deprivation 
(Carstairs 
Index), 
ethnicity
27,686 Census 
Output Areas 
Greater 
London
Full population Higher risk of 
emergency hospital 
admissions for cardio-
respiratory diseases 
among those living 
in areas with the 
highest socioeconomic 
deprivation
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Authors 
and year of 
publication
Pollutant(s)
SES 
indicators
Geographical 
unit
Location Population Findings
Brunt et al 
(2016)52 
Ambient NO
2
, 
PM
10
, PM
2.5
 
concentrations
Area-level 
measure 
of income-
deprivation
1909 Lower-
layer Super 
Output Areas
Wales Full population Interactions between 
air pollution 
and deprivation 
strengthened 
associations with all-
cause and respiratory 
disease 
Milojevic et al 
(2017)53
Ozone and 
particulate 
matter (sub-
divided into 
PM
10
, PM
2.5
, 
PM
2.5-10
, 
primary, nitrate 
and sulphate 
PM
2.5
)
Area-level 
income & 
employment 
domains of 
the Index 
of Multiple 
Deprivation
1,202,578 
residential 
postcodes in 
England Full population PM
2.5
 pollution made a 
modest contribution to 
socioeconomic gradient 
attributable life years 
lost. 
The UK work has covered a variety of different pollutants, 
sources (ambient, trafic, industrial), measures of SES (both 
individual and area-level indicators), populations (adults, 
children) and health outcomes. There has been no relevant 
UK work on indoor pollution.
Studies of overall and cause-speciic mortality, life years lost, 
and hospital admissions point to an increased health risk of 
pollution exposure amongst those living in disadvantageous 
social circumstances. For example, a study in London of 
annual concentrations of a range of trafic pollutants, 
and emergency hospital admissions for cardio-respiratory 
outcomes found some evidence of increased risk amongst 
those living in more socially disadvantaged neighbourhoods.51 
Similar indings have been noted in Leicester for 
hospitalisations amongst children49, all-cause and respiratory 
disease mortality in Wales52, and general health43 and life 
years lost across England53, although in all cases the evidence 
was mixed or suggested modest effects.
A UK wide study of ‘multiple environmental deprivation’ (a 
composite index of various health-related features of the 
environment including measures of PM
10
, NO
2
, SO
2
, and CO) 
found that whilst more socially disadvantaged populations 
were exposed to higher levels of multiple environmental 
deprivation, the inluence of multiple environmental 
deprivation on health was most pronounced in the least 
income-deprived areas.42 Therefore contrary to the indings of 
most other work in the UK, the physical environment did not 
exert a disproportionately detrimental effect on the health of 
the most socially disadvantaged groups, although given the 
small number of areas with high levels of social disadvantage 
and ‘high quality’ environments this inding should be treated 
with caution. 
Finally, a Europe-wide analysis (including the UK) of 268 
subnational regions found that lower income regions had 
higher average pollution (PM
10
) concentrations and that 
populations of these regions were more susceptible to 
pollution, although any effect seemed to be limited to 
circulatory disease mortality in Eastern Europe and male 
respiratory mortality in Western Europe.
UK evidence: summary and limitations
Tentative evidence exists for the UK of an interactive 
relationship between air pollution and socioeconomic status 
in which differential susceptibility affects health outcomes. 
However, several limitations restrict the conclusions that can 
be drawn: 
  Most obviously, the UK evidence base is small, particularly 
when compared to the United States. 
  Unlike elsewhere, all UK studies use cross-sectional study 
designs which limit the quality of the evidence. There are 
no studies examining how SES and air pollution exposure 
accumulate over the life course. 
  Many UK studies rely on ecological associations; key 
variables such as health and SES are captured at the 
ecological (rather than individual) level. There is also a poor 
understanding of scale, with previous international work 
emphasising that indings can be highly sensitive to the 
chosen geographical unit of analysis. 
  There is little understanding of the temporal resolution 
of pollution exposure and the implications for health 
inequalities. For instance, pollution can vary signiicantly 
by season and time of day. Most geographic studies focus 
on home locations yet people move between different 
environments as part of their daily routines.
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Addressing pollution  
inequalities 
There are some established policy measures and sources of 
guidance52-54 on how to intervene in pollution problems and 
their impact on health. Different measures and approaches 
are more or less appropriate to the particular pollutants and 
sources involved, with signiicant differences, for example, 
between point pollution sources, and those that are more 
diffuse. For air quality speciically, the National Institute for 
Health and Care Excellence have recently published guidance 
on ‘what works’ in air quality management, particularly in 
terms of reducing health impacts.54
Guidance on addressing pollution inequalities and their 
relationship with health inequalities is though less well 
developed. It cannot necessarily be presumed that generic 
actions to address pollution problems will automatically 
reduce inequalities and improve the situation most 
substantially for those most exposed.55 Whilst this logic may 
well hold in some circumstances56, there is also evidence (as 
reviewed above) that air quality management strategies in the 
UK have not been as pro-equity as might be expected and 
that in relative terms deprived communities have beneitted 
less from improvements in air quality than others.25 If then it 
is accepted that pollution inequalities should be speciically 
targeted and reduced, it follows that there is a need to 
have policies and measures to identify and act on these 
inequalities. Key examples of such measures include:
Appraisal of the impacts of planning decisions, 
government policies and strategies to explicitly include 
implications for environmental inequalities. This is to 
ensure that decisions are taken with full awareness of their 
potentially unequal consequences.24 Established assessment 
methodologies applied in England often either require 
or provide scope for assessing ‘distributional effects’, but 
are typically poor at speciically identifying environmental 
inequalities57, and beyond a few examples58,59 (see Box 2) are 
not generally carried out very thoroughly. Given the nature 
of the current evidence base, such appraisal needs to extend 
beyond the protected social characteristics identiied in the 
2010 Equality Act, to include socio-economic status. 
Application of impact assessment methods in land 
use and other decision processes to explicitly address 
the cumulative effects of multiple decision processes, 
such as the cumulative effects on a community of a series of 
transport infrastructure and industrial developments. This is 
important given that, as noted above, pollution sources often 
accumulate in deprived areas where people’s health tends to 
be signiicantly worse. It is unfair to add further burdens on 
those already taking more than their ‘fair share’ and suffering 
additional health consequences, and impact assessments 
should clearly identify where this is taking place.
Targeting of investment in local pollution management 
measures specifically on more deprived communities 
where health indicators are most problematic.52 
The identiication of ‘pollution-poverty’ hotspots has 
been suggested as one way of implementing targeting19, 
and in particular where environmental quality standards 
are breached, offer the strongest support for claims of 
environmental injustice.25
Actively supporting innovative community based 
approaches to identifying and addressing local 
pollution problems (see Box 3) recognising that deprived 
communities will typically have fewer resources and less 
capacity to participate and have inluence on decision-making 
than others. The Environment Agency has some experience 
of advocating for and experimenting with participatory 
approaches to working with deprived communities.16 ‘Good 
neighbour agreements’ have also provided the basis for 
negotiating performance standards between industries 
and communities in some localities, although with varied 
outcomes.60,61
Ensuring that socially disadvantaged groups are 
properly included in bio-medical studies. Whilst the 
weight of evidence from environmental justice research 
shows socially disadvantaged groups are often more exposed 
to environmental pollution, some of these groups (for 
example ethnic minorities, homeless) have been found to 
be under-represented in biomedical studies thus potentially 
biasing understandings of health outcomes.62
In following and selecting from such approaches, two further 
considerations are important. First, it makes much sense to 
seek synergies with wider policies focused on addressing 
health inequalities.2,52,63,64 The greening of deprived areas is a 
good example, given that green spaces can be of direct and 
indirect beneit to physical and mental health65 and tree and 
vegetation planting can play a role both in improving general 
environmental quality and in scavenging air pollutants before 
they reach sensitive lungs. Investment in sustainable transport 
modes is another good example of where there can be 
strong policy synergies.
Second, it is a generally accepted principle that those who 
are suffering from pollution inequalities should not be made 
responsible for addressing them – making the polluted rather 
than the polluters pay – and are not unfairly penalised by 
the implementation of pollution reduction policies. Policy 
responses focused principally on personal protective measures 
are problematic in these terms66, as can be policies focused 
on economic penalties and/or with cost implications that 
have disproportionate impact on those with low incomes.67 
Progressive approaches can ameliorate such effects, 
including, for example, focusing car scrappage schemes more 
substantially on low-income households.68
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Box 2 Heathrow expansion and Equality 
Impact Assessment
In 2008 campaigners protesting against proposals to 
further expand Heathrow airport argued that a proper 
assessment and consultation on the ‘equality’ implications 
of the development had not been carried out, and lodged 
legal proceedings against the Department of Transport. 
Their case rested on the obligation on all public authorities, 
under the Race Relations (amendment) Act 2000, to 
ensure that their policies do not have disproportionate 
impacts on ethnic minority groups. The response was 
an initial ‘Equality Impact Assessment’ screening which 
concluded that a full assessment should be undertaken 
because of the high proportion of black and Asian 
minority ethnic (BAME) groups near to the airport. The 
full assessment, undertaken for various potential airport 
expansion options, concluded that:
“Each development option could result in both positive 
and negative noise, air quality and economic impacts on 
equality priority groups. BAME groups, children, young 
people, older people, women / carers, disabled people 
and those with low incomes are likely to be differentially 
affected by the development proposals. Additionally, 
BAME groups, children, older people and those on low 
incomes could also be affected due to their disproportional 
representation in particular areas around the airport.”
Box 3 Mapping for Change
Prof Muki Haklay and Louise Francis, University 
College London
Mapping for Change (MfC) is a social enterprise that was 
founded by University College London (UCL) and London 
21 Sustainability Network in 2009. It builds on ongoing 
research at UCL, focusing on participatory mapping and 
participatory Geographic Information Systems (GIS). These 
focus on the use of geographic information technologies 
to work with communities to solve problems that they 
face. By using mapping and geographical technologies 
such as GIS to collect, analyse and display information 
about communities’ life and environment, MfC projects 
have helped increase community engagement in the local 
environment, led to new environmental monitoring by 
local authorities and stimulated policy debate about noise 
and air pollution.
MfC specialises in community engagement, aiming 
to empower individuals and communities to make a 
difference to their local area through the use of mapping 
and geographical information. In particular, MfC works 
to provide beneit to individuals and communities from 
disadvantaged or marginalised groups, along with 
the organisations and networks that support those 
communities, where the goal is to create positive 
sustainable transformations in their environment.
Since 2010, MfC has been involved in community-led 
air quality studies. In these projects, MfC worked with 
communities to use a dense network of diffusion tubes 
to measure nitrogen dioxide levels at local locations. An 
early study in 2011 with seven community groups from 
across London showed that along main road networks NO
2
 
levels were as much as 75% above EU guidelines; it also 
highlighted issues in several residential back roads, used as 
‘rat-runs’. In Putney, concerns raised about air quality by 
the Putney Society, citing MfC indings, were successful in 
leveraging political support to lobby for change, leading 
Transport for London to introduce to the area new buses 
that comply with higher standards for emissions.
In another study, in the Barbican, in collaboration with the 
City of London, a year-long study was carried out in 2013-
2014 which identiied a number of pollutant hotspots in 
the area. More than 100 residents have been involved in 
the project, with many hosting a diffusion tube for a year. 
More than half of residents said that they would change 
their walking routes as a result of the research; 85% 
reported that they felt more aware of some of the legal 
and technical aspects of air quality and 90% reported 
an improved understanding of the health impacts of 
air quality in London. In addition, the City of London is 
considering how to regulate local trafic in order to reduce 
the exposure of the local residents to harmful pollution.
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Authors’ suggestions for policy 
makers 
There is now substantial evidence across different pollution 
types and sources that there are signiicant pollution 
inequalities in England, with measures of deprivation in 
particular shown to be associated with a higher pollution 
burden. For pollutants injurious to health, this implies a 
priori, an adverse effect on health inequalities. However, 
the interactive consequences of environmental inequalities 
for health inequalities are complex to irmly establish. More 
research and systematic attention to the interaction between 
pollution and health inequalities is undoubtedly needed, 
bringing together research domains that have remained 
largely separate, as recently recognised in a set of priorities 
laid out by Public Health England.5 
There is however suficient knowledge already in place 
to much better integrate pollution reduction and health 
inequality programmes and interventions. In addition to 
further research; 
  Decision-making that has the potential to exacerbate 
or reduce pollution should be better informed about 
how these effects are distributed by social group, and 
the implications for inequality (proactive inequality 
assessment).
  The targeting of interventions to reduce pollution problems 
in particular places or communities should take account of 
the need to, at the same time, address health inequalities 
(targeted intervention).
  Communities should be closely involved in addressing 
pollution problems, particularly where health impacts are 
most severely experienced (participatory monitoring and 
mitigation). 
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Summary
  Pollution has a signiicant negative, and largely avoidable, 
impact on health and well-being.
  Exposure to, and the effects of, pollution are inluenced by 
other environmental, social and biological stressors.
  A good quality environment has a powerful positive effect 
on health and well-being.
  Environmental Public Health (EPH) addresses all aspects 
of health that are affected by the natural and built 
environment.
  A number of government departments, agencies and 
organisations work together to prevent or mitigate the 
impacts of environmental hazards on health in the home, 
in schools, at work and in the wider environment and 
improve health and well-being through safe, health 
promoting and empowering environments. 
• EPH professionals address the direct risks to public 
health arising from noise, air, water and land pollution 
and pollution arising from the transport, treatment and 
disposal of waste; 
• EPH professionals tackle the wider social determinants 
of health and environmental health inequities;
• EPH professionals provide a wide range of public health 
functions at the local level, delivered through local 
authorities.
Introduction and background 
At a local level, Environmental Health professionals (EHPs) 
are public health professionals, currently largely employed by 
local government but also active in Public Health England, the 
NHS, academia, business and the third sector, and are a key 
component of the Environmental Public Health (EPH)1 service. 
EPH is deined as all aspects of health that are affected 
by the natural and built environment. This remit includes, 
amongst other things, communicable disease control, food 
safety, inspection and enforcement, planning and building 
standards, and pollution control.
EHPs protect and improve the public’s health and well-being 
through both regulatory and advocacy functions. They work 
in partnership with planners, Directors of Public Health 
and Public Health England teams, inluencing change to 
secure environmental improvements in their localities. 
EHPs also enforce occupational safety standards preventing 
work-related ill health, such as occupational exposures – a 
signiicant burden for society, businesses and individual 
workers. This requires long-term coordinated local action to 
make the essential sustained improvements.
Environmental hazards impact on health outcomes directly, 
through physiological exposure, and indirectly, e.g. concerns 
about perceived or actual exposures can be detrimental to 
mental health. As EHPs have a thorough knowledge of the 
local environmental risks and mitigation options, they are 
ideally placed to tackle these environmental inequities – and 
the health threats from pollution.
Closer working relationships between key organisations, 
agencies and government departments are central to 
the delivery of Environmental Public Health. Professionals 
within these organisations, agencies or departments may 
not see them themselves as being part of the public health 
workforce; however, they have a key role in bridging 
evidence, policy and practice for environmental public health 
gain. The 2013 return of the NHS public health function in 
England to locally accountable councils, which hold most of 
the levers of inluence in this ield, was widely welcomed as 
an opportunity to underpin interventions with both evidence 
and popular consent. There are several examples of where 
this integration is working well but it is important that this 
good practice is replicated across the country.2
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Health and the physical 
environment
Environmental health professionals have been protecting 
the public from environmental hazards since Victorian times 
(see Box 2). Their enforcement of laws to tackle dangerous 
levels of pollution in air, water, food and land, unsafe housing 
and working conditions, insect and rodent infestations, as 
well as improving basic standards of sanitation and ighting 
infectious diseases, has saved countless lives. EHPs also make 
an enormous contribution to making people’s everyday lives 
better by preventing or stopping public health nuisances.3 
These are not just irritations but serious threats to individual 
and community health and quality of life including ly tipping, 
anti-social behaviour such as noisy late night parties, garden 
bonires producing choking clouds of smoke, and ilthy and 
verminous living conditions. There are hundreds of thousands 
of such complaints made every year to local councils in 
England4 and while EHPs will always try to negotiate a 
resolution, they will use the law if necessary.
The success of EHPs since the 1840s can be seen everywhere 
in the quality of the air we breathe, the food we eat, the 
places we live, work and play in, and the huge reductions in 
levels of previously devastating diseases such as tuberculosis, 
cholera, food poisoning, and typhoid. However, we cannot 
be complacent. The physical environment continues to have 
a major impact on our health and some of issues we thought 
were things of the past have re-emerged or evolved. Broadly, 
for example, diseases such as tuberculosis have re-emerged, 
whilst speciic to pollution, different mixtures of air pollutants 
have become a threat.5
We have had great successes in the past and we can do so 
again through understanding both the causes of ill health 
and the most effective interventions. We have also come to 
recognise that good quality environments improve health 
and well-being and that there are wide differences in the 
experience of both poor and good quality environments 
and the consequences of those experiences e.g. deprived 
people are likely to live in polluted environments and have 
poorer health.6 This applies to most aspects of the physical 
environment – including pollution – and, again, we are 
increasingly aware that there are important interactions 
between them. Polluted areas, for example, also tend to 
have higher concentrations of take away food outlets and 
fewer opportunities for safe recreation in green spaces; 
factors plausibly associated with obesity.7 Innovative urban 
design and planning control can help address all these issues, 
delivering a cost effective intervention by tackling multiple 
challenges and reducing inequalities at the same time.
One of the key beneits of the return of the NHS public 
health function to local authorities8 has been the closer 
collaboration between environmental health, public health, 
planning, transport and housing professionals. It is this 
collaboration that we need to reduce the health burden from 
pollution. There are already many examples of imaginative 
collaborative practices such as ‘greening’ urban corridors, 
improving public transport and improving opportunities 
for walking and cycling. We need to continue inding 
opportunities for collaborative interventions that address 
multiple hazards and target them where they have the most 
impact: some local authorities have used industry quality 
control methods to review public health nuisance complaints 
and environmental threats to do just that.9 We now explore 
two areas of pollution, air and noise pollution, and the role 
that EHPs have in reducing this threat.
Environmental health opportunities – Air 
quality and environmental health
One of the more recent examples is in the area of air quality 
where environmental public health professionals in local 
authorities, government, academia, the NHS and health 
charities are working together to reduce the health burden 
attributable to air pollution10,11 Environmental legislation has 
been successful in tackling some of the traditional domestic 
and industrial sources. However, different air pollutant mixtures 
have evolved as the modern economy and our way of life is 
increasingly reliant on road vehicles. Ironically, this increase in 
road trafic is damaging not only to the global climate, health 
and the environment through the emission of air pollutants 
and noise, but also to the local economy due to, for example, 
road congestion and additional pressure on the NHS.
Renewed efforts are under way to ensure that local actions 
complement the global and national efforts. Environmental 
public health professionals are called to apply their expertise 
and experience in understanding the evolving evidence on 
the impact of environmental stressors on health, considering 
the needs of the local populations, work collaboratively to 
identify priorities and interventions, raise awareness amongst 
health professionals and advocate for behaviour change in 
order to reduce car usage and promote active travel.12
We must encourage environmental public health innovations, 
often driven by local democracy, as the status quo is not 
an option. In order to encourage behaviour change, such 
as encouraging active travel to improve health and reduce 
environmental pollution, we need to do more than simply 
enforce the law, we need to make the ‘doing the right thing’ 
the ‘easy thing to do’ and, along the way, change social 
attitudes as we have with smoking and drink driving. These 
interventions are investments not subsidies. Indeed, poor 
quality environments will put towns and cities at an economic 
disadvantage in attracting businesses.13 Well-planned and 
evidenced-based public health interventions are good value 
for money with high return on Investment and Cost Beneit 
Ratios.14 Transport-induced poor air quality, ill-health and 
road accidents costs society £40 billion per year. Getting 
one more child to walk or cycle to school could pay back as 
much as £768 or £539 respectively in health beneits, NHS 
savings, productivity gains and reductions in air pollution and 
congestion. Basic improvements to damp, cold and unsafe 
housing are an eficient use of resources. Every £1 spent on 
improving homes saves the NHS £70 over 10 years.
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Box 1 Contaminated land
Historically the United Kingdom was the irst industrialised 
country in the world and as a consequence the UK is 
thought to have over 400,000 hectares of land which 
is contaminated, much of it as a legacy of the industrial 
Revolution1. Contaminated land is an issue for public 
health due to the nature of the chemicals contained 
within the soil (which can sometimes be carcinogenic). 
Examples include lead which can lower IQ, benzo(a)pyrene 
which is carcinogenic and asbestos which can cause long 
latency cancers such as mesothelioma. When undertaking 
a contaminated land risk assessment the potential 
contaminant, the routes of exposure such as ingestion or 
inhalation and the potential duration of that exposure are 
considered. 
Contaminated sites where there has been a real potential 
immediate risk of harm to health include those with 
elevated levels of contaminants such as arsenic and lead 
in formerly industrialised areas, which pose a real threat to 
young children. Inadvertent ingestion, pica tendencies and 
tracked-back dust into properties can result in a signiicant 
possibility of signiicant harm to young children.
Perceived risks to residents of remediation include the 
excavation and either treatment on site or removal off-site 
of these soils, which can lead to considerable anxiety and 
concerns to local residents. 
The current gap in the UK for contaminated land is the 
lack of funding and suitably experienced staff within LAs 
to undertake their statutory duty. There is also no ixed 
methodology to ascertain acute risk from contaminants 
in soil that LAs can draw on. There are a number of 
organisations, which include members of the industry, 
trying to ill the gap such as the Society for Brownield Risk 
Assessment (SOBRA), and CL:AIRE who publish guidance 
to support industry such as SOBRA’s Design of an Activity 
Based Sampling Protocol for the Testing of Asbestos Fibre 
Release Potential from Residential Garden Soil which was 
published in 2015.
Source
https://www.gov.uk/government/publications/land-remediation-bringing-brownield-sites-back-
to-use/land-remediation-bringing-brownield-sites-back-to-use)
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Box 2 Pollution history and public health
Stephen Mosley, Leeds Beckett University
Anxiety about the pollution of air, water, and streets in the 
fast-growing cities of nineteenth century Britain saw the rise 
of the public health movement. The world’s irst industrial 
nation was also a pioneer in tackling the harmful side-
effects of unplanned urban growth: sewer rivers, smoke-
illed skies, and vast quantities of organic wastes (such 
as manure from horse-drawn transport). So-called ‘ilth 
diseases’, most notably waterborne cholera, dysentery, and 
typhoid fever, became major killers in overcrowded cities. 
Noxious emissions from factory and domestic chimneys 
caused chronic respiratory diseases, especially bronchitis, 
which claimed many thousands of victims every year. Early 
industrial centres like Glasgow, London, and Manchester 
were ‘devourers of population’.
By the 1830s, pressure was building on Britain’s authorities 
to clean up polluted urban environments that contributed to 
serious health problems and preventable deaths. Inluential 
igures rallying public opinion behind the sanitary movement 
included Edwin Chadwick (author of The Sanitary Condition 
of the Labouring Population, 1842), William Farr (medical 
statistician), and Thomas Southwood Smith (founder of 
the Health of Towns Association). Although the need for 
pure drinking water, clean air, and sanitary streets was not 
perfectly understood (miasmatic theories about disease 
transmission held sway), their lobbying helped to secure 
the passage of the irst statutory nuisance legislation. In 
1846 the Nuisance Removal Act gave justices the power 
to prosecute those responsible for urban ‘nuisances’ – 
deined broadly as accumulations of refuse, foul-smelling 
drains or cesspools, and ‘unwholesome’ housing – that 
were believed to be the source of ‘bad air’ and disease. 
And in 1848 the irst Public Health Act empowered local 
authorities to manage refuse, sewage, and water systems. 
It also established a General Board of Health; an important 
step towards formalising the state’s role in protecting the 
health of the nation. However, the implementation of 
public health legislation was slow initially. For example, it 
took London’s Great Stink of 1858 and fears of a cholera 
outbreak – the faecal stench from the polluted River 
Thames was so disgusting that Parliament was suspended 
– before the money and political will was found to build an 
effective metropolitan sewerage system. The underground 
system, designed by Joseph Bazalgette, was then emulated 
countrywide. 
Advances in waste removal and water supply saw mortality 
rates from ‘ilth diseases’ decline dramatically by the turn 
of the twentieth century, but Britain’s cities still suffered 
from excessive levels of smoke pollution. As air pollution 
was closely linked with jobs and prosperity, anti-smoke 
clauses in public health legislation were weakly drafted and 
rarely enforced. The catalyst for change was London’s Great 
Smog disaster of December 1952, which brought about the 
premature deaths of around 12,000 people by exacerbating 
existing heart and lung conditions. Contemporaries inally 
understood that dirty air could be just as dangerous as 
contaminated water, and most supported the introduction 
of a tough Clean Air Act (1956) and the creation of 
smokeless zones in urban areas. By the 1980s coal smoke 
was no longer considered a signiicant factor in explaining 
respiratory deaths in Britain’s cities. As we struggle today 
with less tangible pollution problems, the history of public 
health shows that positive change is possible. 
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Box 3 Cold ironing
Dr Matthew Loxham, BBSRC Future Leader Fellow, Faculty of Medicine, University of Southampton, Ocean 
and Earth Science, University of Southampton; Southampton Marine and Maritime Institute, University of 
Southampton; Institute for Life Sciences, University of Southampton
Over 90% of the world’s trade travels by ship, the most 
fuel-eficient mode of transport per tonne of goods. When 
berthed in port (termed “hotelling”), cruise and cargo ships 
need to keep their systems powered, and therefore usually 
run their auxiliary engines. The resultant emissions may 
contribute signiicantly to local air pollution, contributing 
around 20% to the local air pollution load by source 
apportionmenti, although other techniques have suggested 
greater contributions. A potential remedy is to connect 
hotelling ships to a shoreside electricity supply, allowing 
the auxiliary engines to be turned off, referred to as “cold 
ironing”. As long as the electricity is from a relatively clean 
source (renewable/LNG/nuclear), this reduces emissions from 
hotelling ships to near zero. Unfortunately, shoreside power 
is not commonplace because of the inability of the local 
power grid to meet the demands of multiple hotelling ships, 
incompatibility between ship- and land-based electrical 
supply characteristics, initial inancial outlay (e.g. €10 million 
for a recent terminal in Hamburg), and debate over who 
should bear the inancial costs.
The Air Resources Board of California has introduced 
At-Berth Regulations to reduce emissions of NO
x
 and 
particulate matter from hotelling ships at six major ports 
in California. Currently, at least 70% of the passenger, 
container, and refrigerated cargo leet’s visits to regulated 
ports (80% by 2020) are limited to three hours of auxiliary 
engine operation with further limits on auxiliary engine 
power generation; additional power must come from 
shoreside supplies. Alternatively, approved emissions 
reduction technology, such as exhaust treatment systems, 
can be used. Importantly, emphasis is placed both on leet 
operators to ensure that their ships are equipped with the 
necessary technology, and on port and terminal operators 
to ensure that infrastructure is available. Air pollution control 
agencies and port operators have made money available to 
contribute to equipment costs. Conversely, non-compliance 
is met with stringent inancial penalties of up to $10,000 per 
violation per day.
In the EU, funding has been made available through the 
Marco Polo programme, ahead of a 2025 deadline for 
mandatory installation of shoreside power. It is noteworthy 
that, while cold ironing is already in operation in several 
EU ports, including Gothenburg, Hamburg-Altona, and 
Rotterdam, it is not used in the UK and nor are there any 
concrete plans for its introduction. Although there are 
barriers to be overcome in its adoption, shoreside power 
offers obvious potential for improvements in port city air 
quality and associated pollution-related health outcomes. 
In the long-term, the costs of installation and operation 
are likely to be signiicantly outweighed by the cost savings 
in terms of the inancial consequences of ill health due 
to shipping emissions which, including in-port and at-sea 
emissions, are estimated to exceed €64 billion in continental 
Europe by 2020.ii,iii
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Box 4 A better real-world vehicle emissions ratings system
Nick Molden, Founder and Chief Executive Oficer, Emissions Analytics
Emissions Analytics (www.emissionsanalytics.com) is a 
specialist in real-world emissions and fuel economy testing. 
Founded in 2011, it has now tested over 1,500 different 
vehicles using regulatory-approved equipment but on a 
standardised, independent protocol. Company funding and 
operations are independent of manufacturers and other 
interested parties. 
Since 2016, Emissions Analytics has published free-to-
access vehicle ratings based on its test data. These make 
up the EQUA® Index (accessed at www.equaindex.com). 
These ratings can be used by leet and private buyers in 
vehicle purchasing, and by manufacturers to evidence the 
performance of their vehicles. Unlike oficial igures, the 
EQUA Index ratings provide the ability to base consumer 
information, incentives and access restrictions on real-world 
performance. This offers a promising route to achieve air 
quality goals as quickly as possible, and with the smallest 
private and public cost. For example, these data could act as 
a baseline for effective clean air zones (CAZs).
Real-world NOx emissions compared to regulated 
levels (the European “Euro” Vehicle certification 
programme)
At each Euro stage (stricter restriction applied through time) 
the cleanest vehicles have been getting cleaner, as measured 
by the EQUA; the dirtiest vehicles have not. Therefore, any 
system of discriminating between vehicles based only on 
Euro stage will be ineficient, permitting some vehicles with 
high real-world emissions. To exemplify the divergence 
between Euro standards and EQUA index, the dirtiest Euro 
6 diesels are six to seven times higher emitting than the 
cleanest Euro 5. More striking still, the dirtiest Euro 6 diesels 
are around three times worse than the cleanest Euro 3/4 
vehicles (remembering a 14 year gap between Euro 3 and 
Euro 6). These variations are due to the oficial laboratory 
testing processes and exploitation of loopholes in the Euro 
standards regulation.
Using the EQUA Indices would allow governments and 
cities to target only those vehicles which are high emitting 
in practice, minimising the private and public cost. By 
using it, for example, estimates suggest that 54% of Euro 
6 diesels would have to be restricted from urban areas to 
achieve an 87% reduction in nitrogen oxide emissions. 
The EQUA index has been designed in the light of lessons 
from other labelling schemes – typically based on oficial 
igures or where multiple pollutants are combined into a 
less transparent “eco” rating – to be simple, accurate and 
action-guiding. Manufacturers would compete to get the 
best ratings, as it would deliver them marketing, sales and 
reputation beneits, thereby harnessing the market to solve 
an environmental and health problem.
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Box 5  A typical day in the life of an Environmental Health Professional
09.30 hrs: 
Responds to complaints about a householder routinely lighting large bonires producing clouds of dense smoke preventing 
neighbours from using their gardens. Advises the householder about the legal requirement not to create a ‘nuisance’ and 
explains the local authority services available for the disposal of garden and other waste. EHO will monitor the situation and 
serve a notice if there are further incidents.
10.00 hrs: 
During the visit EHP is called to a privately rented property by tenants complaining of mould affecting the health of their 
newly born baby. The property has several structural defects, including a leaking roof which the landlord has refused 
to repair. EHP undertakes a thorough inspection of the dwelling based on the housing health and safety rating system 
(HHSRS), an evaluation tool to help local authorities identify and protect against potential risks and hazards to health and 
safety from deiciencies identiied in dwellings.
11.30 hrs: 
EHP attending a complainant’s home that is in a ilthy state with piles of rubbish and food waste cluttering the premises 
and where the adults smoke heavily while the children are watching television. The EHP had attended a training session on 
“making every contact count” (MECC) training the previous week and advises the parents on the health hazards, provides 
detail of the local stop smoking programme and liaises with social services colleagues to arrange the premises to be cleaned 
and the situation assessed for other hazards and interventions.
13.30 hrs: 
Attends meeting with the Director of Public Health (DPH) and planning colleagues about the high levels of NO
2
 around 
a heavily traficked retail high street. Advises that given the impracticality of technical interventions, the council should 
consider, in collaboration with local businesses and residents, a no idling near the school campaign, a walking to school 
plan led by the pupils and parents and potentially, the installation of ‘living walls’ (panels of foliage) at strategic points 
including around a primary school. EHO and DPH advise on ensuring that the interventions are properly evaluated.
15:30 hrs: 
Site visit for a planning application for dwellings with gardens. EHO makes recommendations to the planning inspector on 
the need for a more comprehensive contaminated land assessment by the developer.
16.30 hrs: 
Completes the required evidential and legal documentation.
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Figure 7.1 Reproduction of European Union Tyre label 
(with notes)
Note  Environmental health practitioners have a role in informing the 
public of less polluting behaviours – for car drivers this means 
not leaving engines idling, driving more eficiently (going easy 
on the gas pedal and brakes) and replacing tyres with quieter 
alternatives. 
   Current EU legislation has established a framework for providing 
consistent information on three tyre parameters: fuel eficiency, 
wet grip and external rolling noise. The label provides ratings 
of noise both in decibels and in more general terms for those 
unfamiliar with the decibel system – black waves indicating 
whether the tyres are ‘quiet’, ‘moderate’ or ‘noisy’. Quieter tyres 
are generally no more expensive than standard tyres and perform 
similarly in terms of wet grip and rolling resistance.22
Source Adapted from https://commons.wikimedia.org/wiki/File:EC_tyre_
label_CA.svg
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Environmental health opportunities – reducing 
noise pollution
As well as addressing the direct impact of environmental 
threats on clinical health outcomes, Environmental 
Public Health professionals are faced with environmental 
opportunities and challenges that can be beneicial for, or 
impact on, people’s mental health and quality of life. One 
such issue is sound/noise. Sound is an essential element in 
our daily lives, allowing us to communicate and express our 
feelings and capture information about our environment.15 
Noise is sound that occurs in the wrong place or at the 
wrong time that leads to a negative effect on health and 
well-being.16 
The scale of noise as a public health issue is clear. Noise is 
the single largest issue of complaint made to local authorities 
in the UK. Transportation noise is the second-largest 
environmental health risk factor in Western Europe17 The 
annual social cost of urban road trafic noise in England 
is estimated at £7-£10bn.18 There is good evidence that 
transport related noise is associated with sleep disturbance, 
cardiovascular morbidity, cognitive impairment in children and 
chronic annoyance.19-21 
However, transportation is not the only noise source of 
concern. Environmental Health Practitioners are well aware 
of the impact of nuisances from neighbours and wider 
neighbourhood noise. One in ten people report themselves 
“very or extremely” bothered, annoyed or disturbed by noise 
from neighbours and other people nearby.3 Data from the 
Public Health Outcomes Framework23 show around 400,000 
complaints made to Local Authorities in England every 
year about neighbour and neighbourhood noise, and this 
represents only a small percentage (10-15%) of actions taken 
by those affected by noise.3,24 Several studies have shown 
that neighbour and neighbourhood noise can have a negative 
impact on physical and mental wellbeing in adults24-27, and 
one study found that exposure to neighbour noise at home 
is associated with conduct problems and hyperactivity in 
children.28,29 Statistics compiled in 2014-15 by the CIEH on 
Local Authority noise enforcement activity show that EHPs 
resolved 82% of complaints received.
The journey towards a healthier, less polluted, sound 
environment offers many challenges. Increasing urbanisation 
is bringing people’s dwellings closer together and closer to 
roads, railways, airports and industry. Major infrastructure 
projects are making construction noise a semi-permanent 
feature of the urban sound environment: the 24hr economy 
can be a barrier to people’s desire to “turn down the 
volume” at night to allow a good night’s sleep. But solving 
these problems is not just about reducing noise levels. Noise 
acts as a psychosocial stressor30, and the psychological 
reaction to it is inluenced strongly by a number of personal, 
situational and environmental factors.30-32 A holistic 
sustainable development approach featuring good acoustic 
design33,34 can protect against adverse health outcomes by 
minimising exposure and maximising restorative opportunities 
such as respite35 and tranquil urban areas.36 Behavioural 
interventions such as coping strategies37, should also be 
considered, particularly for those most at risk. 
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Acute incidents and pollution
Another aspect of protecting the environment is to anticipate, 
plan for and respond to acute pollution events.
All human activity generates waste and this can become 
a threat to the environment and ultimately to human 
health. The UK generated 202.8 million tonnes of total 
waste in 2014. Over half of this (59.4%) was produced by 
construction, demolition and excavation, with households 
responsible for a further 13.7% (Figure 7.2).38
The regulatory regimes to mitigate the potential public health 
risk posed by waste disposal and treatment such as deposition 
to landill and incineration, are well documented.39,40
For many years, the policy of prevention, re-use and recycling 
of waste products has driven up recycling rates (Figure 7.3).41 
The preferred option is to reduce the amount of waste that 
is generated at source. If that is not possible, priority should 
be given to preparing the waste material so it can be easily 
re-used or turning it into another useful product or material 
(recycling). Although this has led to an improvement in 
the environment by reducing the impact of waste disposal 
activities such as air, water and land pollution due to landill, 
it has also increased the number of waste storage sites. 
Waste facilities could harm human health by polluting the 
environment unless they are controlled. The environmental 
permitting regime requires operators to obtain permits 
for some facilities and ensures their ongoing supervision. 
Permitting aims to protect the environment, ensure policy 
and legislative standards are met and encourage best 
practice in operation of facilities.42 Of all the serious pollution 
incidents in 2015, 65% had an impact on water and 19% 
had an impact on air. Activities with permits caused 26% of 
incidents affecting water, and 71% of incidents affecting air. 
Non-permitted activities caused 61% of incidents affecting 
water, and 29% of incidents affecting air.38
There are approximately 8,500 permitted sites storing 
combustible wastes in England and each year there are 
around 250-300 ires at such sites. Many of these ires occur 
at sites that are close to local communities, meaning that 
people can be affected by combustion products within the 
smoke. In addition to causing adverse effects on human 
health, smoke can cause signiicant disruption to major travel 
infrastructure, neighbouring businesses, and utilises resources 
from emergency responders.
The Environment Agency has a statutory duty to protect the 
public and the environment at those sites it regulates, by 
controlling emissions to air, land and water. These emissions 
include accidental releases from ires.42 In 2015/16, the 
Environment Agency completed a formal consultation, and 
responses were received from Public Health England and 
other Emergency Responders. These comments were used 
to revise the regulatory guidance on ire prevention. This sets 
out clear objectives that site operators must achieve in order 
to reduce the overall likelihood and the impact of waste ires 
on the public and the environment.
The environmental permitting regime requires operators to 
obtain permits for some facilities and ensures their ongoing 
supervision. For permitted waste sites that store combustible 
wastes, conditions in the permit now require an operator to 
draw up a ire prevention plan. All plans have to be approved 
by the Environment Agency and are required to meet the 
objectives in the regulatory guidance. Over the next few 
years, the requirement for all existing 8,500 permitted sites to 
have an approved ire prevention plan is being phased in.
The composition of the smoke from these ires varies with 
the type of combustion, the availability of oxygen, the 
temperature and the materials involved. The immediate 
adverse health effects are likely to be caused by particulate 
matter, asphyxiants and irritants35, particularly in the most 
vulnerable groups within the local community including 
children, the elderly and pregnant women. Current 
precautionary public health advice provided during many 
ire incidents is for members of the public to reduce their 
exposure by sheltering indoors; keeping windows and doors 
closed. However, sheltering becomes less effective over 
time if outdoor concentrations remain high. Effectiveness 
is dependent on people starting sheltering as soon as a 
ire starts and stopping as soon as it ends. Many Fire and 
Rescue Services routinely use live social media feeds to inform 
the public of local incidents including ires. All emergency 
responders should encourage the public to follow these social 
media feeds, and to immediately shelter if they are within a 
1km radius of a waste ire.
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Figure 7.2 Waste generation by source (United Kingdom, 2014)
Note
C&I = Commercial & Industrial
CD&E = Construction, Demolition & Excavation and includes dredging
‘Other’ consists of waste from mining, agriculture, forestry and ishing
Source Bradley et al. using data from Health Protection Agency, Impact on Health of Emissions from Landill Sites (2011)
Figure 7.3 The Waste Hierarchy
Source Department for Environment, Food and Rural Affairs (Defra). Guidance on applying the Waste Hierarchy (2011)
Annual Report of the Chief Medical Oficer 2017, Health Impacts of All Pollution – what do we know? Chapter 7 page 13
Environmental health – response to pollution
Box 6  Working together to manage risk 
from waste sites
It is not possible to prevent all ires and there is a 
need to minimise the duration of a ire, in order to 
protect members of the public from being exposed 
to unacceptable levels of smoke. In July 2016, the 
Environment Agency revised its regulatory guidance on Fire 
Prevention. Requirements are being phased in, so that all 
permitted sites storing combustible waste are required to 
draw up and implement a plan to meet the objectives of 
the guidance:
  to minimise the likelihood of a ire occurring;
  to extinguish a ire within 4 hours; and 
  to minimise the spread of ire within the site and to 
neighbouring sites.
Waste sites that are regulated by local authorities, 
those that are illegal or exempt, do not comply with the 
objectives of the regulatory guidance.
When ires do occur there is very close working between 
the site operator, the Fire and Rescue Service, public health 
professionals, the local authority and the Environment 
Agency. Such joint working means the ire can often be 
brought under control quickly and a plan developed for 
putting it out. Where ires can be quickly extinguished, 
the health impacts on the local community are reduced 
signiicantly.
Box 7 Bio-aerosols and waste
Recycling waste can bring its own environmental 
challenges such as addressing concerns about the potential 
public health risk from bacteria and fungi arising from 
commercial composting sites.
The Environment Agency worked with PHE, academic and 
commercial partners to identify what levels of exposure to 
bioaerosol may be harmful, what contribution composting 
sites may make to the bioaerosol exposure of people living 
nearby, and how emissions can be mitigated. With our 
data we have developed a regulatory position that protects 
public health while minimizing the inancial and regulatory 
burden on operators.
A literature survey indicated that there is evidence of 
health effects from exposure to high concentrations 
of bioaerosol in some occupational situations, but it is 
not clear whether measurable harm occurs at the lower 
concentrations typically found downwind of biowaste sites. 
A precautionary approach to regulation was therefore 
deemed necessary, under which composting sites would 
not contribute to ambient exposure.
  There is evidence of health effects from exposure to 
high concentrations of bioaerosol in some situations.
  It is not clear whether measurable harm occurs 
downwind of biowaste sites.
  Epidemiological studies conirmed that no statistically 
signiicant health impacts are found in people living 
250m downwind of sites.
  Containment of composting mitigates bioaerosol 
emissions.
  Bioilters are primarily designed to reduce odour 
emissions. Their effectiveness to mitigate bioaerosols is 
variable. 
  Stacks can be used to reduce ground level bioaerosol 
exposure.
In addition to public health risks from bioaerosol from 
waste facilities, there is a potential risk from intensive 
farming facilities. Further evidence is needed to inform us. 
A key question is whether bioaerosols downwind of these 
facilities pose a risk to public health with respect to the 
types of species found in the bioaerosol and the quantities.
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Box 8 Occupational exposures 
Dr Katherine Fuller, Health and Safety Executive
Ill health that develops from exposures in the workplace 
continues to be a signiicant challenge. In 2016/17 an 
estimated 1.3 million people who worked were suffering 
from an illness they believed was caused or made worse 
by work and an estimated 13,000 deaths a year (12,000 
lung disease deaths) are linked to past exposures to 
hazardous substances at work1. In addition to the direct 
personal consequences, this results in a considerable 
economic burden.
New cases of work-related illness resulting from working 
conditions today (excluding long-latency illnesses) led to 
annual costs of £9.7 billion in 2015/16.i But past working 
conditions also continue to cause high costs today. The 
Health and Safety Executive (HSE) estimates that new cases 
of work-related cancer, caused largely by past exposures 
to carcinogens at work, resulted in costs of around £12.3 
billion in 2010.ii
HSE’s Health and Work strategyiii highlights the toll of 
work-related ill health and sets out the actions that it 
will take forward to address this challenge. Exposures 
resulting in work-related ill health can occur across all 
industry sectors irrespective of the sizes of the business. 
However, HSE cannot tackle all work-related ill health at 
once and it will focus on those health issues that have a 
widespread prevalence, the largest lost-time and economic-
cost consequences and/or have life-altering or life-limiting 
impacts for the individual. Using a robust science and 
evidence baseiv, as well as considering the impact of the 
future world of workv, HSE is prioritising its activity on 
tackling exposures that lead to:
  occupational lung diseases;
  musculoskeletal disorders; and 
  work-related stress and related mental health issues.
HSE’s activities are aimed at driving collective action in the 
health and safety system towards managing health in the 
workplace (see example) and it is engaging with a variety of 
stakeholders and partners including industry, trades unions 
and the wider workforce, Local Authority co-regulators, 
professionals and academia to develop its work on the 
priority health areas. Actions include championing the 
need for prevention, working with strategic partners and 
networks (national and international), directing HSE and 
Local Authority inspection and enforcement activity to 
where it can have the most effect and raising awareness 
with employers to promote behavioural change through the 
‘Go Home Healthy’ campaign.vi
An example of collaborative work HSE are undertaking 
for one of the health priority areas is aimed at reducing ill 
health from exposure to respirable crystalline silica 
(RCS) in brick making, stone masonry, foundries, quarries 
and construction industries. Activities include:
Engaging: with workers and employers to drive 
interventions and behavioural change through facilitating 
speciic industry partnership groups to implement tailored 
actions and novel communications materials e.g. the 
Quarries Partnership Team animated YouTube video to 
highlight good and bad working practices 
(https://www.youtube.com/watch?v=X0Whg2BQpDc). 
Promoting: key practical messages e.g. to consider 
workplace exposures when workers return to work 
after illness. Supporting partner’s initiatives e.g. British 
Occupational Hygiene Society and their ‘Breathe Freely’ 
campaign aimed at the construction industry (http://www.
breathefreely.org.uk/) and Institution of Occupational Safety 
and Health on the silica phase of their ‘No Time to Lose’ 
initiative (http://www.notimetolose.org.uk/Free-resources/
Silica-pack-lite-version.aspx).
Anticipating new challenges: through foresight and the 
synthesis of existing evidence to identify novel techniques to 
address RCS health and safety issues, e.g. in mask sampling 
for exposure measurement.
Evidence-based activity: synthesis of the evidence 
base from 20 years of research indings, considered by 
the Workplace Health Expert Committee (lead by an 
independent Chair).
Longitudinal workplace research: undertaking a study of 
workers in stone working, brick-making and foundries.
Policy and operational activity: issuing supplementary 
RCS health surveillance guidance, alongside enforcement 
campaigns in targeted industries as part of wider activity.
Partnership working: establishing a leadership body, the 
Healthy Lung Partnership across existing stakeholder groups 
to co-ordinate activity and provide direction on tackling 
occupational lung diseases.
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Authors’ suggestions for policy 
makers 
  Environmental pollution poses a signiicant burden for 
society, businesses and individuals. Long-term coordinated 
action is required to make sustained improvements. 
Focused engagement with stakeholders and networks of 
individuals to support behaviour change and develop the 
required awareness programmes to achieve tangible health 
outcomes is needed. The consolidation of the public health 
function in local government presents a great opportunity 
for focused, evidence based interventions driven by local 
needs.
  It important to recognise the full scope of environmental 
public health function, which includes research, regulation, 
policy development and advocacy functions. These 
functions are carried out by wide range or government 
departments, agencies, organisations and universities. It is 
crucial to consider all these activities when developing the 
multi-disciplinary workforce required to carry out all these 
functions. 
  There is an urgent need to improve collaborative 
intelligence and horizon scanning activities for 
environmental public health threats to prioritise investment 
in research and prevention activities.
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Summary
1. The large volume of data on pollution and health 
outcomes now, and becoming available (‘big data’), 
provide exceptional opportunities to carry out 
investigations into the impacts of environmental pollution 
on human health and for the detection (‘surveillance’) and 
prevention of non-communicable diseases in England and 
elsewhere.
2. The data needed to realise these opportunities include 
information about personal and population exposures 
to environmental pollutants, for example, through novel 
-omics techniques and use of biomarkers, linked to 
individual health records and geocoded routine health 
statistics.
3. Analyses of such data will improve our understanding of 
the health implications of exposures to a complex range 
of polluants over both short and long time periods. In 
addition, developments in computational processing, 
novel spatio-temporal statistical methodologies and 
innovative technologies such as data mining and artiicial 
intelligence, will facilitate detection of unusual signals in 
the routine health and pollution data for surveillance and 
environmental public health tracking.
4. A multi-disciplinary approach is needed, as exempliied by 
studies conducted by the UK Small Area Health Statistics 
Unit (SAHSU). On-going funding is required both to 
maintain and develop infrastructure to receive, curate, 
hold, link and analyse such data, as well as for speciic 
research projects. 
5. Despite the large volume of data available, they are not 
necessarily easy to access and use. Robust procedures 
need to be in place to assure the quality and completeness 
of data, to make them available for research in timely 
fashion across different linked data sources and to ensure 
that ethical and information governance requirements 
are met.
Overview
Exposure to environmental pollutants, for example from air 
and water, is an inevitable consequence of everyday living. 
Studies of the effects of environmental pollutants on health 
have often been limited by a lack of high quality information 
on what people are exposed to, where and when the 
exposure occurs and by problems linking pollutant data to 
health outcomes, especially over the long term. Interpretation 
of health effects linked to a speciic pollutant may be 
complicated by impacts of lifestyle factors, socioeconomic 
deprivation and exposure to more than one pollutant at a 
time. Better and more integrated data will help to overcome 
these problems for researchers, providing a stronger evidence 
base for policies to reduce exposure to environmental 
pollution and consequently improve health. A further issue 
arises where the impacts on health of any one pollutant may 
be relatively small and dificult to detect compared with the 
effects of lifestyle and other causes (see Chapter 10 of this 
report, ‘Measurement and communication of health risks 
from pollution’). Detecting small risks reliably requires large 
studies – and large datasets. However, increases in disease 
risk that may appear small for any one individual may be 
important for public health as overall they can add up to a 
large disease burden across the population.1
Vast amounts of electronically stored data are now being 
collected about us, the way we live and our environment, 
including information on pollutants and our lifestyles 
(Annex 3). These data can, in principle, be linked to health 
data to investigate risks to health. Sources of health data 
include national health datasets, such as birth and death 
records, general practice patient records, hospital admissions 
and other National Health Service (NHS) data (Annex 4), 
as well as information from speciic surveys and personal 
monitoring devices. Through appropriate linkages of the 
pollution and health data, these ‘big data’ resources can 
provide remarkable opportunities to:
  rapidly investigate associations between our health and the 
environment we live in; 
  identify demographic, environmental and socioeconomic 
risk factors for speciic diseases and ill-health; 
  inform public health policies by improving our scientiic 
understanding about the ways in which environmental 
factors may inluence health. 
Analysis of these data requires the careful use of appropriate 
methodologies, allowing other important health risk factors 
such as age, socioeconomic status and ethnicity to be 
accounted for. Small area studies, such as neighbourhood 
studies, allow for the linkage of such data from multiple 
sources (Box 1). Small-area studies have been used to map 
disease risks (Figure 8.1) and pollutant concentrations 
(Figure 8.2), and to investigate potential health risks 
associated with various pollutants and exposures. Examples 
include waste disposal2,3, temperature extremes4,5, air and 
noise pollution6,7, chlorination by-products in the water 
supply8,9, and electromagnetic ields from overhead power 
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lines and mobile phone masts.10-12 National data coverage 
also allows the investigation of the extent by which different 
population groups, deined by geographical region or 
socioeconomic characteristics, are exposed to different 
levels of environmental pollutants (termed environmental 
inequality).13-16 
Box 1  The UK Small Area Health Statistics 
Unit
The UK Small Area Health Statistics Unit (SAHSU, http://
www.sahsu.org/) holds many of the routinely collected 
national health, environmental and socio-demographic 
data in the UK.17 It was set up 30 years ago following 
the observation of an excess risk of leukaemia and 
lymphoma among children and young people living near 
the Sellaield nuclear plant.18 SAHSU has a national remit 
to develop methodologies, particularly for small areas 
(neighbourhoods) to improve detection of health risks from 
pollution, to conduct targeted research and monitoring 
and advise government on unusual clusters of disease. It 
has an international reputation as a centre of expertise 
in methods in spatial and environmental epidemiology. 
Overall, SAHSU collects, curates and maintains more than 
600 million UK health records. The development of new 
biostatistical methodologies19,20, the use of state of the art 
geographical information systems (GIS) to integrate data 
and develop advanced environmental models21,22, offer 
a powerful approach to study potential health risks to 
the public. 
Data mining capabilities, already commonly used for 
commercial and marketing purposes in other settings (for 
example, by search engines, banks, supermarkets and on 
social media), are starting to be used in health research, 
and offer the prospect of analysing national sources of 
health data for public health surveillance. The government 
Chief Scientist’s Blackett report on wide-area surveillance23 
recently concluded that the rapid detection of unusual 
health signals would have signiicant beneits for public 
health. The use of such methods for health surveillance 
in the public good needs careful attention to privacy 
and data security, as enshrined in Caldicott principles in 
the UK24-26 and the European General Data Protection 
Regulation (GDPR, http://www.eugdpr.org/).
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Figure 8.1  Disease incidence maps of (a) lung cancer in women and (b) mesothelioma in men extracted from 
SAHSU’s Environment and Health Atlas for England and Wales
Source  adapted from data from the Ofice for National Health Statistics
(a)
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Note
1. The incidence risk for each small area (in this case wards) has been smoothed towards a combination of the national average and the averages of neighbouring wards. Smoothing is a statistical method 
used to adjust for chance luctuations in disease risk that can occur when risks are calculated using rare diseases or small populations.27 They show higher risks for lung cancer in urban areas particularly 
those in the north of England and highly localised increased risks of mesothelioma secondary to occupational asbestos exposure. 
2. Maps are available online at www.envhealthatlas.co.uk and can be searched by postcode.
 
(b)
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Figure 8.2 Maps of (a) nitrogen dioxide concentrations (NO
2
, µg/m3), 100m × 100m annual average 
concentrations for 2001 developed using land use regression (LUR), and (b) herbicide usage (kg) per 
census ward in 2000
Source Extracted from SAHSU’s Environment and Health Atlas for England and Wales and based on data from the English 
Department for Environment, Food and Rural Affairs (DEFRA) and the Pesticides Usage Survey (PUS), respectively.
Note
Maps show higher levels of NO
2
 in urban areas relecting road trafic as a major source, and higher usage of herbicides in agriculture intensive areas. 
(a) (b)
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A new era of big data
Accurately estimating exposure to environmental pollution 
and relating that to health over the lifecourse is a major 
challenge. We provide below an overview of the major 
sources of data to investigate ongoing impacts of pollution 
on our health and present some of the methodological 
opportunities and challenges associated with processing and 
analysing such big data.28
The exposome – the totality of exposures
The concept of the exposome is providing a new systems-
wide paradigm to help understand the health effects of 
environmental pollution. The exposome covers the totality 
of all types of exposures – from genetic/genomic sources, 
lifestyle and diet, psychosocial, medical, occupational and 
other sources, as well as environmental pollutants – over 
a person’s lifetime. This concept should help researchers 
gain new mechanistic insights into disease causation and 
progression and to develop novel approaches to treatment 
and disease prevention.29-32 It involves bringing together 
data on measured (e.g. personal monitoring device) and 
modelled (e.g. interpolation based on monitoring network) 
exposures and biological dose (e.g. from biomarkers), as well 
as potential health effects. 
Biological signatures cover a wide range of molecules, 
including metabolites in blood or urine (metabolomics), 
proteins (proteomics), mRNA (transcriptomics), and covalent 
complexes with DNA and proteins (adductomics) (Figure 8.3). 
Such rich biological information allows the assessment of the 
internal (chemical) and external (environmental pollutants 
and stressors) exposures of an individual, especially during 
critical life stages. Proof of concept studies have identiied, 
for example, metabolic proiles that detect early effects of 
environmental and lifestyle exposure to33, and susceptibility 
to tobacco smoke-induced cardiovascular diseases among 
women.34
Figure 8.3 The exposome concept
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Big data on environmental pollution
* https://www.londonair.org.uk/LondonAir/Default.aspx
** http://www.breathelondon.org/plan-lower-pollution-travel-route
The ‘big data’ revolution is providing much improved 
information on pollution and pollutant sources. Publicly 
available data, based on satellite images, aerial photographs 
and ground surveys conducted at increasing resolution, tell 
us about land use changes, the precise geographical location 
of roads, industrial facilities and waste disposal sites, patterns 
of light pollution and pollen concentrations and other sources 
of environmental pollution. Routine meteorological and air 
quality monitoring stations generate precise localised time 
series for large urban areas and reliable modelled surfaces 
nationwide. Local monitoring networks, such as the London 
Air Quality Network* which provides estimates of air pollution 
for 20m grids across the city (one of the most advanced such 
systems worldwide), allow users to access detailed hourly 
forecasts of local air pollution levels (Figure 8.4a). These 
can then be used to offer advanced services, for example, a 
route planner to identify routes that minimise exposure to air 
pollutants when walking or cycling in London.**
It is not practical to make pollutant measurements on the 
whole population, but models can provide proxy estimates 
of pollution exposures experienced by individuals. Local 
monitoring networks support the development of detailed 
air pollution models to assign air pollution exposure 
to individuals, for example, at their residential address 
(Figure 8.4b). A standard method for modelling residential 
air pollution is land use regression (LUR).35 (45). LUR uses 
input from air pollution monitoring sites and geographical 
information on potential sources including local trafic, 
industrial sites and population patterns. This information is 
used to build a statistical model that predicts air pollution 
concentrations in areas where people live.36-40 The 
combination of measurements from 5,220 air monitors across 
58 countries has, for example, enabled the development of 
a global LUR model for nitrogen dioxide air pollution41 that 
is being used to investigate health effects and burden of 
disease. LUR methods have also been applied to assign air 
pollution levels to the UK (Figure 8.4a) and, using historic air 
quality monitoring data going back to the 1970s, to study 
effects of air pollution on health over 30 years.7
The application of advanced methodologies in geographic 
information systems (GIS) and high-performance computing, 
enables the capturing, storing and processing of large 
quantities of spatial and temporal data. This allows the 
modelling and assessment of exposures with complex 
dispersion patterns such as road trafic and aircraft noise 
or electromagnetic ields42,43 Further advances are needed 
to account for activity and migration patterns of people to 
estimate their exposure to different pollutants throughout a 
day, year or lifetime. Combining modelled and measurement 
data, for example through the joint use of satellite-derived 
models44, high-precision exposure methods and information 
from personal monitoring devices45, can provide high 
quality information on pollutant exposures for a subset of 
individuals that can then be extrapolated more generally to 
the population.
Box 2  Air quality exposure application
Dr Andrew Grieve, Kings College London
Air quality monitoring is undertaken by local authorities 
across the UK. The data collected is highly time resolved, 
quality assured and comparable across cities and regions. 
Although these data are collected for compliance 
assessment, they are increasingly being used for public 
dissemination and information.
The City Air app uses a combination of real-time air quality 
monitoring data from the London Air Quality Network 
(LAQN) and highly detailed dispersion modelling to provide 
users with air quality alerts and an innovative low pollution 
routing tool.
Every hour, maps for nitrogen dioxide (NO
2
), PM10 and 
PM2.5 particulates and ozone (O
3
) are updated using the 
latest data from the network to create a ‘Nowcast’ model 
of air quality across the city.
Each map is highly detailed, consisting of 5.5 million 
20x20 metre grid squares so this process involves the 
recalculation of over 10 million grid cells each hour by 
King’s College servers.
Since the pollution concentration in each grid cell 
is known, the app can therefore calculate pollution 
concentrations along any particular route.
When provided with a start and end 
point, the app calculates up to three 
alternative routes between those 
points and calculates the pollution 
difference between the routes by 
summing the average of each of the 
pollutants in all of the grid cells that 
the route transects.
Using data from the LAQN, the app 
provides users with a range of lower 
pollution routes between two points 
thereby helping them to minimise 
their exposure as they travel across 
the city. 
The application was developed by 
King’s College London and City of 
London Corporation and received a 
Defra air quality grant in 2012.
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Figure 8.4  Maps of (a) the air monitoring network and (b) modelled annual average NO
2
 concentrations in 
London estimated by CMAQ-Urban for 2008 
Note
1. Stations monitoring levels above and below the legal limit of 40 µg/m3 are shown in red and green, respectively. 
2. Monitoring stations with insuficient data are shown in white. 
3. CMAQ-urban is a comprehensive system for modelling air quality in large urban areas, cities and towns.46
Furthermore, new technologies of integrated micro sensors 
combined with smartphone applications, accurate GPS 
tracking and Wii connectivity are enabling real-time crowd-
sourced monitoring of a range of environmental parameters 
surrounding users (such as temperature, carbon monoxide, 
particulate matter). 
If widely used across the country, such devices would 
provide a wide network of measurements with relatively 
low maintenance costs. Crowd-sourcing has the potential 
to validate and improve modelled exposure estimates, 
particularly in areas of low population density and to better 
assess differences in health risks between individuals, based 
on real-time monitoring of their pollutant exposures, daily 
activity patterns and health. However, this will require 
detailed assessment of the accuracy and representativeness 
of such methods before they can be widely used.
Despite increasing availability of large environmental datasets, 
we found when compiling for SAHSU the Environment and 
Health Atlas for England and Wales (www.envhealthatlas.
co.uk), that environmental data from different sources are 
collected in different ways with different access permissions 
(Annex 4), not all data are available nationally, while data that 
were available nationally were not readily available at small 
area level. SAHSU therefore had to carry out intensive work 
of data compilation and harmonisation in order to map these 
data at small area level nationally. In some cases, such as in 
an ongoing study of health risks around municipal waste 
incinerators3, paper records may be the only or main source 
of pollution data available especially if looking back in time at 
past exposures. 
a b
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Biomarkers 
* https://www.cdc.gov/nchs/nhanes/about_nhanes.htm
** https://www.umweltprobenbank.de/
*** http://content.digital.nhs.uk/healthsurveyengland
The term biomarker is used to describe either a biological 
measure of current or historic exposure to a pollutant, or a 
biological measure of disease onset. 
A measurement of a pollutant concentration in the 
environment does not always correlate well with an 
individual’s actual exposure. This may be affected by a wide 
range of factors including a person’s daily activities, the 
type and location of their residence, workplace, travel and 
migration patterns, diet, lifestyle, medication, breathing rate 
as well as their genetic make-up. Biomarkers from biological 
samples, such as blood and urine, may allow quantiication 
of these complex lifestyle and exposure factors at the 
individual level, providing data to evaluate population-level 
exposure models. Biomakers can also provide information 
on spatio-temporal variability in exposure data and other 
factors that may be related both to the exposures and 
health outcomes (i.e., confounders). Use of biomarkers can 
therefore lead to improved risk estimates of health effects 
of pollution by providing better estimates of exposure, thus 
reducing measurement errors and other sources of bias and 
strengthening possible causal inferences.47
In a number of countries, nationally representative surveys 
have been set up to collect and store health information 
and biological samples that can be used to investigate 
biomarkers of environmental risks and to monitor how the 
health of the national population changes over time. One of 
the earliest such surveys is the United States National Health 
and Nutrition Examination Survey *(NHANES), which began 
in the 1960s and tests thousands of individual samples for 
hundreds of chemical exposures, allowing the investigation of 
biomarkers of environmental exposure and disease, as well as 
population surveillance of exposures to multiple pollutants48 
(Box 3). Biological samples from NHANES were, for example, 
instrumental in generating biomonitoring data on heavy 
metal concentrations such as lead49,50, cadmium51 and 
manganese.52 Some countries, such as Germany, have gone a 
step further by creating an environmental specimen bank** 
to permanently archive ecological and toxicological evidence 
of current and past pollutant exposures allowing detailed 
retrospective investigations.53,54
The UK government funds the annual Health Survey for 
England (HSE), which has collected data since the early 
90s, on physical health, mental health and wellbeing, social 
care, lifestyle behaviours based on interviews, as well as 
physical measures (height, weight and blood pressure) from 
around 8,000 adults and 2,000 children per survey, who 
are representative of the general population.*** HSE data 
allow the monitoring of changes in health and lifestyles (e.g. 
alcohol drinking, smoking), and the prevalence of speciic 
health conditions, as well as being used to plan services 
and develop and evaluate public health policies. In recent 
years, HSE has also collected saliva, blood and urine samples 
for assessment of, for example, cardiovascular risk (e.g. 
cholesterol) and diabetes. HSE has to date been little used for 
studies on health effects of pollution, though the collection 
and storage of biological samples and health data mean 
that such studies using HSE data could be undertaken were 
funding to become available. 
Box 3  The National Health and Nutrition 
Examination Survey (NHANES)
NHANES (https://www.cdc.gov/nchs/nhanes/index.htm) 
is a programme of national studies in the USA, managed 
by the Centres for Disease Prevention and Control (CDC), 
and designed to assess the health and nutritional status of 
adults and children in the United States through interviews 
(including demographic, socioeconomic, dietary, and 
health-related questions), physical examinations (medical, 
dental, and physiological measurements) and biological 
samples (blood and urine). NHANES includes data on a 
range of medical conditions (e.g. anaemia, cardiovascular 
disease, diabetes, eye diseases, hearing loss) as well as 
on environmental exposures, physical itness and physical 
functioning. 
The ifty years of data from NHANES provide a remarkable 
resource to monitor temporal trends in pollutant levels 
and disease risk factors through direct measurements. 
Some of the main achievements of NHANES are the 
development of new policies to eliminate lead from petrol 
in the US as well as in many other parts of the world; the 
development of growth curves and monitoring of obesity; 
the implementation of a national education programme to 
reduce hypertension and cholesterol levels. NHANES has 
been used, for example, to investigate the potential effects 
of urinary bisphenol A (found in plastics) on diabetes, 
cardiovascular disease and liver function55, and data from 
NHANES have been ‘mined’ to explore effects of a wide 
range of exposures on health.56 The value of NHANES data 
is further increased by being made accessible to users and 
researchers throughout the world.
Public Health England is leading for the UK in the European 
Human Biomonitoring Initiative (HBM4EU), a joint effort of 26 
countries funded by the European Commission to coordinate 
and advance biomonitoring in Europe, which launched in 
2016. This presents an opportunity to create an ongoing 
national resource similar to NHANES, possibly linked to HSE, 
to monitor pollution exposures in the general population. 
These could include both well-known contaminants, such as 
lead and dioxin-like chemicals, as well as newer chemicals 
such as lame retardants and those with endocrine disrupting 
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properties. Such an initiative would provide a rich source 
of information on people’s exposure to pollution and be an 
invaluable resource for studies of environmental hazards and 
health that could both inform public health policies and help 
assess the beneits of policy changes over time. 
In addition, biological samples are collected in large national 
(e.g. UK Biobank) or local (e.g. the Avon Longitudinal Study 
of Parents and Children57) studies, which offer opportunities 
to identify biomarkers of major chronic diseases, as well 
as for analyses of environmental contaminants in stored 
samples. Linkage of such data on individuals with small area 
data, often called “mixed design” studies, presents new 
opportunities to better understand the associations between 
pollutant exposures and health.3,11,58-61 
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Health data
Good quality data on health outcomes as well as pollution 
exposures are crucial to investigate the impact of pollution 
on health. The volume and accessibility of health records in 
England, collected mainly for the purposes of delivering and 
auditing healthcare throughout the NHS, have dramatically 
increased in the last two to three decades. For example, on 
average over 100 million individual records from outpatient, 
maternity, adult critical care and accident and emergency 
(A&E) services across all NHS hospitals are added every year 
to the Health Episode Statistics (HES, http://content.digital.
nhs.uk/hes) database. A remarkable feature of NHS data 
in England and throughout the UK is the near universal 
coverage which allows investigation of environment and 
health associations in neighbourhoods and local areas for any 
part of the country.3,12,62 
In addition to routinely collected health data, around 3.5% of 
the UK general population – 2.2 million people – participate 
in ongoing long-term health studies (cohort studies) following 
people over time to investigate risk factors among people 
who do or do not develop disease. The largest of these 
cohort studies is UK Biobank, mentioned above, which 
includes over 500,000 individuals with clinical measurements, 
demographic and health data and blood, urine and saliva 
samples stored for assessment of biomarkers.63 
There has also been an explosion of data collected by 
individuals through use of smartphone technology and 
personal monitoring devices, including heart rate, physical 
activity, sleep patterns, calorie consumption and other 
health indicators. Such devices collect information in real-
time at short intervals, potentially over long-periods of time, 
accessible to each individual user but also collectively to 
the device manufacturers (and potentially to researchers). 
These emerging data sources provide yet largely untapped 
information on health behaviours of many thousands of 
people at low cost.64 
However, just because health data are collected does not 
mean that they can be used in research on health effects of 
pollution or for health surveillance. For example, their quality, 
coverage or completeness may not be suitable for health 
analysis (Box 4), they may have restricted access or usage, 
or it may be dificult to link them together with pollutant 
data. Issues of data harmonisation and linkage also apply to 
cohort studies and biobanks. Initiatives, such as the Cohort & 
Longitudinal Studies Enhancement Resources (CLOSER, http://
www.closer.ac.uk/), are working to harmonise longitudinally 
collected data from UK cohorts. The European Union funded 
BioSHaRE project (http://www.bioshare.eu/) (2010-15) helped 
develop methods to harmonise and combine data collected 
in large European biobanks including UK Biobank65 and to 
advance data analysis techniques.6 Lessons learned from such 
initiatives could help in integrating and harmonising data 
from newly emerging sources.
Box 4  Selected examples of challenges 
for research related to the use of 
routinely collected health data in 
England 
1. Birth data are collected in four different databases 
in England, each having differing strengths and 
weaknesses.66 Careful assessment of the quality and 
completeness of each database and their overlap is 
needed for use in studies of environment and health 
and for surveillance.
2. Cancer registrations used to be collected in seven 
regional cancer registries with slightly different coding 
practices that led in the past to apparent differences in 
regional incidence and trends for some cancers. There 
is now a uniied cancer registration system for England 
led by Public Health England: the National Cancer 
Registration and Analysis Service (NCRAS). This registry 
records over 300,000 cases of cancer per year (https://
www.gov.uk/guidance/national-cancer-registration-and-
analysis-service-ncras) using the same methods and can 
be used to monitor geographical and time trends.
3. Until now, registries of congenital anomalies were 
managed at the regional level and did not cover the 
whole of England.67 The recent creation of a National 
Congenital Anomaly and Rare Disease Registration 
Service (NCARDRS, https://www.gov.uk/guidance/
the-national-congenital-anomaly-and-rare-disease-
registration-service-ncardrs) for England will greatly 
facilitate studies of anomalies, an important sentinel for 
environmental risks.68,69 
4. Demonstrating responsible handling of personal data, 
including data privacy and good information governance 
is important, e.g. ensuring that outputs comply to 
conidentiality rules (suppression of low number in a 
small area) to reassure patients that their data is not 
identiiable.
5. An increasing proportion of NHS patients in England 
are opting out of the use of their health records beyond 
their GP practice or the NHS system (http://content.
digital.nhs.uk/article/7092/Information-on-type-2-opt-
outs). Although the overall rate of such opt-outs is 
quite low, gaps in the data are highly clustered which 
can create problems when conducting studies of 
environmental hazards and risks to health, particularly at 
the small area level.
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Data methods, linkage and 
analysis
Rigorous protocols are necessary to share, link and analyse 
health and pollution data in a timely fashion.58 Combining 
information from different data sources can provide 
important insights into the effects of pollution on health, but 
complex administrative procedures often mean researchers 
have delays of months or years in accessing and compiling 
the data, requiring approvals from multiple data providers. 
The creation of Health Data Research UK (HDR UK, https://
www.mrc.ac.uk/about/institutes-units-centres/uk-institute-
for-health-and-biomedical-informatics-research/), bringing 
together a consortium of world-leading groups in health and 
biomedical informatics should facilitate ready access to and 
use of large patient and research data sets, while ensuring 
compliance with information governance regulations.
Eficient statistical methods and software are needed to 
process, analyse and visualise the data. Use of dedicated 
analytical software can considerably reduce the time required 
by a researcher or a public health professional to investigate 
potential health risks to the public. The Rapid Inquiry Facility 
(RIF), developed by SAHSU, supports disease mapping and 
risk analysis for environmental health studies, especially 
those in the vicinity of industrial sites or other sources of 
environmental pollution (Box 5), allowing the rapid analysis 
and dissemination of results. 
Data quality checks are essential when compiling and 
processing environment, health and socioeconomic and 
biomarker data to avoid gaps in the data or interpreting 
errors rather than real signals of public health signiicance.70 
Misclassiication can occur due to inaccuracies in the location 
of cases and populations, potentially diluting true associations 
or introducing spurious temporal or spatial patterns in risk.71 
Studies of small numbers of individuals or those conducted at 
small area level are more prone to errors or local variations in 
the quality of both the health (numerator) and the population 
(denominator) data than studies conducted over larger 
areas. Health risks are often mapped to relatively arbitrary 
administrative areas. Grouping data at different levels of 
spatial resolution (e.g., wards, census tracts, regions) or 
aggregating data to different areal arrangements will lead to 
variation in the results and may affect the interpretation and 
generalisability of the indings.58
Box 5  The Rapid Inquiry Facility – RIF 4.0
The Rapid Inquiry Facility (RIF) provides a powerful tool to 
link and evaluate spatial relationships between different 
data sources, to explore and visualise the data through 
disease mapping and to calculate health risks in relation 
to sources of environmental pollution (26, 81). It can 
dramatically speed up data analysis and public health 
inquiries such as those to investigate potential disease 
clusters. The current version of the RIF (4.0) integrates 
advanced methods in statistics, exposure assessment and 
data visualisation. It is based on open-source software 
integrated with the statistical package R with the ability to 
read in local sources of environment and health data for 
data analysis. 
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Surveillance
Public health surveillance mechanisms are well established 
for infectious disease in England and in most other countries 
worldwide to detect outbreaks and inform prevention 
measures. Similar mechanisms for surveillance of non-
communicable diseases (NCDs) or for health risks from 
environmental factors (environmental public health tracking) 
in England are still in development stage (Box 6), despite 
NCDs being a larger public health issue.72,73 One of the best 
established environmental public health tracking (EPHT) 
systems worldwide is in the USA (Box 8), which provides 
timely, accurate and systematic pollution data to both public 
and public health decision makers. 
NCD surveillance in England needs further investment to 
help develop strategies for prevention and for detection and 
treatment of those already affected. Surveillance of exposure 
to pollutants that contribute to NCDs and reliably detecting 
spatio-temporal signals in NCDs data (e.g., ‘clusters’, peaks or 
unusual trends) rely both on high-quality data74 and on use 
of advanced statistical methods.75 Being able to detect areas 
of potentially high risk of speciic NCDs requires methods 
that display both speciicity (few false positive indings) and 
sensitivity (high ability to detect true positives). Apparent 
local clusters of disease may, after investigation, indicate 
areas with higher-quality data registration or areas where 
there are many duplicate registrations. Results from an 
epidemiological study might only apply to a certain portion 
of the population based on, for example, the size of the 
study area, the nature of the environmental risks, the local 
socio-economic context. Differentiating real signals from 
false positive ones is therefore an important methodological 
challenge. Surveillance of chronic diseases has so far mostly 
focused on speciic conditions (e.g. hepatic angiosarcoma76, 
mesothelioma77, leukaemia,78), rather than on a generic 
approach to detecting excesses or anomalies in the data. 
Emerging methods, such as BaySDetect19, along with 
machine learning and other computing intensive data science 
methods, offer potential to carry out such analyses using 
a systematic approach. Potentially, such methods could be 
applied to the national health datasets on an on-going basis, 
to provide early warning of any untoward trends in the data.
Annual Report of the Chief Medical Oficer 2017, Health Impacts of All Pollution – what do we know? Chapter 8 page 15
Environmental pollution - data, surveillance and health impacts
Box 6  Environmental Public Health Tracking in England
Helen Crabbe, Environmental Epidemiology Group, Centre for Radiation, Chemical and Environmental Hazards 
(CRCE), Public Health England
Public Health England (PHE) has a programme of 
Environmental Public Health Tracking (EPHT) much like the US 
CDC (Box 8). 
Environmental Public Health Tracking (EPHT) has been 
deined by the US Centers for Disease Control and 
Prevention as: “The ongoing collection, integration, analysis, 
and interpretation of data about environmental hazards, 
exposure to environmental hazards and human health effects 
potentially related to exposure to environmental hazards. It 
includes dissemination of information learned from these 
data.”i 
EPHT can provide timely, accurate and systematic 
environmental data to public health decision makers on how 
to reduce the environmental health burden. By effectively 
linking environmental health data and translating it into 
meaningful information, EPHT can help protect the health of 
the public. 
PHE’s EPHT programme aims to explore and develop a 
methodology for addressing environmental hazards that 
delivers integrated, local and national surveillance of those 
hazards, exposure assessment and relating health effects 
of environmental exposures to those hazards. This provides 
evidence of the health burden represented by such hazards 
and exposures, informs responses to new exposures, and 
supports the ongoing development of environmental 
epidemiology, toxicology and exposure science. 
Within this remit, PHE has developed an environmental 
public health surveillance system (EPHSS)ii, which facilitates 
collection and collation of environmental hazard and health 
outcome data. The component parts encapsulate:
  Hazard identiication and mapping; 
  Exposure assessment and quantiication; 
  Development of bio-monitoring; 
  Systematic review of health outcomes and disease 
surveillance; 
  Horizon scanning; 
  Development of environment and health indicators. 
The tracking programme builds on the experience and 
expertise developed through the design and operation of 
related systems currently used by PHE and other government 
agencies. The programme aims to benchmark best practices 
in environmental surveillance. It exploits elements of 
existing national non-infectious environmental and chemical 
incidents surveillance systems in England, Wales and 
Scotland. The developing EPHSS is currently being built to 
capture information on environmental hazards, exposures 
and related health outcomes.
PHE’s Tracking programme started in 2010 with two proof 
of concept projects. 
A ‘Hazard tracking’ project explored exposure to chemicals 
(especially arsenic) through drinking water from Private 
Water Supplies (PWS). 500 PWS were tested for arsenic 
and other chemicals and biomonitoring conirmed exposure 
to arsenic through this route. PHE worked with the British 
Geological Survey and the University of Manchester to 
characterise exposures and develop a geological based 
hazard model to estimate risks to health. An ‘Outcome 
tracking’ project involved characterising the burden of 
disease from Carbon Monoxide (CO) poisoning. The project 
aims to quantify the effects of CO exposure, on accidental 
deaths, hospital visits and admissions, GP consultations and 
effects in the community. PHE has been working with the 
Coroner’s Ofice to better understand causes of accidental 
deaths involving CO. 
More recently PHE’s Tracking programme has worked 
with over 200 stakeholders to develop EPHT in England 
over the last few years and is actively delivering on a few 
topics; e.g. developing a prioritisation tool to support local 
authorities Environmental Public Health interventions, public 
health impacts of luoridation of public water supplies, 
set up and development of an International Network 
on Public Health and Environment Tracking (INPHET)iii, 
developing guidance for investigating non-infectious disease 
clusters or environmental exposures with unknown health 
consequences, and implementing surveillance systems for 
Lead Exposures in Children. 
PHE is currently consulting on its National Environmental 
Public Health Strategy with stakeholders. Its’ vision is to 
provide a service to enhance understanding of the health 
effects of environmental exposures and provide expert 
advice and support to public health practitioners and the 
public in minimising the effects of the environment on 
health. The tracking programme is well placed to provide 
data and evidence and the systems to measure success.
References
i US CDC Environmental Public Health Tracking: http://www.cdc.gov/nceh/tracking/
ii https://www.gov.uk/government/publications/environmental-public-health-surveillance-
system/environmental-public-health-surveillance-system-ephss
iii INPHET: http://www.epiprev.it/INPHET/home
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Box 7  Health and Occupation Research (THOR) surveillance network and environmental 
surveillance 
‘Stressors’ often irst occur in the workplace, where 
the same environmental contaminants are present at 
concentrations or intensities which are orders of magnitude 
higher than in the general environment. As an example, we 
recently observed an increase in incidence of occupational 
dermatitis attributed to isothiazolinones 
(MI/MCI), particularly in healthcare and beauty workers. MI/
MCI were present (as preservatives) in many personal care 
products so environmental exposure was highly likely. The 
observations from THOR data strengthened the evidence for 
the subsequent EU regulation banning the use of MI/MCI in 
leave-on cosmetics from 2016/2017.
THOR could provide the platform for public health 
surveillance, particularly of chemical exposures. Reported 
cases are routinely screened to identify new/emerging 
hazards (e.g. novel causes or workplaces, unusual 
clusters etc).
For example, we recently observed increased reports of 
chemical pneumonitis in marine engineers attributed 
to waterprooing spray (the same substance is used to 
waterproof shoes so environmental exposure is likely). 
Additionally, methodologies developed and improved over 
time within THOR, for example to determine incidence, 
trends in incidence and to evaluate change in incidence 
due to speciic interventions, could be applied to non-
occupational disease reporting to determine population 
estimates due to environmental exposures and to identify 
new chemical hazards.
A main advantage of capturing environmental exposures 
through the THOR network is that a well-established 
structure is already in place, thus ensuring an eficient use 
of an existing UK resource. THOR is composed of several 
different reporting schemes (e.g. for chest physicians, 
dermatologists, occupational physicians, GPs) and across all 
the schemes we currently have approximately 900 reporting 
physicians, with in excess of 111,000 cases reported to 
date. Initial discussions with key THOR reporters have 
indicated an interest and a willingness to consider widening 
their reporting to include non-occupational exposures. 
Central to the longevity and success of THOR (the irst 
scheme commenced data collection in 1989) is the loyalty 
of the participating physicians, facilitated by an excellent 
rapport with the medical community in general and with 
the individual reporters themselves (including extensive 
feedback/beneits, including CPD, for participating). 
Source
Carder M, Hussey L, Money A, Gittins M, McNamee R, 
Stock SJ, Sen D, Agius RM. The Health and Occupation 
Research Network (THOR) – an evolving surveillance system. 
SHAW 2017; 8(3):231-236
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Box 8  Environmental Public Health Tracking in the US
Capt. Fuyuen Yip and Ms. Holly Wilson, Centers for Disease Control and Prevention; Dr. Wendy McKelvey, New 
York City Department of Health and Mental Hygiene
In September 2000, the Pew Environmental Health 
Commission issued a report stating that public health 
agencies in the United States lacked capacity to evaluate 
and conduct key investigations into the status of the health 
of their environment (84) The Commission found that 
information on non-infectious diseases was not routinely 
collected; environmental hazard monitoring and data 
collection were conducted for regulatory purposes, not 
public health; and, very little data existed with respect to 
human exposures to environmental hazards. 
In 2002, in response to the Pew report, Congress 
appropriated funds to the Centers for Disease Control 
and Prevention (CDC), under the leadership of the 
National Environmental Public Health Tracking Program, to 
develop an environmental public health tracking network 
(Tracking Network) that would monitor the burden 
from environmentally related disease and help ill in the 
data gaps.
One of the environmental hazards that the Tracking 
Program focuses on is outdoor air pollution. To better 
understand how air pollution affects health, CDC’s Tracking 
Network displays air pollution data on ozone and particulate 
matter (PM2.5) from the U.S. Environmental Protection 
Agency (EPA) (https://ephtracking.cdc.gov/showAirLanding.
action). EPA’s data come from approximately 4,000 
monitoring stations around the country, mainly in urban 
areas. While these data are considered the “gold standard” 
for determining outdoor air pollution, they are limited in 
geographic and temporal scope. CDC and EPA have worked 
together to develop a statistical model to make modelled 
predictions available for environmental public health 
tracking purposes in areas of the country that do not have 
monitors and to ill in the time gaps when monitors may 
not be recording data. State and local health departments 
funded by the CDC National Tracking Program are working 
to ill data gaps. 
An example of how this approach has been used to prevent 
ill-health due to pollution comes from New York. The New 
York City Department of Health and Mental Hygiene, a 
CDC-funded tracking program partnered with Queens 
College of the City University of New York to conduct the 
New York City Community Air Survey (NYCCAS). The survey 
monitors variation in air pollution levels across the city and 
looks at how local sources of air pollution (e.g., vehicles and 
building boilers) contribute to the variation.79 The NYCCAS 
showed that higher levels of PM2.5 were measured in areas 
with the highest densities of oil-burning boilers. Health 
impact analyses suggested that many hospital visits and 
deaths could be prevented by reducing PM2.5 emissions 
generated by burning heating oil. NYC leaders used the 
indings to support a local law, enacted in 2010, and 
regulations, inalized in 2011, to phase out use of the most 
polluting heating oil in NYC.80. Once the clean heating oil 
polices are fully implemented, it is estimated that lower 
PM2.5 levels will prevent an estimated 300 deaths in NYC 
each year.81
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Conclusions
The burden of NCDs in England is increasing, relecting 
the ageing of the population.82 Epidemiological evidence 
to identify risks to health, including from environmental 
pollutants, is fundamental to help prevent future 
complications and high-costs associated with the occurrence 
and management of these diseases. 
This relies on the availability of high-quality data and on 
close partnerships between government, public health and 
academic institutions, as illustrated by the work conducted 
by SAHSU over the last thirty years. As environmental risks 
to health affect populations worldwide, there is enormous 
potential for UK researchers and public health specialists to 
share their world-leading expertise in this ield. This would 
include building local capacity to support the collection of 
appropriate data to study the impact of environmental factors 
on the health of local populations, particularly in low- and 
middle-income countries.
Box 9  What can be done? 
The surveillance of non-communicable disease and 
environmental public health tracking should be given the 
same legal and ethical protections as control of infectious 
disease, including full access to health and other data for 
this speciic purpose. Further investment is needed to fully 
develop methods and systems.
A population biomarker panel would greatly help 
monitoring of personal exposure to chemicals and other 
pollutants that cannot be monitored by other means – i.e. 
NHANES for the UK – using for example, Health Survey for 
England, UK Biobank and British birth cohorts.
Sustained infrastructure support and funding from 
governmental and research funders such as UK Research 
and Innovation (UKRI) are essential to conduct reliable 
and high-quality studies into the health effects of 
environmental pollution for the beneit of the population 
of England and the world. An eficient way forward would 
be to use ongoing programmes and build on the initiatives 
where government is already providing funding for such 
infrastructure such as the Health Survey for England.
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Summary
  With pollution, there is always a trade-off between the 
beneit to humans of the polluting activity and the risk to 
health. 
  Measurement of health harms from pollution is often 
complicated, because of dificulties of measuring exposure, 
the (often long) timescales involved and the fact that a 
pollutant may have different acute and chronic effects, the 
impossibility of most kinds of experimenting on humans 
and hence the dificulty of assigning cause, human 
variability, many sources of uncertainty and the range of 
scientiic disciplines involved.
  There is an extensive research tradition on the 
communication of risk, going back many decades, mostly 
based in psychology and related ields. Psychological 
theories of behaviour change are important in developing 
effective communication of risk.
  Good communication requires a clear understanding of 
the audience and of what one wishes to communicate. 
Research has established the importance of feeling and 
emotion in risk communication. 
  The use of public engagement in developing 
communication on pollution risks has been patchy, though 
the importance of public engagement in most areas of 
communication in medicine and health is well established. 
However, there are good exemplars in pollution 
communication.
  Trust in the research and its communicators are vital. 
A communicator must provide the evidence in a form 
that allows the audience to assess trustworthiness. Trust 
requires a relationship between the communicating 
parties, which is another important reason for considering 
the role of emotive and experiential aspects. 
Introduction 
Pollution poses a range of health risks. That said, the quality 
of current knowledge about the health risks from different 
pollutants is very variable: the risks are not always well 
measured. There are many reasons for this. The presence 
of pollutants changes over time – new threats are less well 
studied, as do the extent of public concern and the quantity 
of research funding – again causing inconsistent focus on 
pollutants. Further, some health effects are fairly direct and 
relatively easy to measure, while others are more complex, 
relating to long-term patterns of exposure, involving many 
speciic pollutants or having a signiicant time lag from the 
exposure.
The emphasis in this chapter is on measuring health risks to 
humans. There are good reasons to monitor pollutant levels 
and to reduce pollution, which are not primarily driven by 
human health concerns. These measurements however, are 
not the focus of this chapter.
It makes little sense to concentrate narrowly on the 
communication of ‘facts’ about health risks from pollution. 
In communicating to the public, the underlying aim is often 
to change individual behaviour to mitigate risk, or to increase 
awareness and engagement. The long tradition of research 
and understanding of communication about risks indicates 
that the communication must go well beyond simply telling 
the public the size of the risk in a comprehensible form.
Issues of measurement and communication of human health 
effects are to some extent common to different pollutants 
and to some extent not (for examples see Boxes 1, 2 and 3). 
Several of the examples in the chapter relate to air pollution; 
this is not because air pollution is necessarily more important, 
in relation to health, than other pollutants, but only because 
it is better researched than many other types of pollution and 
because it demonstrates the issues well.
Putting together an accepted causal narrative about 
the health effects of a pollutant, and communicating it 
effectively, is a complicated business. Box 4 relates the 
research and communication needs for pollution health risks 
to a different kind of example – health harms from smoking. 
Many health risks from tobacco are now well understood and 
effective actions have been taken to mitigate them – but to 
get to this position took many decades. Regarding pollution, 
health risks are more complicated, less clear and usually 
harder to research than with tobacco. Yet the complication is 
not a reason to avoid action.
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Box 1  The nature of our understanding 
of pollution in the environment: 
radioactive particles
Radioactive particles have been discovered in the 
environment near the decommissioned nuclear facility at 
Dounreay. They are small fragments (sand size) of spent 
fuel that were released more than 20 years ago into the 
sea, which have been distributed by tides and storms, 
resulting in their deposition on beaches.1,2,3 The particles 
could prove a hazard if encountered by a beachgoer, 
so the regulator and site operators have been required 
to instigate routine monitoring. The exposure pathways 
include ingestion, inhalation and skin contact. The 
resulting dose depends on several factors, including the 
radionuclide involved, the activity, whether the particle is 
ingested (then how soluble it is), whether it is inhaled and 
how long an individual stays in contact with it (skin dose). 
The detection of the particles is challenging, but a system 
using detectors attached to a beach buggy has been 
built. Each month, it is driven over the beach and when a 
signal is triggered (which depends on the spatially varying 
background radioactivity), the vehicle stops and the 
particle is retrieved and taken back to the laboratory where 
concentrations of radionuclides of interest are measured. 
To cover the entire beach takes the buggy many days and 
the chance of detecting a particle, if present, depends on 
its activity and depth. This is a dificult sampling problem 
since the pollutant is a very small particle, widely distributed 
and not uniform, whilst its detectability also depends on a 
dynamic population of particles on the beach (and tide).
Communicating that risk
For an individual beachgoer, exposure to the hazard 
depends on when they visit, and their activities. There is 
potentially only a small number of particles on the beach 
at any time, so the probability of encountering one is also 
very small. (In over 10 years of monitoring the number 
of particles retrieved is a few hundred). The Dounreay 
Particles Advisory Group concluded that “only those 
particles [whose] activity is above a certain level pose a 
realistic potential to cause harm to members of the public, 
and […] the probability of the most frequent beach-users 
[…] coming into contact with a relevant particle is one 
in 80 million.” Depending on the individual dose, health 
effects could include skin ulceration.4 In this case, the 
contaminant is not widely distributed in the environment 
and relatively few particles have been found, with a widely 
varying distribution of activity. There have been several 
interventions (including removal of seabed particles), but 
still particles are being found on public beaches and the 
risk of harm remains.5
E. Marian Scott, Professor of Environmental Statistics, 
University of Glasgow
Box 2  The nature of our understanding of 
pollution in the environment: soil 
contamination
There are many studies that have shown that exposure 
to high concentrations of certain metals in soil can 
have potentially harmful effects such as cancer or 
developmental effects in young children.6,7,8,9 There 
is a location-dependent natural metal concentration 
background, but as a result of anthropogenic activities, 
heterogeneous elevated concentrations occur.
The measurement of such metals requires soil samples 
to be collected (spot samples) over a region of interest. 
The soil sample (which may be a few tens of grams) is 
subjected to a variety of physical and chemical processes 
in the laboratory before a concentration is reported. How 
sure are we of this value and how it should be interpreted? 
The measured value will have been subject to quality 
control within the laboratory, but will be uncertain to 
within typically a small value (the measurement error). 
In addition, as a spot sample, there will also be the 
uncertainty about the representativeness of the sample for 
the region.
How might the metal present in the soil have a health 
effect? First we need an exposure pathway – in the case 
of soil, this might be inhalation – small particles could 
become lodged in a lung, or by ingestion (eating directly 
or through the food chain – such as in plant’s leaves 
or tubers). Thus an individual’s exposure to the metal 
depends on their habits.10
The biological effect on the individual of the metal then 
depends on the concentration (dose) to which that 
individual is exposed and in a population, individuals will 
experience different doses and will manifest different 
degrees of health effect. There may be more than one 
metal of concern, therefore a combined exposure and 
health effect. Some of the evidence may be based on 
observational epidemiological studies from occupational 
exposure, with others in wider populations.11
Communicating that risk
It may be that advice is offered suggesting that the 
vegetables are safe to consume since their concentrations 
are below a certain concentration; it may be that certain 
critical groups such as pregnant women or young 
children12, 13 are advised not to consume more than a 
certain quantity of the contaminated vegetables.
E. Marian Scott, Professor of Environmental Statistics, 
University of Glasgow
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Box 3  The nature of our understanding 
of pollution in the environment: 
Trihalomethanes (THMs) in drinking 
water
Drinking water needs to be of high quality. We are all 
aware of serious health issues in countries where drinking 
water is not as well regulated and managed as in the 
UK.14 Drinking water lows in a chain from the reservoir 
or other source to treatment works to holding and then 
eventually is pumped to our homes. Our drinking supplies 
are tested for bacteria, lead, iron (which may come from 
cast iron distribution pipes) and other metals, nitrite, 
pesticides (both potentially from agricultural practices 
in the catchment providing the water source), pH, 
trihalomethanes (THMs) and other parameters.15 Water 
at the treatment works is disinfected using chlorine to 
deal with microbial contaminants and THMs are formed 
as a result of the reaction of the chlorine with (naturally 
occurring) organic material.
At elevated levels, THMs have been associated with 
health effects such as cancer and adverse reproductive 
outcomes.16,17 Some studies showing these effects have 
been carried out in animals, while others have used 
observational epidemiology. There are concerns about 
long-term exposure to THMs18, however, the widely held 
view is that the “health risks from THMs are much less 
than the risks from consuming microbiologically unsafe 
water”.19 A clear line has been taken on trading off 
competing health risks. The EU and other bodies have 
deined maximum allowable concentrations in drinking 
water (100 µg (microgrammes) per litre) to help protect 
the population (and indeed especially vulnerable sub-
populations). In deining such levels, the lifetime of the 
individual (assumed 70 years) and typical drinking volumes 
must be considered.
Regular testing is undertaken by the water companies and 
the drinking water regulator. There have been considerable 
improvements in the numbers of failures of the standard 
for THMs (100µg/l) becoming rare (average of just four 
failures a year since 2010) and in 2014, there were no 
failures of the THM standard in England.20 
Communicating that risk
In this example, the hazard being presented by the THMs 
is being balanced against the risk of drinking contaminated 
water. The evidence for health effects of long term 
exposure (in some cases based on animal studies) was 
considered not consistent21, and in some cases, results 
between different studies are inconsistent. 
E. Marian Scott, Professor of Environmental Statistics, 
University of Glasgow
Box 4  Putting together evidence on health 
effects
In investigating possible health gains from an intervention 
at an individual level, the gold standard study is the 
randomised clinical trial. Yet randomised trials are more 
dificult with interventions at a population level and 
carrying out a randomised trial to investigate potential 
adverse health effects is usually ruled out on ethical 
grounds. So how do we establish and measure the harmful 
effects of exposure to a substance such as a pollutant?
It might help to consider a different kind of health risk. 
Nowadays everyone knows that smoking cigarettes vastly 
increases the risk of several diseases. But how do we know 
that? The underlying research did not come from a single 
study, or even a single type of research, but unavoidably 
involved epidemiological research in human populations 
(such as Doll and Hill’s study of British doctors22,23), 
studies which found that exposing experimental animals 
to substances in tobacco smoke led to the development 
of cancers and several other study types. Animal studies 
established the carcinogenic potential of cigarette smoke, 
but could not – on their own – show this in human 
populations. The epidemiological studies showed a (strong) 
correlation between smoking and lung cancer in humans, 
but on their own could not establish that the effect was 
causal. The risk is stochastic – that is, not everyone who 
is exposed will suffer harmful health effects, so that 
an element of chance is operating. To establish a clear 
causal narrative linking smoking to lung cancer and other 
diseases required evidence from all these sources to be put 
together, a process that took many years. And after the 
links were clearly established, there were further issues of 
communicating them to the public and making appropriate 
policy interventions – an ongoing process that has taken 
half a century so far.
Establishing and measuring health risks from pollution has 
to involve a similar process of putting together different 
kinds of evidence from different types of study. Answers 
cannot come from one or two critical experiments. 
With environmental pollutants, exposures are typically 
much harder to measure than with (active) smoking 
and the magnitudes of the health risks at an individual 
level are usually considerably smaller. Yet, because very 
large numbers of people may be exposed, the overall 
public health impact may be very large. Thus it is crucial 
to combine results from different research traditions 
to measure health risks from pollution. Compared 
to investigating the health risks from a pollutant, 
understanding the risks of cigarette smoking was in most 
respects an easy target. It still took a great deal of time 
and effort to provide the necessary evidence and make 
effective policy interventions. Dificulties in measuring, 
communicating and acting on the health risks of pollution 
must not be an excuse for inaction.
Kevin McConway. Emeritus Professor of Applied Statistics, 
Open University
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The contexts
It is important to take account of the contexts within which 
health risks from pollution are discussed and considered. 
Knowledge of these contexts, particularly about the way 
the risks are construed by the general public, is far from 
complete.
Pollutants generally arise because of human activities that 
are desired. People value the products of industrial processes 
that pollute and may not be happy when measures to reduce 
pollution increase the cost of those products, or reduce 
their availability. People, on the whole, like driving their cars 
and many feel that they have rights to do so; these feelings 
conlict with measures to improve air quality by restricting car 
use. More broadly, we wish (indeed, need) to travel, for many 
reasons, and the gains from the travel need to be traded 
off against the various kinds of pollution that arise from 
transport activities. Using precautionary principles may be 
useful in a few contexts, such as where an intervention has 
low costs, in all senses. Yet all mechanised transport cannot 
be ceased on a precautionary principle. This emphasises that 
trade-offs are inevitable.
Trade-offs arise in most economic contexts, but changing 
where the balance lies in a trade-off between a desired 
activity and its polluting consequences can be particularly 
dificult. This is because many important pollutants cannot be 
seen, tasted or felt. Their health impacts may be subtle and 
may take a long time to become apparent after exposure. 
Thus the way that the trade-off works is obscure. Moreover, 
public attitudes to these matters have not been extensively 
researched, though they are likely to be variable between 
individuals and between those who aim to inluence opinion. 
There may well be a range of public opinions, which may 
include, at one extreme, the view that pollution is an 
unavoidable by-product of economic prosperity, and, at the 
other, an exaggerated precautionary principle that everything 
that pollutes and is potentially harmful in any way must cease. 
Both of these extremes have certainly appeared in political 
and academic discourse about pollution. 24,25,26 Arguably 
they are to a considerable extent straw men, but they need 
to be challenged where they arise. We have to work hard if 
we wish to arrive at an evidence-based narrative that will be 
consistent and credible across all the relevant audiences.
All of this implies that evidence for changing behaviours 
needs to be solid (implying good measurement) and 
persuasive (implying good communication).
Measurement
The difficulties with pollution
Arguably, measurement of health risks to the public from 
pollution has not advanced as far as the measurement of 
many other kinds of health risks. This has to do with the 
nature of the work required, with several sources of dificulty:
  Many pollutants are present in the environment, they 
occur together, therefore it is dificult to disentangle 
which pollutant is linked to which health effect. A related 
issue is that some health effects are caused by mixtures 
of substances rather than by single compounds; this 
adds complexity. In the environment, the composition of 
mixtures can vary substantially, making exposure levels 
dificult to measure and to correlate with health.
  The health effects of a pollutant may vary with the 
timescale of exposure. The health effects from a short-
term acute exposure can be very different from those of a 
long-term exposure. Peak exposure may be the key factor 
for some effects on health, while the ambient level may be 
more important for others. (More below.)
  Many health effects of pollution only become apparent 
after a long time. This may be because the condition takes 
a long time to develop, or because it is caused by exposure 
over a long period of time. Long-term effects can be 
measured, but, the longer the term, the harder accurate 
measurement is and the greater the cost of measurement.
  Exposure of individual people to pollutants, in the real 
world, is often very dificult to measure accurately. This 
can even be the case when the levels of pollutants in 
the environment are accurately known. As an example, 
individual exposure to lead depends on childhood 
experience, occupational exposure, whether the individual 
lives or lived in a house that still has lead pipes or lead 
paint, on diet, and on the geographical location where 
one lives. Mathematical modelling may help, though 
it is dificult without detailed lifestyle information. 
Modelling adds to complexity but does not remove all 
the uncertainty.
  Much research in the real world uses observational 
epidemiology. It is dificult, often impossible, to be 
clear about causality in observational studies (Table 9.1) 
because of the effects of confounding. An apparent health 
effect of a water pollutant might be caused by exposure 
through a different diet. Confounders can be allowed for 
statistically, but the possibility of residual confounding 
always remains.
  People vary. In particular they vary, often considerably, 
in the extent to which a particular pollutant may affect 
their health. For instance, the effects of poor air quality 
are different between people with asthma and others, 
between different people with asthma and in the same 
person on different occasions. In some situations, it may 
be possible to model and describe how the health effects 
vary in terms of personal characteristics, but often there 
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is insuficient data or understanding of the mechanisms 
to do this effectively. This variability is different from the 
uncertainty about the size of health effects, although this 
variability can in turn lead to further uncertainty about the 
nature and size of the health effects.
As exempliied in Boxes 1 and 2, developing an 
understanding of health risks from pollution involves multiple 
stages, each with uncertainty and complicated by variability. 
It may be necessary to use mathematical and statistical 
modelling, based on data from several sources, to estimate 
the health effects of a pollutant at local levels. Policy makers 
and others therefore need to be primed to expect different 
(and generally more complicated) forms of evidence and 
measurements of risk than might be used with other threats 
to health. For researchers and advocates in this ield, this 
also draws attention to a need to communicate about the 
nature of the evidence as well as simply communicating the 
evidence.
For policy choices in particular, ideally one needs reasonably 
precise measurement of the effects of pollutants in a real-
world context. It is too much, however, to expect that 
all health effects of pollution can be measured precisely. 
Policy makers need to understand that one can act with 
conidence that the action is appropriate, that is, if one can 
be suficiently conident that the action is beneicial (taking 
costs appropriately into account), even if there remains 
considerable uncertainty about the actual size of an effect.
Measurement methods
It is possible and important to learn about physiological 
effects of pollutants from laboratory experiments on animals 
or tissue samples. This is generally the approach of toxicology 
to investigating health effects of pollution. However, most 
experimental work with humans on health of pollution 
effects is not possible: one cannot choose susceptible people 
at random to be exposed to highly polluted air or water. 
Therefore, studies in humans mostly have to be observational, 
using the methods of epidemiology. Put simply, one 
compares health outcomes in individuals exposed to differing 
levels of pollutants. These two approaches have been 
dominant in measuring health effects of pollution (Table 9.1).
Toxicology and observational epidemiology, although the 
most common, are not the only methods. In some cases, 
health effects in humans can be studied using experiments 
using human volunteers. These have most of the strengths of 
toxicological experiments (Table 9.1) – controlled conditions, 
accurately quantiied exposure, (generally) accurately 
quantiied response and speciicity. However, it is not possible 
to use large numbers of subjects and the need to avoid 
deliberate serious harm to subjects means that only minor 
and temporary effects can be studied and only in those who 
are healthy or mildly ill.
Speciic areas of concern, where there is need for further 
research, include:
  The extent to which health harms from pollutants are 
related to ambient (average) exposures or to peak (acute) 
exposures.30,31,32 
 This is an important knowledge gap, partly because 
appropriate policy responses can depend on the 
balance between these. For example, interventions have 
dramatically reduced the size and number of peaks in 
ground-level ozone, but background levels have risen.33 
Longer-term studies and longer-term, more accurate, 
exposure assessment would help to disentangle the 
two effects. Locations with high peaks tend to have 
high ambient exposures, however, adding dificulty. 
Furthermore, this would require speciic long-term 
(expensive) epidemiological cohort studies. Most previous 
long-term studies in this area have been within cohorts 
designed for other purposes, with exposure measured 
retrospectively. Multi-disciplinary work, including 
research on biological mechanisms, would enhance the 
epidemiology results.
  It is possible to set up mathematical and statistical models 
to investigate the effects of potential policy interventions, 
but this can be hard. One recent example is the modelling 
of potential impacts in the UK Government’s July 2017 Air 
Quality Plan.34 Often, though, this modelling will involve 
extrapolation beyond situations that have been observed 
and there may be limits to the extent to which that 
extrapolation can be based on irm science.
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Table 9.1 Comparison of toxicology and observational epidemiology in investigating health effects of pollution
Toxicology and pollution Epidemiology and pollution
Overview Focus on pollutants (chemicals), examining 
their actual or potential hazard on – in this 
case – humans: laboratory studies
Studies (and seeks to control) the impact 
that pollutants have on human health across 
populations: ‘real-world’ studies
Methods Studies the effects that pollutants have 
on tissue or animal models, in controlled 
conditions, with control groups. It investigates 
the dose-response, mode of action and species 
speciicity – amongst other facets – of an 
agent.
Examines the distribution of health states in 
or across populations, and their association 
with the distribution of exposure to pollutants. 
Pollution epidemiology largely observes existing 
exposures.
Strengths   focus on single agent in a controlled setting, 
therefore no confounding
  exposure to the agent of interest is 
quantiied directly
  examines the mode of action
  unit of study is the unit of interest – the 
human
  ‘real world’ studies, therefore directly relect 
the exposure faced by people
Weaknesses   Extrapolation required from the animal/ 
tissue model to humans
  Effect does not account for impact of other 
‘real world’ stressors which can modify the 
impact of pollutant
  High doses of a substance used in a 
toxicological study might never be seen in 
human populations
  Real world exposure route might differ (e.g. 
through lungs), and impact on biological 
effect
  Confounding and co-occurrence of pollutants 
can be hard to control
  Ubiquity of pollutants can mean little 
variation in exposure across populations
  Even if a pollutant is measured in the 
environment, the dose received by people 
can be hard to measure
  Study samples often not the whole 
population therefore some extrapolation 
needed
Challenges and next 
steps
Fully assess the toxicity and harm from complex 
mixtures and their interactions
Methods and data to assess low level, chronic 
exposure – overcoming co-occurrence of 
pollutants and homogeneity of exposure
Concerns remain that the two disciplines work in parallel, not truly and fully together. They have 
different paradigms, which might be incompatible – but an integrated and systematic use of 
information and evidence would allow stronger inference about causality. Formal frameworks 
have been proposed to do this risk assessment.27
Example A 2000 study exposed 12 dogs to concentrated 
particulate matter (PM) (30 times higher than 
in Boston at the time), 6 of which had induced 
coronary occlusions to mimic existing coronary 
artery disease. Dogs’ response to the PM was 
assessed by ECG.
Dogs with induced coronary artery disease 
and exposed to the PM had a shorter time 
to ST segment elevation and an increase in 
magnitude of it: a sign of myocardial ischaemia 
(restricted oxygen to heart muscle) when in 
humans.28
A 1999 study compared daily counts of 
cardiovascular disease (CVD) hospital admissions 
(in over 65s) with the mean PM
10
 reading from 
the monitoring stations in 8 US counties. 
Allowing for confounding variables, such as 
the daily temperature, the study found that 
the changes in PM
10
 were associated with 
CVD admissions (a central estimate of a 2.8% 
increase across the interquartile range of PM
10
 
exposure).29
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Recent advances and next 
steps
Despite dificulties, progress is being made. For example, in 
measuring individual exposure, there is now instrumentation 
to collect data at a more personal level and mathematical and 
statistical modelling based on individuals’ movements – but 
this requires considerably more development. Rapid advances 
in informatics and in particular in availability of and use of 
big data, are providing new opportunities to learn about (and 
indeed communicate) the health effects of pollution.
Understanding and measuring the health effects of a 
pollution source will involve collaboration between different 
research traditions and professions (toxicology, epidemiology, 
atmospheric chemistry, environmental health, informatics 
and mathematical and statistical modelling etc.). Such 
collaboration does occur already. Some toxicological studies 
investigate whether an effect from an epidemiological study 
is causal. Epidemiology can look at whether effects suggested 
by toxicology operate in human populations. However, 
generally, funding for research into health risks from pollution 
in the UK has been split between different Government 
departments and research councils – leaving gaps unilled. 
The Nurse review35 highlighted a need for better support 
of multi-disciplinary and interdisciplinary research, and UK 
Research and Innovation (UKRI) is currently being set up in 
response. Focused multi-disciplinary and interdisciplinary 
research into health risks from pollution, including research 
into effective methods for synthesising different types of 
information and evidence from different research traditions 
to produce an overall meaningful narrative, and (importantly) 
extending into appropriate ways of communicating the risks, 
is an area where UKRI could make an important difference.
Measurement for a reason 
Measurement in this area, as in others, should always be 
done for a reason. Of course, the overarching reason for 
any measurement in public health is to improve the health 
of the public, but that can operate at many levels. Much 
research on health effects of pollution is aimed primarily at 
understanding those effects scientiically and the associated 
communication would largely be aimed at other researchers 
rather than directly at policy-makers or the public. Yet wider 
consideration of communication needs must sometimes 
inform the planning and execution of research.
One vital and occasionally neglected aspect of the 
measurement of health risks from pollutants, is that 
the outcomes must be expressed in terms that can be 
communicated appropriately, to policy makers and to 
the wider public. There needs to be a comprehensible 
currency for measuring the harms to health. In relation to 
air pollution, COMEAP36 proposed two different measures, 
for different types of communication Boxes 5 and 6. These, 
however, relate only to effects on mortality. There has 
been considerable research measuring morbidity, as well 
as death, for many pollutants but less has been done to 
investigate how to communicate this. Policy makers may 
also require comparative information on different health 
risks. Considerable effort in mathematical modelling may be 
required to produce these comparisons.37 This leads into the 
subject of the next section, but there is a feedback loop. If 
the communication, for example, is to be about deaths or 
years of life lost – in order to compare (with obesity, mental 
illness, etc.) – measurement must provide those quantities. 
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Box 5  Communicating about mortality 
effects: COMEAP’s consideration of 
mortality associated with long-term 
exposure to air pollution
For policy analysis, the beneits of reductions in levels 
of particulate pollution are best assessed using actuarial 
life-table methods to estimate years of life gained because 
of the reduced exposure of the population.13 However, 
mortality beneits of small reductions in pollution, 
expressed as years of life lost, might not be well suited 
to communicating the size of the effect of air pollution 
on public health. Estimates of the mortality burden 
associated with current levels of pollution are more useful 
in highlighting the public health importance of good air 
quality and in encouraging action to reduce pollution.38
The mortality burden can be expressed in a number of 
different ways: attributable fraction; attributable deaths; 
years of life lost; or loss of life-expectancy from birth. All 
of these describe the overall effect across the population, 
rather than representing effects on individuals: long-
term exposure to air pollution is a contributory factor 
to deaths from respiratory and cardiovascular disease 
and is unlikely to be the sole cause of individual deaths. 
Therefore, although ‘percentage of mortality’ or ‘number 
of deaths’ are widely used in communicating public health 
risks, ‘attributable deaths’ is not the number of individuals 
whose length of life has been shortened by air pollution. 
Air pollution contributes a small amount to the deaths of 
a large number of exposed individuals rather than being 
solely responsible for a certain proportion, or number, of 
deaths. Attributable deaths can therefore more accurately 
be described as ‘an effect on mortality equivalent to ‘X’ 
deaths at typical ages’ and this is the terminology that 
the Committee on the Medical Effects of Air Pollutants 
(COMEAP) has recommended.36,38
Although there are some differences in the methods used 
to calculate mortality burdens attributed to different public 
health risk factors (e.g. air pollution, smoking, alcohol), the 
approaches adopted are similar. Nonetheless, the estimates 
are not directly comparable.39 Long-term exposure to 
particulate air pollution affects deaths from the same sorts 
of diseases (respiratory and cardiovascular) as smoking. 
However, air pollution is a contributory factor to mortality 
rather than the sole or primary cause of death. This is 
different from smoking and alcohol, which can be the 
primary underlying cause of some deaths. 
Acknowledgement: 
This information draws on the thinking of the Committee 
on the Medical Effects of Air Pollutants (COMEAP): www.
comeap.org.uk 
Alison Gowers, Air Quality and Public Health Group, Public 
Health England
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Box 6  Putting numbers on the impact of pollution
We’ve seen in Box 5 that communicating the possible harms 
of air pollution is complex. As a speciic example, consider 
the much-quoted claims that 29,000 deaths each year are 
due to ine particulate air pollution.36 This is obtained by a 
complicated statistical model, but in fact it’s easy to get to a 
rough igure.
COMEAP assume a relative risk of 1.06 per 10 µg/m3 
increase in PM
2.5
, meaning that the average risk of dying 
each year is increased by 6% for every extra 10 µg of PM
2.5
 
per cubic meter of air (more formally, this is known as a 
‘hazard ratio’). The average exposure to human-made PM
2.5
 
is around 9 µg/m3 in the UK, so on average mortality risk is 
increased by around 5%, or equivalently around 5% of all 
deaths are associated with PM
2.5
. There are 600,000 deaths 
a year in the UK, and 5% of 600,000 is 30,000 deaths, 
which is remarkably close to COMEAP’s actual estimate of 
28,861 attributable deaths.
But the crucial issue, repeatedly emphasised by COMEAP, is 
that we cannot identify these 29,000 as individuals– nobody 
has ‘pollution’ on their death certiicate as a cause of death. 
As pointed out in Box 5, it might be better to describe this 
as an effect on mortality equivalent to ‘29,000 deaths’ – 
Table 9.2 shows a variety of other ways of expressing the 
same impact.
All these results are driven by this estimated relative risk of 
1.06, a igure that was originally derived from studies of 
US cities41 and has been reinforced by pooled analysis of 
other studies42, but with tighter conidence intervals.
It is important to note the uncertainty associated with these 
estimates. The 6% increase (relative risk 1.06) comes with 
a standard statistical conidence interval, but COMEAP 
carried out an interesting elicitation of expert judgement 
to widen this interval to create a ‘plausibility distribution’, 
which resulted in an assessment that the range of 1% to 
12% represented a 75% plausibility interval and should 
be used for sensitivity analysis: a 95% interval based on 
expert subjective assessment ran from 0% (i.e. no effect 
of particulates) to 15%. This judgement of uncertainty is 
relected in Table 9.2. This plausibility range is remarkably 
wide (although might be somewhat narrower now in 
the light of more recent studies), but there is suficient 
evidence of a substantial impact to justify mitigating actions. 
Additional uncertainty arises from many sources, including 
the structure of the statistical model and the degree of 
overlap of between the effects of different pollutants. 
David Spiegelhalter, Winton Professor of the Public 
Understanding of Risk, University of Cambridge
Table 9.2 Estimated annual impact in UK of human-made PM
2.5
 pollution (2008 level) 
Measure of effect Estimate Plausible interval
‘Attributable deaths’ 28,811 5,000 to 60,000
Burden on total survival (life-years lost) 340,000 55,000 to 680,000
Average loss in life expectancy: 
For whole population aged 30+: (38,000,000)
For all deaths (600,000)
For deaths from cardiovascular causes (191,000)
For ‘attributable deaths’ (29,000)
3 days
7 months
2 years
11.5 years
½ to 6 days
1 to 14 months
4 months to 4 years
2 to 23 years
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Communication
The communication landscape
We are not starting from scratch in communicating health 
risks from pollution to the public and to other audiences. 
The way publics apprehend risks has been an active area of 
research for more than half a century. Perception, as well 
as how targets think about the subject area before the risk 
communications, must be taken into account (and targeted) 
by those needing to communicate risks. Beyond academic 
work, areas of government have worked on managing and 
communicating risk41 and on speciic aspects (Box 7). The 
Academy of Medical Science has produced a major report on 
how best to use scientiic evidence in relation to the beneits 
and harms of medicines, including how to communicate 
them42: much of what it says applies equally to the harms 
and beneits of interventions on pollution. In addition, 
international agencies have developed different ways of 
classifying and communicating risks (Box 87, 43). Speciically 
regarding pollution, COMEAP discusses how to communicate 
the impacts of air quality (Box 9).
One thing that this work into risk communication has 
established clearly is that it is time-consuming and often 
dificult to make changes by way of communication. One 
cannot expect to change either policies or the behaviour of 
individual members of the public solely by communicating 
what has been measured regarding the health effects of 
pollution, however well-understood that communication may 
be. There are no magic communication bullets to bring about 
change.
Box 7  Communicating the risk of severe 
looding
One in six properties in the UK are at risk of looding but 
many residents are unaware whether their home is at risk 
or, if it is, what they can do in the event of a lood. 
Recent research has shown that not only does looding 
present a risk to life and cause damage to property but 
it can also have long-term health and social effects. Such 
effects include anxiety, depression and post-traumatic 
stress. Also, disruption to schooling and friendship groups 
due to living in temporary accommodation (often for a year 
or more) can affect the development of children. Reducing 
or preventing looding can avoid or limit the worst of these 
effects by enabling a return to normal life quickly.
Working with Sciencewise, the Environment Agency, 
undertook a public dialogue to ind out what people 
knew about their own lood risk and how to improve 
communication. The indings showed that people want 
clear and simple information about whether their home 
is at risk of looding and what they can do to prepare for 
a lood. They did not ind information on the probability 
of looding helpful as it was dificult to know what to do 
and how to interpret this. Also, broad scale maps showing 
lood risk across the country were seen as too high-level 
and not giving information relevant to individuals.
The way people, especially Millennials, want to receive 
information is changing. An estimated 99% of this age 
group use social media with over 40% checking it over 
10 times a day. This group of people also tend to live in 
areas of higher lood risk but at the same time have lower 
awareness. 
These insights into the perspectives of those at risk of 
looding have proved very valuable and really challenged 
thinking that more detailed information was better. The 
indings of the public dialogue have inluenced work by 
the Environment Agency to redesign its lood warning 
services with easier ways to ind out about lood risk, 
especially via social media. There are also improved links to 
resources for how to increase lood resilience and actions 
to take if a lood is imminent. 
Doug Wilson, Director of Evidence at the Environment 
Agency 
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Box 8 Examples of approaches to expressing conidence and uncertainty about risks
The UN’s Intergovernmental Panel on Climate Change 
(IPCC) has reined its approach to presenting information 
on uncertainty through its Assessment Reports. The most 
recent, the 5th Assessment Report44 (AR5), distinguishes 
between the conidence of a inding and quantiied 
measures of uncertainty in it.45 Generally, authors were 
discouraged from providing quantiied probability measures, 
except in cases where the conidence in the validity of 
a inding was high – with agreement between experts 
and the robustness of evidence. Levels of conidence are 
expressed in qualitative terms only, using the scale “very 
low,” “low,” “medium,” “high,” and “very high.” (This was 
in contrast to the 4th Assessment Report where the same 
words were explicitly linked to a quantitative scale46).
Where the probability of an outcome had been quantiied, 
at least approximately, authors used an agreed way of 
translating ranges of probabilities into words:
Term Probability
Virtually certain 99-100%
Very likely 90-100%
Likely 66-100%
About as likely as not 33-66%
Unlikely 0-33%
Very unlikely 0-10%
Exceptionally unlikely 0-1%
The IPCC approach has been widely praised; one potential 
issue is that, however consistent authors may be, readers 
may be inconsistent in their understanding of verbal 
descriptions of probability.47
The World Health Organization’s International Agency for 
Research on Cancer (IARC) categorises possibly carcinogenic 
agents, most of which are pollutants, into ive groups in 
terms of hazard, that is, the strength of evidence that they 
have a cancer-causing effect in humans.48 They explicitly 
do not specify the level of risk, partly because, in many 
cases, the main evidence of carcinogenicity comes from 
toxicological and similar studies, which do not generally 
provide measures of individual or population risk in 
humans. Therefore two different agents, both classiied by 
IARC as possibly carcinogenic to humans, such as non-
ionizing electromagnetic radiation from mobile telephones 
and petrol exhaust fumes, may present very different cancer 
risks and levels of public health concern. 
This has caused considerable confusion in media reporting 
of IARC classiications when IARC review an everyday 
exposure49,50, (e.g. mobile phones, eating processed meat), 
despite increasing efforts from IARC to make their system 
clear. This can be seen as a failure of communication in 
which, if the information that people want is not provided, 
they may make false assumptions about the information 
that actually is provided.
Kevin McConway. Emeritus Professor of Applied Statistics, 
Open University
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Box 9  Taking the audience’s views into account when communicating about pollution – 
using COMEAP’s development of the Daily Air Quality Index as an example
The Committee on the Medical Effects of Air Pollutants 
(COMEAP) published updated recommendations for the UK 
Daily Air Quality Index (DAQI) in 2011 at Defra’s request.51 
The DAQI is used to provide information to the public 
about real-time and forecast levels of outdoor air pollution. 
It is accompanied by health advice intended to allow 
individuals who are sensitive to the effects of air pollution to 
modify their behaviour to reduce the likelihood or severity 
of symptoms. 
As well as considering relevant scientiic and technical 
issues, COMEAP was keen to ensure that its 
recommendations would meet the requirements of users of 
the index. In order to inform COMEAP’s review, dedicated 
public insight research was undertaken.52,53 This included:
  small-group workshops of older people with respiratory/
cardiovascular illnesses or children aged 9–11 years old 
(both with and without respiratory illnesses) 
  focus groups with a geographical spread and timed to 
ensure that a cross-section of society (gender, age and 
socioeconomic status) could attend 
  an online questionnaire to gather a broad spectrum of 
views
Public preferences for the DAQI and accompanying health 
advice were for:
  information which is clear, concise and easy to 
understand
  focused, jargon-free, activity (health) advice
  separate health advice for susceptible and non-
susceptible groups
  clear identiication of groups at greater risk than the 
general population
  avoidance of information that might be alarming or fear-
inducing
  use of visual cues and colours
In addition, most participants wanted to know the level 
of air pollution in general, but not information about the 
levels of individual pollutants.
Although there was not a clear preference for the number 
of ‘bands’ or ‘points on a scale’ within the DAQI, a need 
for a scale that allowed greater gradation than provided 
by four pollution bands alone was identiied. Participants 
disliked possible descriptors for pollution bands based on 
health risk (e.g. Low Health Risk to Very High Health Risk) 
but found descriptors based on either air pollution or air 
quality to be acceptable. 
COMEAP found the public insight research at the outset 
of the review very helpful in steering its discussions on 
some aspects of the DAQI. Its initial proposals, which took 
account of the views expressed, were then tested within 
additional focus groups. Feedback from these was used 
to further reine COMEAP’s inal recommendations for a 
revised DAQI and accompanying health advice.
Acknowledgement: 
This information draws on the work and thinking of 
the Committee on the Medical Effects of Air Pollutants 
(COMEAP): www.comeap.org.uk 
Alison Gowers, Air Quality and Public Health Group, Public 
Health England
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Communication for a purpose
We cannot communicate effectively without a reasonably 
clear understanding of which audience we are 
communicating to and what the aims are. This determines 
the choice of what is communicated, and how it is 
communicated. For instance, communicating to policy makers 
is, in several respects, different from communicating to the 
public (Box 10).
In communicating lood risk to the public (Box 9.6), for 
example, one may need to get people to take action to 
mitigate the effects of an imminent lood, or one may need 
to communicate levels of risk to people deciding where to 
live, or where to build houses. These different purposes 
require rather different approaches. Some pollution issues, 
such as communicating about peaks of air pollution to 
particularly susceptible individuals who ought to take action 
quickly, are similar to the situation of an imminent lood, 
but most pollution issues are less immediate and (in public 
communication) the need is to extend awareness or promote 
behaviour change.
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Box 10  Communicating across disciplines including policy makers
Communication needs to be focused on the intended 
audience, so communication with experts in other 
disciplines and with those developing policy will necessarily 
be different from that designed for the public. The metrics 
in which results are expressed may also differ from those 
easily understood by the public. Life-years* (or quality-
adjusted life years) are more appropriate for analysing 
policies than numbers of deaths, as it is when people die 
rather than whether they die that matters. They can be 
used to communicate relative importance of different policy 
areas, such as the fact that removing widespread exposure 
to air pollution would lead to more life-years gained than 
preventing road accidents (although the causal basis of the 
latter is clearer). 
Working across disciplines can lead to a powerful 
improvement in the ongoing development of the quality of 
the evidence supporting measures to improve health. For 
example, understanding the correlation between pollutants 
is key to interpreting epidemiology studies. With older 
techniques, air pollution effects stopped being detected54 
until statisticians applied time-series analysis.55
It is important for communication to be interactive. Other 
disciplines may identify new questions that need to be 
asked. Government committees provide one forum for 
multi-disciplinary discussions.56,57 Disciplines have different 
strengths – epidemiology studies relect reality more closely, 
in all its complexity, whereas toxicology studies are more 
speciic but less representative. Relecting these perspectives 
and systematically reviewing the expanding literature, needs 
to be maintained and resourced. Focusing on one area 
or only updating previous documents58 is understandable 
for short-term prioritisation but would lead to loss of 
knowledge long-term.
In the policy context, joint working across Departments 
allows discussion of the health risks and the implications 
as a policy develops. This has been the practice in outdoor 
air quality policy59 as acknowledged by the National Audit 
Ofice60, but may be less developed in other areas e.g. 
indoor air quality policy. 
Investigating questions that are crucial for policy can be 
scientiically demanding. Economists designing questions for 
willingness to pay studies61 wish to transmit information that 
may not be easily derived from population-wide studies. 
Regulation by speciic pollutant requires disentangling of 
effects in a way that may be dificult in epidemiological 
studies.62 Those developing environment and health policies 
need to communicate policy challenges to specialists who 
need access to research funds that can be targeted at these 
questions.63,64
Heather Walton, Senior Lecturer in Environmental Health, 
King’s College London
*
* One year lived by one person, adding up across the population and over time.
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Risk perception theory
Several areas of psychological research are relevant to the 
communication of pollution’s health risks. Firstly the area 
of risk perception has provided insight into the three key 
factors that lead people to be concerned about risks65 their 
demographics (groups with less political or socio-economic 
power feel more concerned), the characteristics of the 
risks themselves (e.g. how controllable and dreaded they 
are perceived to be) and a range of cognitive mechanisms 
(e.g. optimistic bias, overconidence and the availability 
heuristic), which are lenses with which people absorb the 
risks communicated to them. More recently there has been 
a shift from focus on these more cognitive aspects of risk 
apprehension to the more affective, emotive aspects (Box 11). 
This may weaken direct links between measurement and 
communication. If the aim is to engage the audience and 
(potentially) change what they do, it is not enough simply to 
get across the size of the risk. Box 12 explains the relevance 
of disgust to air pollution and health-related behaviours and 
Box 13 highlights a campaign from a different public health 
area that was particularly successful in engaging a wide 
public using more emotive queues.
Both the more cognitive and the more affective aspects have 
been reviewed, regarding climate change, in a model – the 
‘Dragons of Inaction’66. Stemming from the risk perception 
ield, a burgeoning risk communication ield has produced a 
set of key principles for effective risk communication.67 This 
includes use of images and human stories to convey risk, 
rather than numbers.
Box 11  Why risk information should not 
form the central aspect of a risk 
communication: Dual Processing
Communications to change health-related awareness 
and behaviours traditionally rest on the assumption that 
if experts can provide the public with information in an 
absorbable format, the information will then be known 
and heeded. However, this model suffers a number of 
problems addressed by the Psychology of Risk over the 
past half century. Most recently, within Psychology, there 
has been vociferous rejection of the importance of health 
risk information’s potential to change awareness and, 
especially, behaviour. This is based on dual-process models 
that advocate that human behaviour is shaped by two 
systems: one more non-conscious, automatic and affective 
and another more deliberative and rational. This idea, 
popularised in Kahneman’s68 ‘Thinking fast and slow’, sees 
the irst characterised by habit, impulse and emotion and 
the second as more consciously cognitive. Recent work 
in the risk sphere talks not just of the existence of the 
separate automatic/emotive and deliberative dimensions 
but of a sequence: ‘feeling before thinking’.69 The thesis 
that the irst type is more primary when humans process 
risks is increasingly supported by neuroscience.70
Numerical risk communications, therefore, are likely to 
be processed by the secondary, deliberative system, 
which is the less inluential of the two systems. The 
empirical evidence for this is strong: two major reviews of 
health-related risk interventions found that information, 
even when given in a highly personalised form, had no 
perceptible effect on the targeted behaviour.71,72 Marteau 
et al.73 advocate that environmental cues can therefore 
be used to change health-related behaviours as such 
change occurs at a non-conscious level – not amenable to 
information. However, one might argue, especially with 
promising communication effects seen in interventions 
with visual elements,74 that another way of inluencing the 
non-conscious is persuasion via visuals, with their tendency 
to be more emotionally evocative than textual and verbal 
messages.75
The take home message is that risk information should not 
be a central aspect of risk communication to the public 
and that messages that speak to non-conscious affective 
systems are more likely to be effective.
Helene Joffe, Professor of Psychology, University College 
London
Annual Report of the Chief Medical Oficer 2017, Health Impacts of All Pollution – what do we know? Chapter 9 page 17
Measurement and communication of health risks from pollution
Box 12  How do people living in cities 
experience pollution? A Liveable 
Cities perspective from London and 
Birmingham dwellers
Using a novel, free association technique76 that taps more 
latent factors than survey techniques do, we set out to 
examine aspirations for future cities in matched samples 
of people who dwell in the UK’s two largest cities: London 
and Birmingham.77 When we tapped the naturalistic, 
stored and arguably less conscious (and more primary, 
see Box 11) conceptualisations, the wish for clean air 
featured prominently regarding desired aspects of future 
cities. When the city dwellers elaborated on their free 
associations in interviews that followed the task, transport, 
both public and private, was seen to be a source of 
pollution and dirt which evoked strong feelings of disgust. 
Disgust was associated with air pollution’s sensory assault 
rather than with concern for its environmental impact or 
worry about its fatal consequences. 
This intense dislike of pollution and exaltation of clean air 
could be garnered in efforts to reduce harmful emissions. 
Research demonstrates that disgust can be used highly 
effectively in risk communications to change risky health 
behaviours. In relation to smoking, in particular, exposure 
to disgusting messages, for example on cigarette 
packets, seems to reduce smoking behaviour. The use of 
graphic cigarette packaging warning labels in Canadian 
smokers, lead to 20% of the sample reporting smoking 
less as a result of the labels and 63% reporting at least 
one cessation beneit.78 Similar results regarding hand 
hygiene in Australian experimental and ield-based tests,79 
demonstrate that even brief disgust-based communications 
are effective. It is not only the emotional tone of disgust 
that is at work in graphic cigarette packaging warning 
labels but a visual, rather than textual or verbal, approach 
to communication (see Box 11). Emotive images play an 
effective role in communicating risk to the public.
Helene Joffe, Professor of Psychology, University College 
London
Box 13  A successful risk intervention in 
public health: The Swiss Stop AIDS 
campaign
The Swiss Stop AIDS campaign began in 1987 and is 
ongoing, having broadened out to the host of sexually 
transmitted infections. The campaign has provided 
amusing, surprising, seductive visuals, as well as 
communications regarding the need for social solidarity, 
loving life and valuing of quality of life. This highly 
positively toned campaign has been accompanied by a 
vast and sustained increase in condom sales and condom 
use, with major health effects including a reduction in 
AIDS and sexually transmitted infections rates as a whole. 
Condom use in the Swiss public increased from 8% when 
the campaign irst started in 1987 to 60% in 1992.80,81
Persuasion was brought about by emotions such as 
humour, surprise and stressing the joy of life, as well 
as by calling for identiication with people with AIDS 
rather than psychological (or spatial) distancing from 
them. Such distancing plays a major role in people’s dis-
identiication from (and therefore dismissing of) a host of 
risk communications.82,83 This central insight has now been 
adopted in a new generation of studies testing how to 
induce people to identify more with risk communications. 
One might argue that The Swiss Stop AIDS campaign’s 
emotive visuals appealed primarily to the more emotive 
system of processing messages, rather than to the 
deliberative, rational system (see Box 11). It also, unusually, 
inserted its messages into commercial advertisements, 
for example, by inserting its symbol, a pink condom, 
into the Volkswagen symbol and so mixed public health 
broadcasting with private sector advertising.
This highly individual, closely evaluated campaign, 
with its strong emphasis on visual, emotive content 
demonstrates the potential for positively-valenced emotive 
communications (i.e. those communications tending to 
elicit ‘positive’ feelings’) to facilitate absorption of risk 
messages.
Helene Joffe, Professor of Psychology, University College 
London
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Behaviour change theory
Theories of behaviour change are also relevant to the 
communication of pollution’s health risks. In the ascendant 
within this domain is the COM-B model84, which posits that 
in order for behaviours to be taken on or changed, people 
need to have the capability, opportunity and motivation. 
Here, aspects like people’s sense of self-eficacy affect their 
capability. Interestingly the risk communication and behaviour 
change literatures operate independently yet both would be 
enriched by the insights of the other.
While there has been widespread recognition of the limited 
role that information plays in changing health-related 
behaviours85, it remains important to know what the 
numbers say. Awareness of the objective risk is a necessary 
though far from suficient condition for behaviour change. 
Knowledge of the scale of a problem is central for policy 
makers, who must allocate resources on this basis. That said, 
a range of interests make it dificult for even the most severe 
risks to become prominent policy concerns. A concept of 
the different information needs of policy-makers and more 
general audiences is behind COMEAP’s recommendation of 
different measures of health impact for different audiences 
(see Boxes 9 and 10). Research-based insights into effective 
ways of conveying information on health risks do exist and 
should be used where appropriate. 
Communicating complexity
The scientiic position on health risks from most pollution 
sources is complex and involves serious uncertainty. Therefore 
the question arises as to how far to reduce this complexity 
in communicating the risks. There has been considerable 
research and discussion into the most appropriate numerical 
measures to use in communicating health risks from air 
pollution. Gigerenzer’s approach86 does use numbers, 
but in ways that have been demonstrated to be more 
comprehensible. COMEAP proposed using different numerical 
measures for different purposes, and this has arguably had 
important impacts on how the risks are communicated 
(see Boxes 5 and 6). Communications from bodies such 
as COMEAP do not usually go directly to the public. This 
can introduce error. COMEAP’s recommended wording for 
numbers of attributable deaths from air pollution, “an effect 
equivalent to a speciic number of deaths at typical ages”, 
seems not to be popular, unfortunately. Re-use and reporting 
of their conclusions largely omits their caveats.
While there is substantial uncertainty concerning the true 
magnitude of health impacts of air pollution (see Box 6), the 
high chance that there are substantial effects means that 
there is suficient justiication for mitigating actions. This can 
be communicated informally or in more formal sensitivity 
analysis in a cost-beneit model.
Next steps
The importance of engaging the public (and service users) in 
research and service development on health matters is clear 
in relation to risk communication.42 Despite some excellent 
exemplars (see Box 7), in developing a shared understanding 
of the communication of quantitative information and use 
of emotion, such engagement is not as common as it ought 
to be. In the longer term, improvements in education on 
the environment, pollution and its health consequences, 
particularly at school level, can be an important step in 
increasing public awareness and engagement, though it does 
not remove the need to consider emotion and motivation in 
promoting behaviour change.
Finally, a key aspect of effective communication of 
information based on scientiic research, of whatever kind, 
is the trust placed in the research and in its communicators. 
It must be remembered that it is the audience that 
decides whether a communicator or information source is 
trustworthy, not the communicator. Trust in science and 
scientists and in Government, is not always high.42 Openness 
and transparency are ways to help audiences to judge 
trustworthiness. The key aim should be for a communicator 
to provide evidence in a form such that its trustworthiness 
can be assessed87,88 – in that it makes sense to the audience, 
and they can see the evidence and act on it where necessary. 
Trust requires a relationship between the parties involved – 
another reason why more emotive, experiential aspects need 
to enter the communication. 
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Authors’ suggestions for 
policy makers
  The involvement of several research disciplines and 
traditions in measuring the health effects of pollution 
is valuable and inevitable given the complexity of the 
ield. However, there is a clear need for more funding 
and coordination of interdisciplinary work on such 
measurement, potentially also linking measurement to 
communication. This should also include research into 
effective methods for synthesising information and 
evidence from different research traditions. Responsibility 
thus far has been divided between several research 
councils (at least EPSRC, MRC, ESRC, NERC) as well as 
Government departments (Department for Environment, 
food and Rural Affairs, Department of Health and Social 
Care, and others). The start-up of UKRI provides an 
opportunity for better coordination and particularly for 
removing some of the barriers that have stood in the way 
of interdisciplinary and multi-disciplinary research.
  Public engagement has not been as prominent or 
routine in research on health effects of pollution and on 
communication of the health risks and calls for action, 
as in many other areas of health research and service 
development. In particular, there is a need for more direct 
research that engages with the public on communication 
needs and methods. There are successful examples of such 
work that can be learned from, particularly in relation to 
air quality and (in another context) lood risk.
  Ways of communicating risk have differed, in their general 
approach and in the kinds of information, between 
pollutants, between health risks from pollution and other 
health risks and (arguably) between health risks and other 
risks to public safety. While the diversity of this approach 
is a good thing, given the importance of context in 
communication and given the different audiences involved, 
we do wonder whether there is suficient awareness 
across Government of the successes (or otherwise) of risk 
communication in different areas. The 2014 Government 
Chief Scientiic Adviser’s report41 is an excellent basis 
for such co-operation, but are enough internal channels 
of communication in place to share good practice 
consistently?
Conclusion 
The measurement and communication of health risks from 
pollution is inevitably complex. Interactions can be complex, 
both between the pollutants themselves and between the 
various research disciplines that are necessary to cover the 
wide ield. Good progress is being made and must continue 
to be made, given the level of the threat to the public health 
and the need to allow desired activities that may pollute, to 
continue in an appropriate manner. Further opportunities 
for collaboration and coordination in measurement must, 
however, be promoted.
To communicate, we need evidence from measurement, but 
communication is never just a matter of getting the evidence 
across. Given a good understanding of the audience and 
the reasons for communication, it is important to realise that 
psychological insights into communication and behaviour 
change do not apply only to ways of helping the public to 
change behaviour, but can also inform the implementation of 
policy, particularly where there are multiple agents involved. 
Whatever the audience, effective communication requires 
trust and trust requires a real and transparent relationship 
between those concerned.
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